{"title":"Medicines for Constipation, Bloating and Difficult Digestion","description":"\u003cp\u003eOver-the-counter medications and medical devices to promote regular bowel movements and support digestion. Osmotic laxatives, emollients, stimulants and suppositories for the treatment of occasional or chronic constipation. Digestives, enzymes, simethicone and products against bloating and aerophagia to improve gastrointestinal function. Suitable for adults, children or the elderly, even in the presence of intestinal sensitivity. Fast shipping in 24\/48 hours.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e","products":[{"product_id":"buscopan-40-compresse-rivestite-10-mg","title":"Buscopan 40 Coated Tablets 10 mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuscopan\u003c\/span\u003e\u003cspan\u003e is a drug used to treat cramps and abdominal pain, particularly those related to gastrointestinal and urinary tract disorders. The active ingredient, \u003c\/span\u003e\u003cspan\u003ebutylscopolamine bromide\u003c\/span\u003e\u003cspan\u003e, acts as an antispasmodic, relaxing the smooth muscles of the gastrointestinal and urinary tract, thus reducing pain and discomfort. Thanks to its localized action, Buscopan is effective in the treatment of intestinal spasms, colic and similar disorders\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuscopan is indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e\u003cspan\u003eSymptomatic treatment of abdominal cramps\u003c\/span\u003e\u003cspan\u003e and pain caused by gastrointestinal spasms.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e\u003cspan\u003eRelief of pain from renal and biliary colic\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e\u003cspan\u003eTreatment of spasms and pain related to urinary tract disorders\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Buscopan 40 Coated Tablets 10 mg used? What is it for?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eSymptomatic treatment of spastic-painful manifestations of the gastrointestinal tract.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Buscopan 40 Coated Tablets 10 mg?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eCoated tablets, one coated tablet contains: Hyoscine N-butylbromide 10 mg. Excipients: sucrose. Suppositories, one suppository contains: Hyoscine N-butylbromide 10 mg. For the complete list of excipients see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eCoated tablets; core: calcium hydrogen phosphate, corn starch, soluble starch, anhydrous colloidal silica, tartaric acid, stearic acid. Coating: povidone, sucrose, talc, gum arabic, titanium dioxide (E171), macrogol 6000, carnauba wax, white wax. Suppositories: solid semi-synthetic glycerides.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow is Buscopan 40 Coated Tablets 10 mg taken?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage: the following dosages are recommended for adults and children over 14 years of age. Coated tablets: 1-2 coated tablets 3 times a day. Suppositories: 1 suppository 3 times a day. Single doses can be increased according to the doctor's judgment. In pediatrics, children between the ages of 6 and 14 must follow the doctor's prescription exactly. Method of administration: the tablets must be taken whole with an adequate quantity of water. Buscopan should not be taken daily on a regular basis or for prolonged periods without investigating the cause of abdominal pain.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Buscopan 40 Coated Tablets 10 mg not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to the active substance or to any of the excipients. Acute angle glaucoma. Prostatic hypertrophy or other causes of urinary retention. Pyloric stenosis and other conditions that stenose the gastrointestinal tract. Mechanical stenosis of the gastrointestinal tract. Paralytic or obstructive ileus. Megacolon. Ulcerative colitis. Reflux esophagitis. Intestinal atony in the elderly and debilitated subjects. Myasthenia gravis. Children under 6 years of age. In case of rare hereditary conditions of incompatibility with one of the excipients (see section 4.4 \"\"Special warnings and precautions for use\"\"), the use of the medicine is contraindicated.\u003c\/span\u003e\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eMany of the side effects listed can be attributed to the anticholinergic properties of Buscopan. The anticholinergic side effects of Buscopan are generally mild and self-limiting. Immune system disorders. Uncommon frequency: skin reactions, urticaria, itching; frequency not known*: anaphylactic shock, anaphylactic reactions, dyspnoea, skin rash, erythema and other manifestations of hypersensitivity. *These adverse reactions have been observed in post-marketing experience. At 95% probability, the frequency category is no higher than uncommon (3\/1368), but could be lower. A precise estimate of the frequency is not possible since these adverse reactions did not occur in 1368 patients in clinical trials. Cardiac diseases. Uncommon frequency: tachycardia. Gastrointestinal disorders. Uncommon frequency: dry mouth. Constipation was also observed. Pathologies of the skin and subcutaneous tissue. Uncommon frequency: alterations in sweating. Renal and urinary disorders. Rare frequency: urinary retention. The following side effects have also been observed. Eye disorders: mydriasis, accommodation disorders, increased ocular tone. Nervous system disorders: drowsiness. High doses may cause signs of central stimulation and more serious signs of interference with the nervous system, the state of consciousness and cardiorespiratory function. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eINTERACTIONS\u003c\/h2\u003e\n\u003ch3\u003eWhich medicines or foods can modify the effect of Buscopan 40 Coated Tablets 10 mg?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eanticholinergic drugs such as tri- and tetracyclic antidepressants, phenothiazines, butyrophenones, antihistamines, antipsychotics, quinidine, amantadine, diisopyramide and other anticholinergics (e.g. tiotropium, ipratropium and atropine-like compounds) may be accentuated by Buscopan. Concomitant treatment with dopamine antagonists, such as metoclopramide, can lead to a reduction in the impact of both drugs on the gastrointestinal tract. Tachycardia induced by beta-adrenergic drugs may be accentuated by Buscopan. Do not drink alcohol during therapy. Because antacids may reduce the intestinal absorption of anticholinergics, these drugs should not be administered simultaneously.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Buscopan 40 Coated Tablets 10 mg be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eLimited data are available regarding the use of hyoscine N-butylbromide in pregnant women. Animal studies do not indicate direct or indirect harmful effects of reproductive toxicity (see section 5.3). There is insufficient information on the excretion of Buscopan and its metabolites in human milk. As a precautionary measure, it is preferable to avoid the use of Buscopan during pregnancy and breastfeeding. No studies on the effects on human fertility have been conducted (see section 5.3).\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Buscopan 40 Coated Tablets 10 mg?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eIf you experience severe abdominal pain of unknown cause, that persists or worsens, or that occurs together with other symptoms such as fever, nausea, vomiting, changes in bowel movement, abdominal tenderness, decreased blood pressure, fainting or blood in the stool, you should contact your doctor immediately. Anticholinergics should be used with caution in the elderly, in patients with disorders of the autonomic nervous system, in cardiac tachyarrhythmias, in arterial hypertension, in congestive heart failure, in hyperthyroidism and in patients with liver and kidney disease. Due to the potential risk of complications related to an excessive anticholinergic effect, caution should be exercised in patients subject to acute-angle glaucoma as well as in patients susceptible to intestinal and urinary stasis and in those prone to tachyarrhythmias. Anticholinergics may prolong gastric emptying time and cause antral stasis. Because of the possibility that anticholinergics may reduce sweating, Buscopan should be administered with caution in patients with pyrexia. Treatment with high doses should not be abruptly stopped. Minor side effects can be controlled by appropriately reducing the dose; the appearance of important secondary manifestations requires the interruption of therapy. A 10 mg coated tablet contains 41.2 mg of sucrose equal to 247.2 mg per maximum recommended daily dose. Therefore patients suffering from rare hereditary problems of fructose intolerance should not take this medicine.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Buscopan 40 Coated Tablets 10 mg stored?\u003c\/h3\u003e\u003cp dir=\"ltr\"\u003e\u003cspan\u003eCoated tablets: this medicine does not require any special storage conditions. Suppositories: Do not store above 30 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Buscopan 40 Coated Tablets 10 mg?\u003c\/h3\u003e\u003cp\u003e40 Coated Tablets 10 mg\u003c\/p\u003e\n\u003ch2\u003eDRUG LEGAL TEXT\u003c\/h2\u003e\n\u003cp\u003eContent responsibility\u003c\/p\u003e\u003cp\u003eThis sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.\u003c\/p\u003e\u003cp\u003ePlease note\u003c\/p\u003e\u003cp\u003eThe product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.\u003c\/p\u003e\u003cp\u003eData source: Farmadati Italia\u003c\/p\u003e\u003cp\u003eWebsite: www.farmadati.it\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO\/IEC 27001:2017 for information security management systems.\u003c\/p\u003e","brand":"Sanofi","offers":[{"title":"Default Title","offer_id":40207822454899,"sku":"006979088","price":17.01,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sanofi-spa-buscopan-40-compresse-rivestite-10-mg-farmacia-dottor-tili-1213792764.jpg?v=1767125423"},{"product_id":"pursennid-30-compresse-lassative-12-mg","title":"Pursennid 40 Laxative Tablets 12 mg","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne coated tablet contains: - Active ingredient: sennosides A + B (as calcium salts) 12 mg. - Excipients with known effects: lactose monohydrate; anhydrous glucose; sucrose. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eLactose monohydrate\u003c\/b\u003e; stearic acid; talc; corn starch; \u003cb\u003eanhydrous glucose\u003c\/b\u003e; \u003cb\u003esucrose\u003c\/b\u003e; gum arabic; anhydrous colloidal silica; titanium dioxide; cetyl palmitate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Contraindicated if the following medical conditions exist: - Inflammatory diseases of the digestive system (i.e. Crohn's disease, ulcerative colitis, liver disease, peritonitis and inflammatory intestinal diseases); - Irritation or obstruction of the gastrointestinal tract (i.e. spastic constipation, obstruction of the ileum\/preileum, cramps and pain, nausea, vomiting and colic); - Abdominal symptoms that may be due to an undiagnosed underlying condition, such as acute intestinal conditions that may require surgery (i.e. acute diverticulitis, appendicitis and massive diarrhea); - states of severe dehydration, with loss of water and electrolytes, especially hypokalemia. Contraindicated in children under 10 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDosage\u003c\/b\u003e Adults and children over 12 years of age: 2-4 coated tablets per day. Children between 10 and 12 years: 1-2 coated tablets per day. After a short period of treatment without appreciable results, consult your doctor. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. \u003cb\u003ePediatric population\u003c\/b\u003e Contraindicated in children under 10 years of age. \u003cb\u003eMethod of administration\u003c\/b\u003e Take preferably in the evening. The action of Pursennid occurs after 6-12 hours. Administered in the evening, the effect of Pursennid appears the following morning. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe established dose must not be exceeded. Prolonged indiscriminate use of laxatives can lead to addiction and a deterioration of intestinal functions. The lowest effective dosage should be used to restore normal intestinal function. If no improvement has been achieved in the intestine, the dosage can be increased under medical supervision. Products containing senna and sennosides should only be used if a therapeutic effect cannot be achieved through a change in diet or the administration of bulking agents. The use of these drugs requires medical supervision: - if there are no positive effects following the treatment; - if use is prolonged beyond one week of treatment; - if symptoms persist or worsen; - after a laparotomy or abdominal surgery; - if a skin rash is present, because it can be a sign of hypersensitivity; - if nausea and vomiting are present, because these symptoms may be signs of a potential or existing intestinal blockage (ileus); - in children between 10 and 12 years old. \u003cu\u003eInformation relating to excipients\u003c\/u\u003e - Lactose: patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine. - Glucose: patients suffering from rare problems of glucose-galactose malabsorption should not take this medicine. - Sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant use of other drugs that induce hypokalemia (i.e. diuretics, adrenocorticosteroids and licorice) may increase electrolyte imbalance. Hypokalemia (resulting from abuse of laxatives taken for a long time) enhances the action of cardiac glycosides and interferes with antiarrhythmic drugs, with other drugs that induce the return to sinus rhythm (quinidine) and with drugs that induce prolongation of the Q-T interval.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine may cause mild abdominal discomfort such as abdominal pain, cramps, irritation of the colonic and gastric mucosa. Other effects such as dehydration, hypotension, fatigue, myopathies, stomach pain, hyponatremia, renal disorders, secondary hyperaldosteronism, hypocalcemia and hypomagnesemia have also been reported. These adverse reactions are usually reversible once you stop taking the laxative. Prolonged use or overdose of this drug may cause nausea, diarrhea with excessive loss of electrolytes, especially potassium (hypokalemia). There is also the possibility of developing megacolon. During treatment, a yellow-brownish coloration (pH-dependent) of the urine may occur due to metabolites, which has no clinical significance. Habituation has been reported after prolonged treatment. Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: \u003ci\u003every common\u003c\/i\u003e (≥ 1\/10), \u003ci\u003ecommon\u003c\/i\u003e (≥ 1\/100, \u0026lt; 1\/10); \u003ci\u003euncommon\u003c\/i\u003e (≥ 1\/1.000, \u0026lt; 1\/100); \u003ci\u003erare\u003c\/i\u003e (≥ 1\/10.000; \u0026lt; 1\/1.000); \u003ci\u003every rare\u003c\/i\u003e (\u003c 1\/10,000), or \u003ci\u003enot known\u003c\/i\u003e (frequency cannot be estimated from the available data). \u003cb\u003eTable 4-1 Undesirable effects in the post-marketing experience \u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypersensitivity reactions (itching, urticaria, local or generalized rash).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Megacolon.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Nausea.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Fatigue.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Drug tolerance.\u003c\/p\u003e\n\u003cp\u003ePathologies of the musculoskeletal system and connective tissue.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Myopathy.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Kidney problems.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Chromaturia.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hyperaldosteronism.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypocalcemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypomagnesemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Dehydration.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypokalemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hyponatremia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Decreased blood electrolytes.\u003c\/p\u003e\n\u003cp\u003eVascular pathologies.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypotension.\u003c\/p\u003e\n\u003cp\u003eThe adverse events listed above are based on spontaneous post-marketing reports and represent a less precise estimate of the incidence that would be obtained in clinical trials. \u003cb\u003ePediatric population\u003c\/b\u003e The same frequency, type and severity of adverse events are expected in children and adults. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e The most important symptoms related to overdose\/excessive use are abdominal colic and severe diarrhea resulting in losses of fluids and electrolytes, which must be replaced. Diarrhea especially can cause potassium loss, which can lead to cardiac disorders and muscular asthenia, particularly when cardiac glycosides, diuretics, adrenocorticosteroids or licorice root are administered at the same time. \u003cb\u003eManagement\u003c\/b\u003e Treatment must be supportive with generous quantities of fluids. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. Chronic overdose of anthraquinone drugs can cause toxic hepatitis. Further treatment modalities should take into account clinical indications or poison control center recommendation, where available.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate data on the use of sennosides in pregnant women. Animal studies have not shown reproductive toxicity. The potential risk for humans is unknown. Pregnant women should consult their doctor before taking this medicine. \u003cu\u003eBreastfeeding\u003c\/u\u003e Use during breastfeeding is not recommended as there are insufficient data on the excretion of the metabolites in breast milk. Small quantities of metabolites (rein) are excreted in breast milk. No laxative effect has been reported on breast-fed infants. \u003cu\u003eFertility\u003c\/u\u003e Preclinical studies with sennosides do not indicate particular risks for fertility at therapeutically relevant doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine has no or negligible influence on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Gsk","offers":[{"title":"Default Title","offer_id":40207823732851,"sku":"004758025","price":12.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/glaxosmithkline-c-health-spa-pursennid-30-compresse-lassative-12-mg-farmacia-dottor-tili-1213792748.jpg?v=1767125872"},{"product_id":"glicerolo-carlo-erba-18-supposte-2250-mg","title":"Glycerol Carlo Erba 18 Suppositories 2250 mg.","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL CARLO ERBA Early childhood 900 mg suppositories\u003c\/i\u003e An early childhood suppository contains: active ingredient: Glycerol 900 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 1375 mg\u003c\/i\u003e \u003ci\u003esuppositories\u003c\/i\u003e One children's suppository contains: active ingredient: Glycerol 1375 mg. \u003ci\u003eGLYCEROL CARLO ERBA Adults 2250 mg suppositories\u003c\/i\u003e An adult suppository contains: active ingredient: Glycerol 2250 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 2.25 g. \u003ci\u003eGLYCEROL CARLO ERBA Adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 6.75 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSuppositories\u003c\/u\u003e: sodium stearate; sodium carbonate. \u003cu\u003eRectal solution\u003c\/u\u003e: chamomile fluid extract; mauve fluid extract; wheat starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active ingredient or to any of the excipients; • acute abdominal pain or pain of unknown origin; • nausea or vomiting; • intestinal obstruction or stricture; • rectal bleeding of unknown origin; • acute hemorrhoidal crisis with pain and bleeding; • severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eSuppositories\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2 – 11 years\u003c\/u\u003e: 1 suppository for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 1 month and 2 years\u003c\/u\u003e: 1 early childhood suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cb\u003eRectal solution\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 6 – 11 years\u003c\/u\u003e: 1 or 2 single-dose containers for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 2 – 6 years\u003c\/u\u003e: 1 single-dose container for children as needed for a maximum of 1 or 2 administrations per day. \u003cu\u003eMethod of administration\u003c\/u\u003e \u003cu\u003eSuppositories\u003c\/u\u003e: Remove the suppository from its container and then, if necessary, moisten it to facilitate rectal introduction. If the suppositories appear softened, immerse the containers in cold water before opening them. \u003cu\u003eRectal solution\u003c\/u\u003e: To remove the safety cannula cover from the single-dose container, place your index finger and thumb on the round ring placed above the bellows and, with the other hand, bend the cannula cover until it detaches from the body of the container. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥1\/10; Common ≥1\/100, \u003c1\/10; Uncommon ≥1\/1,000, \u003c1\/100; Rare ≥1\/10,000, \u003c1\/1,000; Very rare \u003c1\/10,000; Not known (frequency cannot be estimated from the available data). The available data are insufficient to establish the frequency of the individual effects listed.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known: Cramp-like pain in the abdomen*; abdominal colic, diarrhea**, anal irritation.\u003c\/p\u003e\n\u003cp\u003e*usually isolated ** with loss of fluids and electrolytes Isolated cramping pain or abdominal colic and diarrhea are more frequent in cases of severe constipation. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \"www.agenziafarmaco.gov.it\/it\/responsabili\".\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives – frequent or prolonged use or with excessive doses) can cause abdominal pain and persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more serious cases, the onset of dehydration or hypokalaemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlycerol has no influence on the ability to drive vehicles and use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Carlo Erba","offers":[{"title":"Default Title","offer_id":40207823896691,"sku":"029651039","price":6.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/carlo-erba-otc-srl-glicerolo-carlo-erba-18-supposte-2250-mg-farmacia-dottor-tili-1213792744.jpg?v=1767125952"},{"product_id":"verolax-ad-rettale-6-clismi-6-75g","title":"Verolax AD Rectal 6 Enemas 6.75g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConstipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eVerolax “6.75 g Adults Rectal Solution” 6 Single-dose Containers 9 G\u003c\/i\u003e: Each 9G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 6.75 g \u003ci\u003eVerolax “2.25 g Children Rectal Solution” 6 Single-dose Containers 3 G\u003c\/i\u003e: Each 3G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “2.25 g Adult Suppositories” 18 Suppositories\u003c\/i\u003e:Each adult suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “1,375 g Children Suppositories” 18 Suppositories\u003c\/i\u003e: Each children's suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 1.375 g \u003ci\u003eVerolax “0.675 g Infant Suppositories” 12 Suppositories\u003c\/i\u003e: Each infant suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 0.675 g\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution for adults and children:\u003c\/i\u003e Mallow fluid extract; Chamomile fluid extract; Wheat starch; Purified water. \u003ci\u003eSuppositories Adults, Children, Infants:\u003c\/i\u003e Sodium stearate, Sodium carbonate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndividual hypersensitivity confirmed towards the product. Anorectal diseases, hemorrhagic rectocolitis and inflammation of hemorrhoids. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution:\u003c\/i\u003e 1 or 2 single-dose containers in 24 hours. In case of stubborn constipation, no more than 2 doses can be introduced into the rectum at the same time. \u003ci\u003eSuppositories:\u003c\/i\u003e 1 suppository as needed. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe continuous use of laxatives can cause addiction or damage of various types. Do not use laxatives if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interactions with other drugs have been found. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe only effects that may be encountered are irritative, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking the drug does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Angelini","offers":[{"title":"Default Title","offer_id":40207824453747,"sku":"026525055","price":5.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-verolax-ad-rettale-6-clismi-6-75g-farmacia-dottor-tili-1254215759.jpg?v=1786737460"},{"product_id":"lattulosio-sand-sciroppo-180-ml","title":"Lactulose Sand Syrup 180 ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation. \u003cu\u003eAdults:\u003c\/u\u003e occasional constipation; adjuvant in intestinal bacterial diseases caused by coliform germs (Salmonella, Shigella, etc.) \u003cu\u003eChildren and infants:\u003c\/u\u003e constipation; treatment of putrefactive syndromes due to eating disorders; as a corrective to the infant's diet, especially in the transition from maternal to artificial breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e66.7% syrup, 180 ml bottle\u003c\/u\u003e 100 ml of syrup contains 66.7 g of lactulose Excipients with known effect: 100 ml of syrup contains 0.118 g of sodium benzoate. For the complete list of excipients see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003esodium benzoate; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects suffering from galactosemia. Generally contraindicated in pediatric age (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage \u003cu\u003eAdults: \u003c\/u\u003ethe average daily dosage is 10-15 g in two administrations. This dosage can be doubled or halved depending on the individual response or clinical picture. Pediatric population \u003cu\u003eChildren:\u003c\/u\u003e from 2.5 to 10 g\/day, even in a single administration, depending on the age and severity of the case. \u003cu\u003eInfants:\u003c\/u\u003e on average 2.5 g per day. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSpecial warnings\u003c\/u\u003e Lactulose is absorbed to a very small extent and has no caloric value. However, in addition to lactulose, Lactulose Sandoz also contains galactose, lactose and small quantities of other sugars. This must be taken into account in the treatment of diabetic patients and in patients following low-calorie diets. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cu\u003ePrecautions for use\u003c\/u\u003e Do not use the medicine if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult a doctor. In patients who present disorders caused by excessive intestinal meteorism it is advisable to start treatment with the minimum doses indicated; these doses can be gradually increased in relation to the patient's response. In children under 12 years of age the medicine can only be used after consulting a doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of medicines and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003cb\u003e \u003cu\u003eImportant information about some excipients\u003c\/u\u003e \u003c\/b\u003e Lactulose Sandoz contains 26.4 mg of sodium benzoate per average daily dose equivalent to 0.14 mg\/ml. Sodium benzoate may increase jaundice (yellowing of the skin and eyes) in newborns up to 4 weeks of age. The increase in bilirubin following its detachment from albumin can increase neonatal jaundice which can progress to kernicterus (deposits of unconjugated bilirubin in the brain tissue). Lactulose Sandoz contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBroad-spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce degradation, limiting the possibility of acidification of the intestinal contents and consequently the therapeutic efficacy. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other medicines administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Occasionally: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. Frequency not known: flatulence. Immune system disorders: Frequency not known: hypersensitivity reactions. Skin and subcutaneous tissue disorders: Frequency not known: rash, itching, urticaria. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLactulose sandoz does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Sandoz","offers":[{"title":"Default Title","offer_id":40207839035507,"sku":"027668019","price":7.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sandoz-lattulosio-sand-sciroppo-180-ml-farmacia-dottor-tili-1254215794.jpg?v=1786737131"},{"product_id":"aboca-sollievo-fisiolax-90-compresse","title":"Aboca Relief Fisiolax 90 Tablets","description":"\u003cp\u003eAboca Sollievo Fisiolax is a medical device based on senna, chicory, fennel, dandelion, caraway and cumin. It works with a \u003cstrong\u003elaxative effect in case of constipation\u003c\/strong\u003e, protects the intestinal mucosa from inflammation and irritation, \u003cstrong\u003enaturally stimulates intestinal motility\u003c\/strong\u003e promoting the \u003cstrong\u003eintestinal contractions\u003c\/strong\u003e and drawing water into the intestine for \u003cstrong\u003esoften the stool and facilitate evacuation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe action of Aboca Sollievo FisioLax is obtained thanks to the set of natural active ingredients that act on the functions used by the intestine to regulate transit. These determine a natural laxative action, a propulsive effect on intestinal transit and a protective effect on the intestinal mucosa as Aboca Sollievo FisioLax:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCause a \u003cstrong\u003eincreased intestinal motility\u003c\/strong\u003e, promoting the contraction of the intestine.\u003c\/li\u003e\n\u003cli\u003eIt favors the\u003cstrong\u003ehydration of feces\u003c\/strong\u003e, reducing the reabsorption of water in the intestine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForms a barrier\u003c\/strong\u003e which adheres to the intestinal mucosa for a \u003cstrong\u003ecomplete protection of the intestinal wall.\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModulates inflammation\u003c\/strong\u003e which is counteracted by the protective barrier of the mucosa\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMethod of use and dosage of Aboca Sollievo Fisiolax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAverage analysis 1 tablet Aboca Sollievo FisioLax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFisiolax Relief Complex 420mg\u003cbr\u003ePolyphenolic complex with flavonoids and sennosides ≥ 3.1%\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWarnings and Contraindications Aboca Sollievo Fisiolax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Aboca Sollievo Fisiolax 90 Tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on senna, chicory, fennel, dandelion, caraway and cumin, indicated for the relief of constipation; promotes intestinal motility and hydration of feces, exerting a protective action on the intestinal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Aboca Sollievo Fisiolax 90 Tablets contain?\u003c\/h3\u003e\u003cp\u003eFisiolax Relief Complex (senna, chicory, fennel, dandelion, caraway and cumin).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAverage values for 1 tablet\u003c\/strong\u003e\u003cbr\u003eFisiolax Relief Complex (obtained from senna, chicory, fennel, dandelion, caraway and cumin): 420 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003eIt is recommended to take 1 to 3 tablets in the evening, when you feel they are useful, with a large glass of water. The correct dosage is the minimum sufficient to promote physiological intestinal transit without producing liquid stools, and can therefore be customized according to individual needs. In general, to promote intestinal transit, it is recommended to drink throughout the day, take the right amount of fiber and do physical activity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eDo not exceed the maximum recommended dose.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eIn case of persistent constipation, it is important to consult your doctor.\u003cbr\u003eThe product is recommended from 12 years of age.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Aboca Sollievo Fisiolax 90 Tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, in a cool, dry place away from light.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003eBottle containing 90 tablets of 420 mg\u003cbr\u003eNet Weight: 37.8g\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":40720992665715,"sku":"981920933","price":19.07,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/aboca-spa-societa-agricola-aboca-sollievo-fisiolax-90-compresse-farmacia-dottor-tili-1213792520.jpg?v=1767131052"},{"product_id":"laevolac-sciroppo-stitichezza-180-ml","title":"Laevolac Constipation Syrup 180 ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLAEVOLAC 66.7 g\/100 ml syrup 100 ml of syrup contain: active ingredient: lactulose 66.7 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSyrup: none.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• Hypersensitivity to lactulose or to any of the excipients listed in section 6.1. • Acute abdominal pain or pain of unknown origin, • nausea or vomiting, • intestinal obstruction or stenosis, • rectal bleeding of unknown origin, • severe dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eDosage\u003c\/i\u003e The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is recommended to initially use the minimum doses envisaged. Do not exceed the maximum recommended daily dose. \u003cb\u003eAdults \u003c\/b\u003e The recommended dose is 15 - 30 ml (corresponding to 10 - 20 g of lactulose) to be taken in one or two administrations per day. When necessary the dose can be increased. The maximum daily dose is 45 ml (corresponding to 30 g of lactulose). \u003cb\u003eAdolescents and children ≥ 10 years \u003c\/b\u003e The recommended dose is 15 ml (corresponding to 10 g of lactulose) to be taken in one or two doses per day. The maximum daily dose is 15 ml. \u003cb\u003eChildren 5 - \u003c 10 years\u003c\/b\u003e The recommended dose is 10 ml (corresponding to 6.67 g of lactulose) to be taken in one or two administrations per day. The maximum daily dose is 10 ml. \u003cb\u003eChildren \u003e1 - \u003c 5 years\u003c\/b\u003e The recommended dose is 5 ml (corresponding to 3.33 g of lactulose) to be taken in one or two administrations per day. The maximum daily dose is 5 ml. \u003cb\u003eChildren 1 month - 1 year\u003c\/b\u003e The recommended dose is 2.5 ml (corresponding to 1.66 g of lactulose) to be taken in a single administration in the evening. The maximum daily dose is 2.5 ml. \u003ci\u003eDuration of treatment\u003c\/i\u003e Laxatives should be used as infrequently as possible and for no longer than seven days. The prescription for prolonged use must be established after adequate clinical evaluation. \u003ci\u003eMethod of administration\u003c\/i\u003e In case of single daily administration, take preferably in the evening. If the dose is divided into two administrations per day, take preferably in the morning and in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSyrup: Store below 25°C. Shelf life after first opening the bottle: 12 months if stored at temperatures below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings:\u003c\/u\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact ones (stimulant laxatives), can cause addiction (possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). If diarrhea appears, therapy should be suspended. LAEVOLAC contains galactose and lactose. Patients with rare hereditary problems of galactose intolerance, e.g. galactosemia, or glucose-galactose malabsorption, should not take this medicine. LAEVOLAC contains fructose. The additive effect of co-administration of medicinal products containing fructose (or sorbitol) and dietary intake of fructose (or sorbitol) should be considered.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Laevolac may lead to increased toxicity of digitalis due to potassium depletion. A synergistic effect with neomycin is possible. Broad-spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce its degradation, limiting the possibility of acidification of the intestinal contents and, consequently, the therapeutic efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following are the side effects organized according to the MedDRA System Organ classification. The frequency is defined as follows: very common (≥1\/10), common (≥1\/100 to \u003c1\/10), uncommon (≥1\/1000 to \u003c1\/100), rare (≥1\/10,000 to \u003c1\/1000), very rare (\u003c1\/10,000), not known (the frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very common. Side effect: Abdominal pain, flatulence.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Common. Side effect: Abdominal distention, urgency of evacuation, diarrhea, nausea.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Uncommon. Side effect: Vomiting.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Common. Side effect: Reduced appetite.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Frequency: Common. Side effect: Headache.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Frequency: Not known. Side effect: Electrolyte depletion.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Not known. Side effect: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency: Not known. Side effect: Skin rash, itching, urticaria.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea, in which case treatment should be suspended and the resulting losses of fluids and electrolytes must be replenished.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or during breastfeeding. The use of LAEVOLAC should be considered only in case of actual need and if the expected benefit for the mother outweighs the risk for the child.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaevolac does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Chiesi","offers":[{"title":"Default Title","offer_id":46369303200071,"sku":"029565013","price":9.69,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/chiesi-farmaceutici-spa-laevolac-sciroppo-stitichezza-180-ml-farmacia-dottor-tili-1213792502.webp?v=1767131379"},{"product_id":"glicerolo-carlo-erba-6-microclismi-soluzione-rettale-6-75g","title":"Glycerol Carlo Erba 6 Microenemas Rectal Solution 6,75g.","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL CARLO ERBA Early childhood 900 mg suppositories\u003c\/i\u003e An early childhood suppository contains: active ingredient: Glycerol 900 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 1375 mg\u003c\/i\u003e \u003ci\u003esuppositories\u003c\/i\u003e One children's suppository contains: active ingredient: Glycerol 1375 mg. \u003ci\u003eGLYCEROL CARLO ERBA Adults 2250 mg suppositories\u003c\/i\u003e An adult suppository contains: active ingredient: Glycerol 2250 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 2.25 g. \u003ci\u003eGLYCEROL CARLO ERBA Adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 6.75 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSuppositories\u003c\/u\u003e: sodium stearate; sodium carbonate. \u003cu\u003eRectal solution\u003c\/u\u003e: chamomile fluid extract; mauve fluid extract; wheat starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active ingredient or to any of the excipients; • acute abdominal pain or pain of unknown origin; • nausea or vomiting; • intestinal obstruction or stricture; • rectal bleeding of unknown origin; • acute hemorrhoidal crisis with pain and bleeding; • severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eSuppositories\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2 – 11 years\u003c\/u\u003e: 1 suppository for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 1 month and 2 years\u003c\/u\u003e: 1 early childhood suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cb\u003eRectal solution\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 6 – 11 years\u003c\/u\u003e: 1 or 2 single-dose containers for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 2 – 6 years\u003c\/u\u003e: 1 single-dose container for children as needed for a maximum of 1 or 2 administrations per day. \u003cu\u003eMethod of administration\u003c\/u\u003e \u003cu\u003eSuppositories\u003c\/u\u003e: Remove the suppository from its container and then, if necessary, moisten it to facilitate rectal introduction. If the suppositories appear softened, immerse the containers in cold water before opening them. \u003cu\u003eRectal solution\u003c\/u\u003e: To remove the safety cannula cover from the single-dose container, place your index finger and thumb on the round ring placed above the bellows and, with the other hand, bend the cannula cover until it detaches from the body of the container. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥1\/10; Common ≥1\/100, \u003c1\/10; Uncommon ≥1\/1,000, \u003c1\/100; Rare ≥1\/10,000, \u003c1\/1,000; Very rare \u003c1\/10,000; Not known (frequency cannot be estimated from the available data). The available data are insufficient to establish the frequency of the individual effects listed.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known: Cramp-like pain in the abdomen*; abdominal colic, diarrhea**, anal irritation.\u003c\/p\u003e\n\u003cp\u003e*usually isolated ** with loss of fluids and electrolytes Isolated cramping pain or abdominal colic and diarrhea are more frequent in cases of severe constipation. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \"www.agenziafarmaco.gov.it\/it\/responsabili\".\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives – frequent or prolonged use or with excessive doses) can cause abdominal pain and persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more serious cases, the onset of dehydration or hypokalaemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlycerol has no influence on the ability to drive vehicles and use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Carlo Erba","offers":[{"title":"Default Title","offer_id":46656239042887,"sku":"029651066","price":3.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/carlo-erba-otc-srl-glicerolo-carlo-erba-6-microclismi-soluzione-rettale-6-75g-farmacia-dottor-tili-1213792487.jpg?v=1767112571"},{"product_id":"glicerolo-afom-adulti-6-75g-soluzione-rettale-6-contenitori-monodose-con-camomilla-e-malva","title":"Glycerol Afom Adults 6.75g Rectal Solution 6 Single-Dose Containers with Chamomile and Mallow","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL AFOM early childhood 2.25 g rectal solution - 6 single-dose containers with chamomile and mallow\u003c\/i\u003e. Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 2.25 g. \u003ci\u003eGLYCEROL AFOM children 4.5 g rectal solution - 6 single-dose containers with chamomile and mallow\u003c\/i\u003e. Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 4.5 g. \u003ci\u003eGLYCEROL AFOM adults 6.75 g rectal solution - 6 single-dose containers with chamomile and mallow.\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 6.75 g. For the complete list of excipients see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eChamomile fluid extract, Mallow fluid extract, Potato starch, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients, - acute abdominal pain or pain of unknown origin, - nausea or vomiting, - intestinal obstruction or stenosis, - rectal bleeding of unknown origin, - acute haemorrhoidal crisis with pain and bleeding, - severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eAdults and adolescents (12-18 years)\u003c\/u\u003e: 1 single-dose adult container of 6.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 6-11 years\u003c\/u\u003e: 1 single-dose container of 4.5 g for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2-6 years\u003c\/u\u003e: 1 single-dose infant container of 2.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eInstructions for use\u003c\/u\u003e: Remove the cap of the single-dose container; it may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of glycerol organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives - frequent or prolonged use or with excessive doses) can cause abdominal pain, persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Aeffe Farmaceutici","offers":[{"title":"Default Title","offer_id":50753944453447,"sku":"029916083","price":2.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aeffe-farmaceutici-srl-glicerolo-afom-adulti-6-75g-soluzione-rettale-6-contenitori-monodose-con-camomilla-e-malva-farmacia-dottor-tili-1213792420.jpg?v=1767131746"},{"product_id":"glicerolo-marco-viti-soluzione-rettale-adulti-6-75g-6-contenitori-monodose-con-camomilla-e-malva","title":"Glycerol Marco Viti rectal solution adults 6.75g 6 single-dose containers with chamomile and mallow","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL MARCO VITI early childhood 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 2.25 g \u003ci\u003eGLYCEROL MARCO VITI children 4.5 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 4.5 g \u003ci\u003eGLYCEROL MARCO VITI adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 6.75 g For the complete list of excipients see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eChamomile fluid extract; mauve fluid extract; pregelatinized starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients, - acute abdominal pain or pain of unknown origin, - nausea or vomiting, - intestinal obstruction or stenosis, - rectal bleeding of unknown origin, - acute haemorrhoidal crisis with pain and bleeding, - severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003ci\u003eAdults and adolescents (12-18 years)\u003c\/i\u003e: 1 single-dose adult container of 6.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003eChildren aged 6-11 years\u003c\/i\u003e: 1 single-dose container of 4.5 g for children as needed, for a maximum of 1 or 2 administrations per day \u003ci\u003eChildren aged 2-6 years\u003c\/i\u003e: 1 single-dose infant container of 2.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003eInstructions for use\u003c\/i\u003e: Remove the cap. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original package in order to protect the medicine from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of glycerol organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives - frequent or prolonged use or with excessive doses) can cause abdominal pain, persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51130948223303,"sku":"030334080","price":5.12,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-glicerolo-marco-viti-soluzione-rettale-adulti-6-75g-6-contenitori-monodose-con-camomilla-e-malva-farmacia-dottor-tili-1213792421.jpg?v=1767130949"},{"product_id":"clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-133ml","title":"Fleet Enema 21.4g\/9.4g Rectal Solution Ready to Use 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children over 3 years of age; pre- and post-operative intestinal emptying, in obstetrics, in preparation for radioscopic examinations and endoscopic investigations of the last intestinal tract.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach 118 ml dose contains the equivalent of 21.4 g (18.1% w\/v) sodium dihydrogen phosphate dihydrate and 9.4 g (8.0% w\/v) disodium hydrogen phosphate dodecahydrate. Contains 4.4 g of sodium per 118 ml dose delivered. Excipient with known effects: This medicinal product contains 0.0006 g\/ml benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride Disodium edetate Distilled water q.s.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is contraindicated in patients with: • Hypersensitivity to the active ingredients or to any of the excipients listed in paragraph 6.1. • Conditions causing increased absorptive capacity, decreased elimination capacity, or decreased gastric motility, for example: o   suspected intestinal obstruction o   paralytic ileus o   anorectal stenosis o   perforated anus o   congenital or acquired megacolon o   Hirschsprung's disease. • Undiagnosed gastrointestinal disorders, for example: o   symptoms suggestive of appendicitis, intestinal perforation or active inflammatory bowel disease o   undiagnosed rectal bleeding. • Congestive heart failure. • Dehydration. • Children under 3 years of age. • Clinically significant renal insufficiency. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and children over 12 years of age: 1 bottle (118 ml delivered dose) no more than once a day or as directed by the doctor (see section 4.4). Children aged 3 to 12 years: Half dose no more than once a day or as directed by the doctor (see sections 4.4 and 4.9). Enema Fleet is contraindicated in children under 3 years of age (see paragraph 4.3). In occasional constipation, laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate assessment of the case. Renal insufficiency: Do not administer to patients with clinically significant impairment of renal function (see section 4.3). The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia (see section 4.4). \u003cu\u003eMethod of administration\u003c\/u\u003e For rectal use only: Lie on your left side with both knees bent, arms at rest. Remove the orange protective cap. With constant pressure, gently insert the Comfortip enema into the anus with the cannula pointing towards the navel. Press the bottle until almost all the liquid has come out. Discontinue use if resistance is encountered. Forcing the enema can cause injury. 2 to 5 minutes are enough to obtain the desired effect. For occasional constipation, rectal enemas are used to provide relief and only on a short-term basis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use Clisma Fleet in case of nausea, vomiting or pain. Patients should be advised to expect loose stools and should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans) or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Enema Fleet contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels and consequently hypernatremia, hyperphosphatemia, hypocalcemia and hypokalemia which may occur with clinical signs such as tetany and renal failure. Fluid and electrolyte changes are of particular concern in children with megacolon or any other condition in which there is retention of enema solution, and in patients with comorbidities. This is why Enema Fleet should be used with caution in: • elderly or weakened patients and in patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures); • subjects with colostomy, patients taking diuretics or other medicines that can modify fluid and electrolyte levels; • subjects who are taking medicines known to prolong the QT interval (for example amiodarone, arsenic trioxide, astemizole, azithromycin, erythromycin, clarithromycin, chlorpromazine, cisapride, citalopram, domperidone, terfenadine, procainamide), or with known fluid and electrolyte imbalance, such as hypocalcemia, hypokalemia, hyperphosphatemia, hypernatremia. Also use with caution in patients taking medications known to affect perfusion, renal function, or hydration status. Where there is suspicion of hydroelectrolyte disorders and risk of hyperphosphatemia, hydroelectrolyte levels must be monitored before and after the administration of Fleet Enema. The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia. Repeated and prolonged use of Clisma Fleet is not recommended as it may cause habituation. Administering more than one enema in a 24-hour period may be harmful. Enema Fleet should not be used for more than a week. Clisma Fleet must be administered according to the instructions for use (see paragraph 4.2). Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. Rectal bleeding after using Fleet Enema may indicate a serious condition. In this case the administration must be stopped immediately. In general, evacuation occurs approximately 5 minutes after administration of Fleet Enema, therefore, retention times of more than 5 minutes are not recommended. If evacuation does not occur after using Clisma Fleet or if the retention time lasts more than 10 minutes, serious side effects may occur. No other administrations must be used and the patient's condition must be evaluated in order to identify any hydroelectrolyte alterations and to minimize the risk of severe hyperphosphatemia (see sections 4.8 and 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e Due to the presence of benzalkonium chloride, the product is irritating and can cause local skin reactions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in patients who are receiving calcium channel blockers, diuretics, lithium or other medicinal products that may affect fluid and electrolyte levels as hyperphosphataemia, hypocalcaemia, hypokalaemia, acidosis and hypernatremic dehydration may occur (see section 4.4). Other preparations with sodium phosphates including oral solutions or sodium phosphate tablets should not be administered simultaneously (see section 4.3). Since hypernatremia is associated with low lithium levels, concomitant use of Fleet Enema and lithium may cause a reduction in serum lithium levels with decreased efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is well tolerated if used as indicated. However, adverse events associated with the use of Enema Fleet have frequently been reported. In some cases, adverse events may occur, especially if the enema is used inappropriately. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Undesirable effects are listed below, by MedDRA system organ class and using the following frequency: very common (≥ 1\/10), common (≥ 1\/100, \u003c1\/10), uncommon (≥ 1\/1,000, \u003c1\/100), rare (≥ 1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data): \u003cu\u003eImmune system disorders\u003c\/u\u003e: Very rare: hypersensitivity e.g. urticaria. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e: Very rare: blisters, itching, burning. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: Very rare: dehydration, hyperphosphatemia, hypocalcaemia, hypokalaemia, hypernatraemia, metabolic acidosis. \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: Very rare: nausea, vomiting, abdominal pain, abdominal distension, diarrhoea, gastrointestinal pain, anal discomfort and proctalgia. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e: Very rare: rectal irritation, pain, burning, chills. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFatal cases have been reported after administration of excessive doses, after retention, in case of administration to pediatric patients or in obstructed patients. In case of overdose or retention, hyperphosphatemia, hypocalcemia, hypernatremia, hyperphosphatemia, hypernatremic dehydration, hypokalaemia, hypovolemia, acidosis and tetany may occur. Recovery from toxic effects can normally be achieved by rehydration. Treatment of electrolyte imbalances may require immediate medical intervention through the administration of adequate electrolytes and fluid therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince there are no relevant data available to evaluate the potential for fetal malformation or other foetotoxic effects when administered during pregnancy, Fleet Enema should be used under direct medical supervision only at the time of delivery or postpartum. Because sodium phosphate may pass into breast milk, it is recommended that breast milk be expressed and discarded for at least 24 hours after administering Fleet Enema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eClisma Fleet does not affect the ability to drive and use machinery, but it is necessary to remain near toilets after using this medicine.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51131195883847,"sku":"029319011","price":5.58,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-sl-clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-133ml-farmacia-dottor-tili-1213792402.jpg?v=1767132647"},{"product_id":"citrosodina-effervescente-granulato-150g","title":"Citrosodina effervescent granules 150g","description":"\u003cp\u003eThe \u003cstrong\u003eCitrosodine effervescent granules 150g\u003c\/strong\u003e is a natural remedy formulated to offer rapid relief from digestive disorders such as heaviness in the stomach, hyperacidity and abdominal swelling. Thanks to its composition based on \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e e \u003cstrong\u003ecitric acid\u003c\/strong\u003e, this product acts as an effective antacid, neutralizing excess gastric acidity and relieving heartburn.\u003c\/p\u003e\n\u003cp\u003eThe effervescent granules are enriched with sucrose and coloring E132, offering a pleasant and refreshing tasting experience. Its formulation is designed to be easily soluble in water, allowing for practical and quick intake. Citrosodine is particularly suitable for those looking for an immediate and natural remedy to improve intestinal function and counteract digestion-related discomfort.\u003c\/p\u003e\n\u003cp\u003eProduced by \u003cstrong\u003eBayer\u003c\/strong\u003e, a brand synonymous with quality and reliability, effervescent Citrosodine is available in a practical 150 g jar, ideal for prolonged use. Perfect for those who wish to maintain digestive well-being even during pregnancy, this effervescent granules are a precious ally for those who suffer from occasional digestive disorders.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Citrosodine effervescent granules 150g used? What is it for?\u003c\/h3\u003e\u003cp\u003eAntacid based on sodium bicarbonate and citric acid, indicated for rapid relief from heartburn, gastric hyperacidity and heaviness linked to occasional digestive difficulties.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eSucrose, sodium bicarbonate, citric acid, color E132.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Citrosodine effervescent granules 150g contain?\u003c\/h3\u003e\u003cp\u003eSucrose, sodium bicarbonate, citric acid, color E132.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Citrosodine effervescent granules 150g contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per 100 g\u003c\/strong\u003e\u003cbr\u003eEnergy value: 1.96 kJ, 352 kcal\u003cbr\u003eFat: 0 g\u003cbr\u003e-of which saturated fatty acids: 0 g\u003cbr\u003eCarbohydrates: 88 g\u003cbr\u003e-of which sugars: 70.8 g\u003cbr\u003eProtein: 0 g\u003cbr\u003eSalt: 11.25 g\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eDissolve two teaspoons of granulated Citrosodine in a glass of water and drink during the effervescence. How to open: grab the tab and pull it upwards and to the right to free the lid, detaching the ring that holds it. After each withdrawal, carefully close the jar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eDissolve two teaspoons of granulated Citrosodine in a glass of water and drink during the effervescence.\u003cbr\u003eOpening method: grab the tab and pull it upwards and to the right to free the lid, detaching the ring that holds it. After each withdrawal, carefully close the jar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eExcessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Citrosodine effervescent granules 150g stored?\u003c\/h3\u003e\u003cp\u003eTo be stored in a cool, dry place.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eNet weight: 150g.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51131195916615,"sku":"938181462","price":6.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-citrosodina-effervescente-granulato-150g-farmacia-dottor-tili-1213792389.jpg?v=1767132628"},{"product_id":"dulcolax-5mg-40-compresse-rivestite","title":"Dulcolax 5mg 40 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS One coated tablet contains: bisacodyl 5 mg. Excipients with known effects: lactose, sucrose, castor oil. ADULTS SUPPOSITORIES One suppository contains: bisacodyl 10 mg. CHILDREN SUPPOSITORIES One suppository contains: bisacodyl 5 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS \u003cb\u003eLactose\u003c\/b\u003e \u003cb\u003emonohydrate\u003c\/b\u003e, corn starch, modified starch, glycerol, magnesium stearate, \u003cb\u003esucrose\u003c\/b\u003e, talc, gum arabic, titanium dioxide (E171), methacrylic acid\/methyl methacrylate copolymer (1:1), methacrylic acid\/methyl methacrylate copolymer (1:2), \u003cb\u003ecastor oil\u003c\/b\u003e, macrogol 6000, iron oxide (E172), white wax, carnauba wax, shellac. SUPPOSITORIES Triglycerides of saturated fatty acids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Dulcolax is also contraindicated in patients with paralytic ileus, acute abdominal conditions, such as appendicitis, and severe abdominal pain associated with nausea and vomiting which may be indicative signs of serious pathological conditions, intestinal obstruction or stenosis, acute inflammation of the gastrointestinal tract, rectal bleeding of unknown origin, severe state of dehydration. Pregnancy and breastfeeding (see section 4.6). The use of Dulcolax is contraindicated in cases of rare hereditary conditions that may be incompatible with the intake of one of the excipients (see section 4.4 \"special warnings and precautions for use\"). Dulcolax is contraindicated in children under 2 years of age. Suppositories are contraindicated in cases of anal fissures and ulcers (perianal pain and bleeding may occur).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS - Adults: 1-2 coated tablets per day. \u003cu\u003ePediatric population\u003c\/u\u003e \u003ci\u003e - \u003c\/i\u003eChildren over 10 years: 1-2 coated tablets per day. - Children aged between 2 and 10 years: 1 coated tablet per day. It is advisable to start with the minimum expected dose. The dose can then be increased, up to the maximum recommended dose, for regular stool evacuation. The maximum daily dose must never be exceeded. \u003cu\u003eInstructions for use\u003c\/u\u003e Take the coated tablets preferably in the evening to determine an evacuation the following morning (after approximately 10 hours). When administered in the morning, on an empty stomach, the effect is obtained after approximately five hours. The coated tablets should not be administered together with products that reduce the acidity of the upper gastrointestinal tract, such as milk, antacids (e.g. bicarbonate) or proton pump inhibitors. The coated tablets should be swallowed whole. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. SUPPOSITORIES - Adults: 1 adult suppository (10 mg) per day. \u003cu\u003ePediatric population\u003c\/u\u003e - Children over 10 years: 1 adult suppository (10 mg) per day. - Children aged between 2 and 10 years: 1 children's suppository (5 mg) per day. The maximum daily dose must never be exceeded. Children aged 10 years and younger with chronic or persistent constipation should take Dulcolax under their doctor's supervision. Dulcolax must not be administered to children under two years of age. \u003cu\u003eInstructions for use\u003c\/u\u003e The effect of suppositories usually occurs in about 20 minutes (range: 10 - 30 minutes). Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCoated tablets: this medicine does not require any special storage conditions. Suppositories: Do not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Dulcolax should not be taken continuously every day or for long periods of time without investigating the cause of the constipation. In case of diabetes mellitus, hypertension or heart disease, use only after consulting your doctor. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Intestinal loss of fluids can cause dehydration. Symptoms may be thirst and oliguria. In patients for whom dehydration may be dangerous (patients with renal insufficiency, elderly patients), treatment with Dulcolax should be stopped and restarted only under medical supervision. Hematochezia (blood in the stool) may occur in patients, which is usually mild and goes away on its own. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Cases of dizziness and\/or syncope have been reported after taking Dulcolax. The data relating to these cases suggest that the events, rather than a phenomenon related to the intake of Dulcolax, could be interpreted as a manifestation of \"defecation syncope\" (attributable to the effort of the act of defecation), or as a vasovagal response to abdominal pain related to the constipation itself. The use of suppositories can lead to painful sensations and local irritation, in particular, in patients with fissures and ulcerative proctitis (see section 4.3 “contraindications”). Stimulant laxatives including Dulcolax do not contribute to weight loss (see section 5.1 “Pharmacodynamic properties”). \u003cb\u003eImportant information about some excipients:\u003c\/b\u003e Dulcolax tablets contain 33.2 mg of \u003cu\u003elactose\u003c\/u\u003e equal to 66.42 mg in case of taking the maximum daily dose, for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine tablets. Dulcolax tablets contain 23.4 mg of \u003cu\u003esucrose\u003c\/u\u003e equal to 46.8 mg when taking the maximum daily dose for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency should not take this medicine tablets. Dulcolax tablets may cause gastric upset and diarrhoea. \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 2 years and 10 years the medicine can only be used after consulting the doctor (see section 4.3). Like all laxatives, it should not be taken daily or for prolonged periods without first evaluating the cause of the constipation. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant administration of diuretics or adrenocorticosteroids and excessive doses of Dulcolax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other laxatives may potentiate the gastrointestinal side effects of Dulcolax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly reported side effects during treatment with Dulcolax are abdominal pain and diarrhea. \u003cu\u003eImmune system disorders\u003c\/u\u003e: anaphylactic reactions, angioneurotic edema as well as other hypersensitivity reactions. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: dehydration. \u003cu\u003eNervous system disorders\u003c\/u\u003e: dizziness, syncope. The phenomena of dizziness and syncope that occur after taking bisacodyl appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain, or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: abdominal cramps, abdominal pain, diarrhea, nausea, hematochezia (blood in stool), vomiting, abdominal discomfort, anorectal discomfort, colitis including ischemic colitis. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e \u003cu\u003eReporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: \u003c\/u\u003e \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa.\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e Excessive doses can cause abdominal pain and diarrhea, and significant losses of potassium and other electrolytes. Chronic overdose of Dulcolax, as with other laxatives, can cause chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. Renal tubular injury, metabolic alkalosis, and muscle weakness secondary to hypokalemia have also been described in association with chronic laxative abuse. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting the oral form of Dulcolax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in elderly and young patients. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Therefore, although unwanted or toxic effects have never been reported during pregnancy, like all medicines, Dulcolax must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to investigate the effects on human fertility. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active form of bisacodyl BHPM, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor its glucuronic derivatives are excreted in breast milk, however the medicine should only be used if necessary, under direct medical supervision, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131201257799,"sku":"008997064","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-dulcolax-5mg-40-compresse-rivestite-farmacia-dottor-tili-1258975859.jpg?v=1789561897"},{"product_id":"marco-viti-magnesio-solfato-30g","title":"Marco Viti Magnesium Sulphate 30g","description":"\u003cp\u003e\u003cstrong\u003eMarco Viti Magnesium Sulphate\u003c\/strong\u003e it is a magnesium salt with properties \u003cstrong\u003elaxatives and purifiers\u003c\/strong\u003e, used to promote intestinal regularity and digestive function.\nThanks to its osmotic action, it helps to draw water into the intestine, promoting smoother intestinal transit.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Marco Viti Magnesium Sulphate 30g? What is it for?\u003c\/h3\u003e\u003cp\u003eMagnesium sulphate-based supplement, used to promote intestinal regularity and digestive function thanks to its osmotic action, which draws water into the intestine.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Marco Viti Magnesium Sulphate 30g contain?\u003c\/h3\u003e\u003cp\u003eThe product contains:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePure Magnesium Sulphate\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eWithout additives and preservatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Marco Viti Magnesium Sulphate 30g?\u003c\/h3\u003e\u003cp\u003eIt is recommended to dissolve \u003cstrong\u003e1-2 teaspoons of powder\u003c\/strong\u003e in a glass of water. Take preferably in the morning on an empty stomach. Follow the instructions of your doctor or pharmacist for personalized use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Marco Viti Magnesium Sulphate 30g?\u003c\/h3\u003e\u003cp\u003eDo not exceed the recommended daily dose. Keep out of reach of children. Do not use for prolonged periods without consulting a doctor. Do not take in case of renal insufficiency or severe gastrointestinal disorders. Store in a cool, dry place.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Marco Viti Magnesium Sulphate 30g?\u003c\/h3\u003e\u003cp\u003eSachet from \u003cstrong\u003e30 g\u003c\/strong\u003e of soluble powder.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51131202371911,"sku":"908670058","price":1.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-marco-viti-magnesio-solfato-30g-farmacia-dottor-tili-1213792377.jpg?v=1767132791"},{"product_id":"citrosodina-classica-30-compresse-masticabili","title":"Classic Citrosodine 30 chewable tablets","description":"\u003cp\u003eThe \u003cstrong\u003eClassic Citrosodine 30 chewable tablets\u003c\/strong\u003e it is the ideal solution for those looking for a practical and quick remedy against difficult digestion and heaviness in the stomach. These chewable tablets, from \u003cstrong\u003erefreshing lemon flavour\u003c\/strong\u003e, are formulated with sodium bicarbonate and citric acid, known for their antacid and effervescent properties. Thanks to their sugar-free and lactose-free composition, they are also suitable for those following a vegan diet.\u003c\/p\u003e\n\n\u003cp\u003eThe tablets are perfect to always carry with you, thanks to their practical and portable format, and can be used at any time of the day, especially after meals, to relieve symptoms such as \u003cstrong\u003ebloating, heartburn and nausea\u003c\/strong\u003e. Classic Citrosodine is a precious ally for those who want effective and uncompromising digestive support, guaranteeing rapid relief from stomach acid.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Citrosodine Classic 30 chewable tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eAntacid based on sodium bicarbonate and citric acid in lemon-flavoured chewable tablets, indicated for rapid relief from difficult digestion, heavy stomach, bloating, heartburn and nausea linked to gastric acidity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Classic Citrosodine 30 chewable tablets contain?\u003c\/h3\u003e\u003cp\u003eSweeteners: xylitol, mannitol; sodium bicarbonate, anhydrous citric acid; aroma: lemon; anti-caking agent: magnesium stearate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Classic Citrosodine 30 chewable tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per 100 g\u003c\/strong\u003e\u003cbr\u003eEnergy value: 980 kJ, 234 kcal\u003cbr\u003eFat: 0.9 g\u003cbr\u003e-of which saturated fatty acids: 0.9 g\u003cbr\u003eCarbohydrates: 85.37 g\u003cbr\u003e-of which sugars: 0 g\u003cbr\u003eProtein: 0.1 g\u003cbr\u003eSalt: 11 g\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003eOral use. The chewable tablets are indicated at any time of the day, particularly at the end of meals.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eExcessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Citrosodine Classic 30 chewable tablets stored?\u003c\/h3\u003e\u003cp\u003eTo be stored in a cool, dry place.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003e30 tablets.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51131228848455,"sku":"939466900","price":7.53,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-citrosodina-classica-30-compresse-masticabili-farmacia-dottor-tili-1213792337.jpg?v=1767143009"},{"product_id":"onligol-macrogol-4000-20-bustine","title":"Onligol Macrogol 4000 20 sachets","description":"\u003cp\u003eOnligol Macrogol 4000 20 sachets is a \u003cstrong\u003epowder laxative for oral solution\u003c\/strong\u003e designed to provide effective relief from chronic and occasional constipation. Its formula based on \u003cstrong\u003eMacrogol 4000\u003c\/strong\u003e it is free of excipients, flavorings and sugars, making it suitable for those looking for a delicate and natural product. Onligol stands out for its ability to \u003cstrong\u003esoften the stool\u003c\/strong\u003e, facilitating evacuation without causing cramps or abdominal pain.\u003c\/p\u003e\n\n\u003cp\u003eThanks to his \u003cstrong\u003eaffinity for water\u003c\/strong\u003e, Onligol acts naturally, without being absorbed or fermented in the intestine, and is eliminated in the feces in unchanged form. This makes it ideal for those who want a treatment that does not irritate the intestinal mucosa. Onligol is versatile and can be dissolved in any drink, such as tea, herbal tea, milk, broth or fruit juice, without altering its flavor, thus offering a pleasant and discreet user experience.\u003c\/p\u003e\n\n\u003cp\u003eSuitable for both adults and children, Onligol offers broad dosing flexibility, allowing you to tailor your intake to individual needs. Its effectiveness does not reduce over time, guaranteeing a \u003cstrong\u003eintestinal relief\u003c\/strong\u003e constant and long-lasting. Onligol is produced by Alfasigma SpA, a trusted brand in the pharmaceutical sector, and is supplied in practical 10g disposable sachets, ideal for quick and easy use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Onligol Macrogol 4000 20 sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eLaxative based on Macrogol 4000, indicated for the treatment of chronic and occasional constipation; softens the stool, facilitating evacuation without causing cramps or abdominal pain, acting without being absorbed by the intestine.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003eDissolve the dose of product in at least 125 ml (increase up to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal tea, milk, broth or fruit juice. Onligol does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take Onligol between meals. DOSAGES (unless otherwise prescribed by a doctor): Onligol allows wide dosage flexibility. Adults and children weighing more than 20 kg (11 years): the dose is 10 g (2 level teaspoons), 1-3 times a day, according to individual response. To obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (2 level teaspoons) 1-2 times a day, even every other day, preferably in the evening. Children 6-9 kg (6 months-1 year): 5 g. Children 10-12 kg (1-2 years): 7.5 g. Children 13-16 kg (2-6 years): 10 g. Children 17-20 kg (6-11 years): 12.5 g. In children up to 20 kg it is recommended to personalize the dose according to the child's real needs until soft stools are obtained.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003eDissolve the dose of product in at least 125 ml (increase up to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal tea, milk, broth or fruit juice. Onligol does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take Onligol between meals.\u003cbr\u003eDosages (unless otherwise prescribed by a doctor): Onligol allows for wide dosage exibility.\u003cbr\u003eAdults and children weighing more than 20 kg (11 years): the dose is 10 g (2 level teaspoons), 1-3 times a day, according to individual response.\u003cbr\u003eTo obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (2 level teaspoons) 1-2 times a day, even every other day, preferably in the evening.\u003cbr\u003eChildren 6-9 kg (6 months-1 year): 5 g.\u003cbr\u003eChildren 10-12 kg (1-2 years): 7.5 g.\u003cbr\u003eChildren 13-16 kg (2-6 years): 10 g.\u003cbr\u003eChildren 17-20 kg (6-11 years): 12.5 g.\u003cbr\u003eFor children up to 20 kg it is advisable to personalize the dose according to the child's real needs until soft stools are obtained.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not exceed the maximum daily dosage of 30 g (6 level teaspoons).\u003cbr\u003eDo not take Onligol in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction. During pregnancy and breastfeeding the product must be used upon medical prescription.\u003cbr\u003eDo not use under 6 months. Close the bottle tightly after use.\u003cbr\u003eDuring treatment with Onligol it is advisable to follow an adequate diet, accompanied by the administration of an oral rehydration solution (ORS) to avoid dehydration, however it is advisable to consult your doctor. Do not use Onligol for more than 30 consecutive days, if symptoms persist consult your doctor.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Onligol Macrogol 4000 20 sachets not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not take Onligol in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Onligol Macrogol 4000 20 sachets be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eDuring pregnancy and breastfeeding the product must be used upon medical prescription.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Onligol Macrogol 4000 20 sachets stored?\u003c\/h3\u003e\u003cp\u003eStore in the original packaging in a cool, dry place.\u003cbr\u003eThe expiry date indicated refers to the product in intact packaging and correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003e20 disposable sachets of 10 g.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131252670791,"sku":"930327008","price":15.07,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-onligol-macrogol-4000-20-bustine-farmacia-dottor-tili-1213792307.jpg?v=1767143609"},{"product_id":"clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-4-flaconi-133ml","title":"Fleet Enema 21.4g\/9.4g Rectal Solution Ready to Use 4 Bottles 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children over 3 years of age; pre- and post-operative intestinal emptying, in obstetrics, in preparation for radioscopic examinations and endoscopic investigations of the last intestinal tract.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach 118 ml dose contains the equivalent of 21.4 g (18.1% w\/v) sodium dihydrogen phosphate dihydrate and 9.4 g (8.0% w\/v) disodium hydrogen phosphate dodecahydrate. Contains 4.4 g of sodium per 118 ml dose delivered. Excipient with known effects: This medicinal product contains 0.0006 g\/ml benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride Disodium edetate Distilled water q.s.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is contraindicated in patients with: • Hypersensitivity to the active ingredients or to any of the excipients listed in paragraph 6.1. • Conditions causing increased absorptive capacity, decreased elimination capacity, or decreased gastric motility, for example: o   suspected intestinal obstruction o   paralytic ileus o   anorectal stenosis o   perforated anus o   congenital or acquired megacolon o   Hirschsprung's disease. • Undiagnosed gastrointestinal disorders, for example: o   symptoms suggestive of appendicitis, intestinal perforation or active inflammatory bowel disease o   undiagnosed rectal bleeding. • Congestive heart failure. • Dehydration. • Children under 3 years of age. • Clinically significant renal insufficiency. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and children over 12 years of age: 1 bottle (118 ml delivered dose) no more than once a day or as directed by the doctor (see section 4.4). Children aged 3 to 12 years: Half dose no more than once a day or as directed by the doctor (see sections 4.4 and 4.9). Enema Fleet is contraindicated in children under 3 years of age (see paragraph 4.3). In occasional constipation, laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the case. Renal insufficiency: Do not administer to patients with clinically significant impairment of renal function (see section 4.3). The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia (see section 4.4). \u003cu\u003eMethod of administration\u003c\/u\u003e For rectal use only: Lie on your left side with both knees bent, arms at rest. Remove the orange protective cap. With constant pressure, gently insert the Comfortip enema into the anus with the cannula pointing towards the navel. Press the bottle until almost all the liquid has come out. Discontinue use if resistance is encountered. Forcing the enema can cause injury. 2 to 5 minutes are enough to obtain the desired effect. For occasional constipation, rectal enemas are used to provide relief and only on a short-term basis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use Clisma Fleet in case of nausea, vomiting or pain. Patients should be advised to expect loose stools and should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans) or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Enema Fleet contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels and consequently hypernatremia, hyperphosphatemia, hypocalcemia and hypokalemia which may occur with clinical signs such as tetany and renal failure. Fluid and electrolyte changes are of particular concern in children with megacolon or any other condition in which there is retention of enema solution, and in patients with comorbidities. This is why Enema Fleet should be used with caution in: • elderly or weakened patients and in patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures); • subjects with colostomy, patients taking diuretics or other medicines that can modify fluid and electrolyte levels; • subjects who are taking medicines known to prolong the QT interval (for example amiodarone, arsenic trioxide, astemizole, azithromycin, erythromycin, clarithromycin, chlorpromazine, cisapride, citalopram, domperidone, terfenadine, procainamide), or with known fluid and electrolyte imbalance, such as hypocalcemia, hypokalemia, hyperphosphatemia, hypernatremia. Also use with caution in patients taking medications known to affect perfusion, renal function, or hydration status. Where there is suspicion of hydroelectrolyte disorders and risk of hyperphosphatemia, hydroelectrolyte levels must be monitored before and after the administration of Fleet Enema. The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia. Repeated and prolonged use of Clisma Fleet is not recommended as it may cause habituation. Administering more than one enema in a 24-hour period may be harmful. Enema Fleet should not be used for more than a week. Clisma Fleet must be administered according to the instructions for use (see paragraph 4.2). Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. Rectal bleeding after using Fleet Enema may indicate a serious condition. In this case the administration must be stopped immediately. In general, evacuation occurs approximately 5 minutes after administration of Fleet Enema, therefore, retention times of more than 5 minutes are not recommended. If evacuation does not occur after using Clisma Fleet or if the retention time lasts more than 10 minutes, serious side effects may occur. No other administrations must be used and the patient's condition must be evaluated in order to identify any hydroelectrolyte alterations and to minimize the risk of severe hyperphosphatemia (see sections 4.8 and 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e Due to the presence of benzalkonium chloride, the product is irritating and can cause local skin reactions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in patients who are receiving calcium channel blockers, diuretics, lithium or other medicinal products that may affect fluid and electrolyte levels as hyperphosphataemia, hypocalcaemia, hypokalaemia, acidosis and hypernatremic dehydration may occur (see section 4.4). Other preparations with sodium phosphates including oral solutions or sodium phosphate tablets should not be administered simultaneously (see section 4.3). Since hypernatremia is associated with low lithium levels, concomitant use of Fleet Enema and lithium may cause a reduction in serum lithium levels with decreased efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is well tolerated if used as indicated. However, adverse events associated with the use of Enema Fleet have frequently been reported. In some cases, adverse events may occur, especially if the enema is used inappropriately. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Undesirable effects are listed below, by MedDRA system organ class and using the following frequency: very common (≥ 1\/10), common (≥ 1\/100, \u003c1\/10), uncommon (≥ 1\/1,000, \u003c1\/100), rare (≥ 1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data): \u003cu\u003eImmune system disorders\u003c\/u\u003e: Very rare: hypersensitivity e.g. urticaria. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e: Very rare: blisters, itching, burning. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: Very rare: dehydration, hyperphosphatemia, hypocalcaemia, hypokalaemia, hypernatraemia, metabolic acidosis. \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: Very rare: nausea, vomiting, abdominal pain, abdominal distension, diarrhoea, gastrointestinal pain, anal discomfort and proctalgia. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e: Very rare: rectal irritation, pain, burning, chills. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFatal cases have been reported after administration of excessive doses, after retention, in case of administration to pediatric patients or in obstructed patients. In case of overdose or retention, hyperphosphatemia, hypocalcemia, hypernatremia, hyperphosphatemia, hypernatremic dehydration, hypokalaemia, hypovolemia, acidosis and tetany may occur. Recovery from toxic effects can normally be achieved by rehydration. Treatment of electrolyte imbalances may require immediate medical intervention through the administration of adequate electrolytes and fluid therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince there are no relevant data available to evaluate the potential for fetal malformation or other foetotoxic effects when administered during pregnancy, Fleet Enema should be used under direct medical supervision only at the time of delivery or postpartum. Because sodium phosphate may pass into breast milk, it is recommended that breast milk be expressed and discarded for at least 24 hours after administering Fleet Enema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eClisma Fleet does not affect the ability to drive and use machinery, but it is necessary to remain near toilets after using this medicine.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51131262697799,"sku":"029319023","price":16.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-sl-clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-4-flaconi-133ml-farmacia-dottor-tili-1213792287.jpg?v=1767144047"},{"product_id":"mylicongas-40mg-50-compresse-masticabili","title":"MyliconGas 40mg 50 chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of gastrointestinal meteorism and aerophagia in adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: simethicone (activated dimethylpolysiloxane) 40 mg. Excipient with known effects: Lactose, sodium. For the full list of excipients, see 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSaccharin; alginic acid; \u003cb\u003elactose\u003c\/b\u003e; sodium bicarbonate; povidone; hydrated calcium silicate; magnesium stearate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the components listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003cu\u003eAdults\u003c\/u\u003e: 4 tablets per day. Do not exceed the recommended doses. After a short period of treatment without appreciable results, consult your doctor. \u003ci\u003ePediatric population\u003c\/i\u003e Mylicongas is not suitable for pediatric use. \u003cu\u003eMethod of administration\u003c\/u\u003e Take 2 tablets at the end of each main meal. The tablets must be chewed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore the medicine in the original packaging to protect the product from light and humidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter a short period of treatment without appreciable results, consult your doctor. In case of persistence, worsening of symptoms, or if new symptoms appear or in case of prolonged constipation, stop treatment and consult your doctor. Do not use in case of suspected intestinal perforation or ileus. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e Mylicongas contains \u003cb\u003elactose\u003c\/b\u003e. Patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, e.g. galactosemia, or suffering from glucose\/galactose malabsorption, should not take this medicine. Mylicongas contains less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per dose. It can therefore be considered essentially sodium-free.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking SIMETICONE and mineral oil (paraffin) laxatives at the same time is not recommended, as the combination of these two products reduces their effectiveness.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSide effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥ 1\/10; Common ≥ 1\/100 and \u003c 1\/10; Uncommon ≥ 1\/1,000 and \u003c 1\/100; Rare ≥ 1\/10,000 and \u003c 1\/1,000; Very rare \u003c 1\/10,000.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Vomiting, diarrhoea, abdominal pain, ileus, nausea.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eVery rare: Angioedema, Rash.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003erare: hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at “https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse”.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo overdose phenomena have been reported with the use of Mylicongas.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e \u003ci\u003ePregnancy \u003c\/i\u003e \u003c\/u\u003e There are no adequate data on the use of Mylicongas in pregnant women, therefore it should not be used during pregnancy unless clearly necessary and after a risk\/benefit assessment by the doctor. \u003cu\u003e \u003ci\u003eBreastfeeding \u003c\/i\u003e \u003c\/u\u003e It is not known whether simethicone is excreted in breast milk. The excretion of simethicone in breast milk has not been studied in animals. The decision whether to continue\/discontinue breastfeeding or to continue\/discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the infant and of simethicone therapy for the woman. Consult a doctor before taking Mylicongas during pregnancy or breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo effects on the ability to drive or use machines are reported.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51131265745223,"sku":"038140012","price":16.27,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-mylicongas-40mg-50-compresse-masticabili-farmacia-dottor-tili-1213792264.jpg?v=1767144150"},{"product_id":"lacdigest-lactofree-30-compresse","title":"Lacdigest Lactofree 30 tablets","description":"\u003cp\u003e\u003cstrong\u003eLacdigest Lactofree 30 tablets\u003c\/strong\u003e is a food supplement designed to support the digestion of lactose, ideal for those suffering from lactose intolerance. Thanks to the presence of the enzyme \u003cstrong\u003elactase\u003c\/strong\u003e, derived from \u003cem\u003eAspergillus oryzae\u003c\/em\u003e, this product helps improve the metabolic process of lactose, facilitating the digestion of foods containing this sugar. The chewable tablets are practical and easy to take, making them an excellent solution for those who want to enjoy their meals without worries.\u003c\/p\u003e\n\n\u003cp\u003eFormulated without \u003cstrong\u003egluten\u003c\/strong\u003e, these tablets are also suitable for those following a gluten-free diet. The supplement contains sweetener and anti-caking agents such as magnesium salts of fatty acids and silicon dioxide, ensuring optimal consistency and a pleasant taste. Each tablet provides 4,500 FCC of lactase, a measure of enzymatic activity according to the Food Chemical Codex, ensuring effective digestive action.\u003c\/p\u003e\n\n\u003cp\u003eProduced by \u003cstrong\u003eItalchemists\u003c\/strong\u003e, Lacdigest Lactofree is a precious ally for those who want to manage lactose intolerance in a simple and safe way. Packaged in a practical format of 30 chewable tablets, it is perfect to always carry with you, guaranteeing the freedom to enjoy your favorite foods on any occasion.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Lacdigest Lactofree 30 tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on the lactase enzyme, indicated to aid the digestion of lactose contained in foods; useful for those suffering from lactose intolerance, in gluten-free chewable tablets.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Lacdigest Lactofree 30 tablets contain?\u003c\/h3\u003e\u003cp\u003eSweetener: sorbitol; lactase (beta-galactosidase from Aspergillus oryzae), aroma; anti-caking agents: magnesium salts of fatty acids, silicon dioxide.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Lacdigest Lactofree 30 tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eNutritional information for 1 tablet\u003c\/strong\u003e\u003cbr\u003eLactase (beta-galactosidase from Aspergillus oryzae): 4,500 FCC*\u003c\/p\u003e\u003cp\u003e*FFC: Food Chemical Codex (measurement of enzymatic activity)\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Lacdigest Lactofree 30 tablets?\u003c\/h3\u003e\u003cp\u003eWe recommend 1 or 2 chewable tablets, as needed, before consuming foods containing lactose.\u003cbr\u003eThe quantity to be taken depends on the type of diet.\u003cbr\u003eThe beneficial effect is obtained with the intake of 4,500 FCC with each lactose-containing meal.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Lacdigest Lactofree 30 tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eLactose tolerance is variable and it is advisable to seek advice on the role of this substance in your diet.\u003cbr\u003eExcessive consumption can have laxative effects.\u003cbr\u003eDo not dispose of in the environment after use.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Lacdigest Lactofree 30 tablets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from light and at a temperature below 25°C.\u003cbr\u003eThe minimum shelf life refers to the product correctly stored in intact packaging.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Lacdigest Lactofree 30 tablets?\u003c\/h3\u003e\u003cp\u003ePack of 30 chewable tablets of 450 mg\u003cbr\u003eNet weight 13.5 g\u003c\/p\u003e","brand":"Italchimici","offers":[{"title":"Default Title","offer_id":51131282686279,"sku":"982476285","price":18.53,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/italchimici-spa-lacdigest-lactofree-30-compresse-farmacia-dottor-tili-1213792241.jpg?v=1767133907"},{"product_id":"mannite-f-u-stitichezza-panetto-10gr","title":"Mannite FU Constipation Tablet 10gr","description":"\u003cp data-end=\"501\" data-start=\"94\"\u003eThe \u003cstrong data-end=\"113\" data-start=\"97\"\u003eMannite F.U.\u003c\/strong\u003e is an ideal natural supplement to promote intestinal transit in a delicate and effective way. Thanks to its osmotic action, it draws water into the intestine, promoting evacuation without irritating the mucosa. This 10g block represents a natural solution for those looking for help with occasional constipation, contributing to greater digestive and intestinal comfort.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Mannite F.U. used? Constipation 10g block? What is it for?\u003c\/h3\u003e\u003cp\u003eNatural supplement with osmotic action, indicated to promote intestinal transit in case of occasional constipation; draws water into the intestine, softening the stool and promoting evacuation in a delicate way.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Mannite F.U. contain? Constipation 10g block?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eMannite F.U.\u003c\/strong\u003e: natural compound known for its delicate laxative effect and its regulating action on the intestine.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Mannite F.U. Constipation 10g block?\u003c\/h3\u003e\u003cp\u003eHire \u003cstrong\u003e1-2 loaves\u003c\/strong\u003e as needed. The product can be:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eChewed directly\u003c\/strong\u003e \u003cstrong\u003eDissolved in water, milk or other drink\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eIt is recommended to start with a minimum dose and gradually increase until the desired result is achieved. It is essential to accompany intake with an adequate quantity of liquids to optimize effectiveness. For personalized dosage, consult a health professional.\u003c\/p\u003e\u003cp\u003eThe recommended quantity may vary depending on individual needs. It is preferable to start with a small quantity and adjust the dosage based on the body's response and the indications of an expert.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Mannite F.U. Constipation 10g block?\u003c\/h3\u003e\u003cp\u003ePack of \u003cstrong\u003e10g\u003c\/strong\u003e, containing individually sealed blocks to guarantee convenience and freshness.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51131295138119,"sku":"900166594","price":2.7,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-mannite-f-u-stitichezza-panetto-10gr-farmacia-dottor-tili-1213792216.jpg?v=1767134369"},{"product_id":"clisma-lax-soluzione-rettale-133ml","title":"Clisma Lax rectal solution 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml contain 13.91 g of anhydrous monobasic sodium phosphate (NaH\u003csub\u003e2\u003c\/sub\u003ePO\u003csub\u003e4\u003c\/sub\u003e); 3.18 g of dibasic sodium phosphate (Na\u003csub\u003e2\u003c\/sub\u003eHPO\u003csub\u003e4\u003c\/sub\u003e). Excipients with known effects: sodium benzoate (100mg per 100ml) and methylparahydroxybenzoate (50mg per 100ml). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium hydroxide, sodium benzoate, methyl parahydroxybenzoate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e-Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - acute abdominal pain or of unknown origin - nausea or vomiting - intestinal obstruction or stenosis or anorectal stenosis - intestinal sub-occlusion - mechanical ileus - paralytic ileus - inflammatory intestinal disorders and other conditions that can increase the absorption of the medicine - anal perforation - congenital or acquired megacolon - Hirschsprung's disease - rectal bleeding of unknown origin - acute haemorrhoidal crisis with pain and bleeding - severe state of dehydration - children under the age of twelve. Phosphates are contraindicated in patients with cardiac disorders, severe renal insufficiency or in the presence of hyperphosphatemia. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and adolescents (12-18 years): the entire dose of the bottle. \u003cu\u003eMethod of administration\u003c\/u\u003e Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Take preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The 133 ml bottle should not be used in children under 12 years of age. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Patients should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration, or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans), or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Clisma lax contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels, and consequently hypernatraemia, hyperphosphataemia, hypocalcaemia and hypokalaemia, which may occur with clinical signs such as tetany and renal failure. Abuse of laxatives can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Repeated use of laxatives can give rise to addiction or various types of damage. Prolonged use of a laxative to treat constipation is not recommended. The pharmacological treatment of constipation must be considered an adjuvant to the hygienic-dietary treatment (e.g. increase in vegetable fibers and liquids in the diet, physical activity and re-education of intestinal motility). The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. A careful evaluation by the doctor is essential when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. Elderly people or those in poor health and patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures) should consult their doctor before using the medicine. Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe systemic absorption of sodium phosphate rectal solution is limited, however in some conditions it may be increased and predispose to possible interactions with other drugs. The simultaneous intake of drugs that can have effects on electrolyte balance (such as diuretics, cortisone, calcium channel blockers, lithium) can facilitate the onset of hyperphosphatemia, hypercalcemia and hypernatremia. Patients taking drugs that can prolong the QT interval may be at greater risk of developing this adverse reaction if treated concomitantly with sodium phosphate. Since hypernatremia is associated with low lithium levels, the concomitant use of Enema lax and lithium may cause a reduction in serum lithium levels, with a decrease in efficacy. Concomitant use of calcium supplements or calcium-containing antacids may increase the risk of ectopic calcification. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of sodium phosphate organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e Hypersensitivity reactions (e.g. urticaria) \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Blisters, itching, burning \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation. Nausea, vomiting. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e Hyperphosphatemia, hypokalemia, hypernatremia, hypocalcemia, and tissue calcification may rarely occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe effect most frequently observed following ingestion or rectal administration is gastrointestinal irritation (abdominal pain, nausea, vomiting, diarrhoea). Persistent diarrhea results in loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Fluid and electrolyte losses must be replaced. Generally, conservative measures are sufficient; plenty of liquids must be given, especially fruit juices. See also what is reported in paragraph 4.4 regarding the abuse of laxatives. If a significant amount of phosphate is absorbed, hyperphosphatemia, hypocalcemia, and hypomagnesemia may occur. Alterations in fluid and electrolyte balance have been observed following oral, rectal and intravenous exposure. Severe hyperphosphatemia and hypocalcemia may cause tetany, convulsions, bradycardia, QT interval prolongation, arrhythmia, coma and cardiac arrest. Severe dehydration, hypernatremia, hypotension, metabolic acidosis, and tachycardia may also occur. The elderly, children and patients with renal insufficiency are at increased risk of toxic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131295793479,"sku":"024995033","price":5.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-clisma-lax-soluzione-rettale-133ml-farmacia-dottor-tili-1213792210.jpg?v=1767134489"},{"product_id":"melilax-pediatric-6-microclismi","title":"Melilax Pediatric 6 microenemas","description":"\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e is a class IIb medical device, specially formulated to offer a delicate evacuating action and a protective and soothing action on the rectal mucosa. This product is particularly suitable for the treatment of \u003cstrong\u003econstipation\u003c\/strong\u003e in children and infants, ensuring effective relief from the discomfort, irritation and inflammation associated with this condition.\u003c\/p\u003e\n\n\u003cp\u003eIts effectiveness is due to \u003cstrong\u003ePROMELAXIN\u003c\/strong\u003e, an active complex of nectar and honeydew honeys, enriched with polysaccharides derived from \u003cstrong\u003eAloe and Mallow\u003c\/strong\u003e. This unique combination allows Melilax to stimulate physiological and balanced evacuation, without irritating the rectal mucosa. Furthermore, thanks to its mucous-like properties and its viscosity, the product protects the mucosa during the passage of feces, mimicking the lubricating action of physiological mucus.\u003c\/p\u003e\n\n\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric\u003c\/strong\u003e it is also ideal in conditions such as \u003cstrong\u003evisceral hypersensitivity\u003c\/strong\u003e, irritable colon, fissures and hemorrhoids, thanks to its indirect anti-inflammatory action and antioxidant properties. This microenema is gluten-free, making it also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eWith the \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e, parents can count on a safe and effective product to relieve constipation in children, guaranteeing a delicate and respectful action on the intestinal physiology of children and infants.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Melilax Pediatric 6 microenemas used? What is it for?\u003c\/h3\u003e\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e is a class IIb medical device, specially formulated to offer a delicate evacuating action and a protective and soothing action on the rectal mucosa. This product is particularly suitable for the treatment of \u003cstrong\u003econstipation\u003c\/strong\u003e in children and infants, ensuring effective relief from the discomfort, irritation and inflammation associated with this condition.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Melilax Pediatric 6 microenemas contain?\u003c\/h3\u003e\u003cp\u003ePromelaxin complex of honey and polysaccharides from aloe and mallow\u003cbr\u003eTitle in: monosaccharides ≥ 50%, polysaccharides (Molecular Weight \u003e 20,000 Daltons) ≥ 0.3%.\u003cbr\u003eIt also contains: hydroglycerine mixture; Lemon juice; Lavender essential oil.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003e• Children aged 3-12 years: 1 microenema of 5 g as needed. In case of stubborn constipation, apply 2 doses consecutively.\u003cbr\u003e• Children from 1-3 years: 1 microenema of 5 g as needed.\u003cbr\u003e• Infants from 0-1 year: half microenema of 5 g as needed.\u003c\/p\u003e\u003cp\u003eOpen the microenema by removing the safety cannula cover:\u003cbr\u003e- grasp the white round ring located above the bellows;\u003cbr\u003e- with the other hand bend the cannula cover until it breaks and completely detaches from the ring nut;\u003cbr\u003e- remove the cannula cover.\u003cbr\u003eTo facilitate the application of the microenema, it is preferable to position the child on his left side with his knees bent towards his abdomen.\u003cbr\u003eApply a few drops of product to the perianal area and gently introduce the cannula into the rectum. Press the microenema thoroughly and at the end of the application keep it pressed until the cannula is completely extracted, to prevent the product from being re-aspirated.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eIn case of persistent constipation it is important to consult your doctor to rule out other pathologies.\u003cbr\u003eThe microenema is disposable, therefore it must not be reused if half a dose is administered, as in the case of infants.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Melilax Pediatric 6 microenemas stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, away from heat sources and protected from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product. Do not use after the indicated expiry date.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003e6 disposable microenemas with cannula cover for children and infants of 5 g each.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51131300544839,"sku":"932501416","price":11.31,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-melilax-pediatric-6-microclismi-farmacia-dottor-tili-1213792188.jpg?v=1767127270"},{"product_id":"dulcosoft-polvere-20-bustine","title":"Dulcosoft powder 20 sachets","description":"\u003cp\u003e\u003cstrong\u003eDulcosoft powder 20 sachets\u003c\/strong\u003e is a medical device designed for the symptomatic treatment of \u003cstrong\u003eoccasional constipation\u003c\/strong\u003e and to soften hard stools, facilitating evacuation and offering immediate relief. Its formula is based on \u003cstrong\u003eMacrogol 4000\u003c\/strong\u003e, an osmotic laxative that retains water, acting as a transporter and delaying intestinal absorption. This process increases the amount of water in the colon, softening the stool and increasing its volume.\u003c\/p\u003e\n\n\u003cp\u003eDulcosoft is suitable for adults and children aged 8 and over, and is particularly suitable for the elderly, pregnant women (under medical supervision), celiacs and diabetics, thanks to its formulation \u003cstrong\u003esugar free and gluten free\u003c\/strong\u003e. The powder is flavorless, making it easily mixable with any drink you like, for simple and discreet intake.\u003c\/p\u003e\n\n\u003cp\u003eProduced by \u003cstrong\u003eOpella Healthcare Italy\u003c\/strong\u003e, Dulcosoft powder 20 sachets is an effective and delicate solution for those looking for a safe and non-invasive remedy for the management of occasional constipation. The package contains 20 pre-measured sachets, each with 10 g of Macrogol 4000, ensuring practicality and ease of use. Discover the comfort of regular and effortless evacuation with Dulcosoft, your ally for optimal intestinal well-being.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Dulcosoft powder 20 sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on Macrogol 4000, indicated for the symptomatic treatment of occasional constipation; softens hard stools promoting their evacuation, also suitable for the elderly, celiacs and diabetics thanks to the sugar-free and gluten-free formulation.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Dulcosoft powder 20 sachets contain?\u003c\/h3\u003e\u003cp\u003eMacrogol 4000.\u003c\/p\u003e\u003cp\u003eWithout flavouring, sugar and \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Dulcosoft powder 20 sachets?\u003c\/h3\u003e\u003cp\u003eAdults and children over 8 years:\u003cbr\u003eunless otherwise prescribed by a doctor, the recommended dose is:\u003cbr\u003e1-2 sachets per day, dissolved in a drink, to be taken preferably in a single administration in the morning.\u003cbr\u003eThe dose can be adapted to individual needs, without exceeding the maximum recommended dose: it can vary from one intake per day to one intake every two days. The appropriate dose is the minimum sufficient to produce the regular evacuation of soft stools.\u003cbr\u003eDissolve the contents of 1 sachet in a glass of water (about 150 ml), or other drink of your choice, and drink immediately.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Dulcosoft powder 20 sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eKeep the medical device out of the sight and reach of children. Do not exceed the recommended daily dose. Consult the instructions for use. Do not use in children under 8 years of age. Use in children under 12 years of age should preferably take place under medical supervision. For pregnant and breastfeeding women, consult your doctor before using DulcoSoft.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow do you store Dulcosoft powder 20 sachets?\u003c\/h3\u003e\u003cp\u003eStore at a temperature not exceeding 25°C.\u003cbr\u003eDo not use after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Dulcosoft powder 20 sachets?\u003c\/h3\u003e\u003cp\u003eBox of 20 pre-measured sachets of 10 g of Macrogol 4000 each.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131300970823,"sku":"971635735","price":14.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-dulcosoft-polvere-20-bustine-farmacia-dottor-tili-1213792186.jpg?v=1767127359"},{"product_id":"dulcolax-adulti-10mg-6-supposte","title":"Dulcolax adults 10mg 6 suppositories","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS One coated tablet contains: bisacodyl 5 mg. Excipients with known effects: lactose, sucrose, castor oil. ADULTS SUPPOSITORIES One suppository contains: bisacodyl 10 mg. CHILDREN SUPPOSITORIES One suppository contains: bisacodyl 5 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS \u003cb\u003eLactose\u003c\/b\u003e \u003cb\u003emonohydrate\u003c\/b\u003e, corn starch, modified starch, glycerol, magnesium stearate, \u003cb\u003esucrose\u003c\/b\u003e, talc, gum arabic, titanium dioxide (E171), methacrylic acid\/methyl methacrylate copolymer (1:1), methacrylic acid\/methyl methacrylate copolymer (1:2), \u003cb\u003ecastor oil\u003c\/b\u003e, macrogol 6000, iron oxide (E172), white wax, carnauba wax, shellac. SUPPOSITORIES Triglycerides of saturated fatty acids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Dulcolax is also contraindicated in patients with paralytic ileus, acute abdominal conditions, such as appendicitis, and severe abdominal pain associated with nausea and vomiting which may be signs indicative of serious pathological conditions, in intestinal obstruction or stenosis, acute inflammation of the gastrointestinal tract, rectal bleeding of unknown origin, severe state of dehydration. Pregnancy and breastfeeding (see section 4.6). The use of Dulcolax is contraindicated in cases of rare hereditary conditions that may be incompatible with the intake of one of the excipients (see section 4.4 \"special warnings and precautions for use\"). Dulcolax is contraindicated in children under 2 years of age. Suppositories are contraindicated in cases of anal fissures and ulcers (perianal pain and bleeding may occur).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS - Adults: 1-2 coated tablets per day. \u003cu\u003ePediatric population\u003c\/u\u003e \u003ci\u003e - \u003c\/i\u003eChildren over 10 years: 1-2 coated tablets per day. - Children aged between 2 and 10 years: 1 coated tablet per day. It is advisable to start with the minimum expected dose. The dose can then be increased, up to the maximum recommended dose, for regular stool evacuation. The maximum daily dose must never be exceeded. \u003cu\u003eInstructions for use\u003c\/u\u003e Take the coated tablets preferably in the evening to determine an evacuation the following morning (after approximately 10 hours). When administered in the morning, on an empty stomach, the effect is obtained after approximately five hours. The coated tablets should not be administered together with products that reduce the acidity of the upper gastrointestinal tract, such as milk, antacids (e.g. bicarbonate) or proton pump inhibitors. The coated tablets should be swallowed whole. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. SUPPOSITORIES - Adults: 1 adult suppository (10 mg) per day. \u003cu\u003ePediatric population\u003c\/u\u003e - Children over 10 years: 1 adult suppository (10 mg) per day. - Children aged between 2 and 10 years: 1 children's suppository (5 mg) per day. The maximum daily dose must never be exceeded. Children aged 10 years and younger with chronic or persistent constipation should take Dulcolax under their doctor's supervision. Dulcolax must not be administered to children under two years of age. \u003cu\u003eInstructions for use\u003c\/u\u003e The effect of suppositories usually occurs in about 20 minutes (range: 10 - 30 minutes). Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCoated tablets: this medicine does not require any special storage conditions. Suppositories: Do not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Dulcolax should not be taken continuously every day or for long periods of time without investigating the cause of the constipation. In case of diabetes mellitus, hypertension or heart disease, use only after consulting your doctor. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Intestinal loss of fluids can cause dehydration. Symptoms may be thirst and oliguria. In patients for whom dehydration may be dangerous (patients with renal insufficiency, elderly patients), treatment with Dulcolax should be stopped and restarted only under medical supervision. Hematochezia (blood in the stool) may occur in patients, which is usually mild and goes away on its own. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Cases of dizziness and\/or syncope have been reported after taking Dulcolax. The data relating to these cases suggest that the events, rather than a phenomenon related to the intake of Dulcolax, could be interpreted as a manifestation of \"defecation syncope\" (attributable to the effort of the act of defecation), or as a vasovagal response to abdominal pain related to the constipation itself. The use of suppositories can lead to painful sensations and local irritation, in particular, in patients with fissures and ulcerative proctitis (see section 4.3 “contraindications”). Stimulant laxatives including Dulcolax do not contribute to weight loss (see section 5.1 “Pharmacodynamic properties”). \u003cb\u003eImportant information about some excipients:\u003c\/b\u003e Dulcolax tablets contain 33.2 mg of \u003cu\u003elactose\u003c\/u\u003e equal to 66.42 mg in case of taking the maximum daily dose, for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine tablets. Dulcolax tablets contain 23.4 mg of \u003cu\u003esucrose\u003c\/u\u003e equal to 46.8 mg when taking the maximum daily dose for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency should not take this medicine tablets. Dulcolax tablets may cause gastric upset and diarrhoea. \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 2 years and 10 years the medicine can only be used after consulting the doctor (see section 4.3). Like all laxatives, it should not be taken daily or for prolonged periods without first evaluating the cause of the constipation. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant administration of diuretics or adrenocorticosteroids and excessive doses of Dulcolax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other laxatives may potentiate the gastrointestinal side effects of Dulcolax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly reported side effects during treatment with Dulcolax are abdominal pain and diarrhea. \u003cu\u003eImmune system disorders\u003c\/u\u003e: anaphylactic reactions, angioneurotic edema as well as other hypersensitivity reactions. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: dehydration. \u003cu\u003eNervous system disorders\u003c\/u\u003e: dizziness, syncope. The phenomena of dizziness and syncope that occur after taking bisacodyl appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain, or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: abdominal cramps, abdominal pain, diarrhea, nausea, hematochezia (blood in stool), vomiting, abdominal discomfort, anorectal discomfort, colitis including ischemic colitis. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e \u003cu\u003eReporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: \u003c\/u\u003e \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa.\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e Excessive doses can cause abdominal pain and diarrhea, and significant losses of potassium and other electrolytes. Chronic overdose of Dulcolax, as with other laxatives, can cause chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. Renal tubular injury, metabolic alkalosis, and muscle weakness secondary to hypokalemia have also been described in association with chronic laxative abuse. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting the oral form of Dulcolax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in elderly and young patients. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Therefore, although unwanted or toxic effects have never been reported during pregnancy, like all medicines, Dulcolax must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to investigate the effects on human fertility. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active form of bisacodyl BHPM, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor its glucuronic derivatives are excreted in breast milk, however the medicine should only be used if necessary, under direct medical supervision, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131302641991,"sku":"008997025","price":8.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-dulcolax-adulti-10mg-6-supposte-farmacia-dottor-tili-1213792177.jpg?v=1767134627"},{"product_id":"buscopan-compositum-10mg-500mg-20-compresse-rivestite","title":"Buscopan Compositum 10mg + 500mg 20 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eParoxysmal pains in diseases of the gastrointestinal tract, spastic pain, dyskinesias of the biliary tract.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eBuscopan Compositum 10 mg + 500 mg coated tablets\u003c\/b\u003e One coated tablet contains: \u003cb\u003eActive ingredients:\u003c\/b\u003e Hyoscine N-butylbromide 10 mg, paracetamol 500 mg \u003cb\u003eBuscopan Compositum 10 mg + 800 mg suppositories\u003c\/b\u003e One suppository contains: \u003cb\u003eActive ingredients:\u003c\/b\u003e Hyoscine N-butylbromide 10 mg, paracetamol 800 mg Excipient with known effects: sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCoated tablets\u003c\/b\u003e: \u003cu\u003eCore\u003c\/u\u003e: microcrystalline cellulose, sodium carmellose, corn starch, ethyl cellulose, colloidal silica, magnesium stearate. \u003cu\u003eCoating\u003c\/u\u003e: hypromellose, polyacrylates, titanium dioxide, macrogol 6000, talc, silicone-antifoaming agent. \u003cb\u003eSuppositories\u003c\/b\u003e: glyceride esters of saturated fatty acids, soy lecithin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBuscopan Compositum is contraindicated in case of: - hypersensitivity to the active ingredients (hyoscine N-butylbromide and paracetamol), to non-steroidal anti-inflammatory drugs or to any of the excipients listed in paragraph 6.1; - acute angle glaucoma; - prostatic hypertrophy or other causes of urinary retention; - mechanical stenosis of the gastrointestinal tract; - pyloric stenosis and other conditions that stenose the gastrointestinal tract; - paralytic or obstructive ileus; - megacolon; - ulcerative colitis; - reflux esophagitis; - intestinal atony in the elderly and debilitated subjects; - myasthenia gravis; - pediatric age; - paracetamol-based products are contraindicated in patients with manifest insufficiency of glucose-6-phosphate dehydrogenase and in those suffering from severe hemolytic anemia; - severe hepatocellular insufficiency (Child - Pugh C). \u003cb\u003e \u003ci\u003eThe use of Buscopan Compositum is contraindicated in cases of rare hereditary conditions that may be incompatible with an excipient of the product (see section 4.4).\u003c\/i\u003e \u003c\/b\u003e Buscopan Compositum 10 mg + 800 mg suppositories should not be used in patients with a history of soy or peanut allergy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following dosage is recommended for adults, unless otherwise prescribed by a doctor: \u003cu\u003eCoated tablets\u003c\/u\u003e 1-2 tablets 3 times a day. Do not exceed 6 tablets per day. The tablets should not be chewed, but swallowed whole with a sufficient amount of water. \u003cu\u003eSuppositories\u003c\/u\u003e 1 suppository 3-4 times a day. Do not exceed 4 suppositories per day. \u003cu\u003eDuration of treatment\u003c\/u\u003e Buscopan Compositum must not be taken for more than three days unless following a medical prescription (see section 4.4). \u003cb\u003e \u003ci\u003ePediatric population\u003c\/i\u003e \u003c\/b\u003e The use of Buscopan Compositum is not recommended in children under 10 years of age. The simultaneous administration of other drugs containing paracetamol may require a dosage adjustment, see section 4.4.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCoated tablets: store below 25°C. Suppositories: store below 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBuscopan Compositum should not be taken for more than 3 days unless directed by your doctor. Instruct the patient to seek medical attention if pain persists or worsens, if new symptoms occur, or if redness or swelling occurs because these may be symptoms of a serious condition. If you experience severe abdominal pain of unknown origin that persists, worsens, or is accompanied by symptoms such as fever, nausea, vomiting, change in bowel movements, distended abdomen, drop in blood pressure, fainting, or blood in the stool, contact your doctor immediately. To prevent overdose, you must ensure that other medicines taken at the same time do not contain paracetamol, one of the active ingredients of Buscopan Compositum. Liver damage may occur if the recommended dosage for paracetamol is exceeded (see section 4.9). Buscopan Compositum must be used with caution in case of: • glucose-6-phosphate dehydrogenase insufficiency; • liver dysfunction (e.g. due to chronic alcohol abuse, hepatitis); • chronic use of alcohol even in case of recent cessation; • impaired renal function; • Gilbert syndrome; • mild to moderate hepatocellular insufficiency (Child - Pugh A\/B); • low glutathione reserves. \u003cb\u003eAdminister with caution in subjects with renal or hepatic insufficiency.\u003c\/b\u003e In such conditions Buscopan Compositum must be administered only under medical supervision, if necessary, reducing the dose or prolonging the interval between individual administrations. Blood counts and renal and liver function should be monitored after prolonged use. The extensive use of analgesics, especially at high doses, can induce headache which must not be treated with increased doses of the medicine. Severe acute hypersensitivity reactions (e.g. anaphylactic shock) are observed very rarely. Treatment should be discontinued at the first signs of a hypersensitivity reaction following administration of Buscopan Compositum. Serious skin reactions: Potentially fatal reactions such as Stevens-Johnson syndrome (SSJ) and toxic epidermal necrolysis (TEN) have been reported with the use of Buscopan Compositum. Patients should be informed about the signs and symptoms and monitored carefully for skin reactions. If symptoms or signs of Stevens-Johnson syndrome, toxic epidermal necrolysis occur (e.g. progressive skin rash associated with blisters or mucosal lesions), the patient should immediately discontinue treatment with Buscopan Compositum and consult a doctor. Hepatotoxicity may occur with paracetamol even at therapeutic doses, after short-term treatment and in patients without pre-existing liver dysfunction (see section 4.8). Abrupt discontinuation of analgesics after prolonged use at high doses may cause withdrawal symptoms (e.g. headache, tiredness, nervousness), which usually resolve within a few days. The resumption of analgesics must be subject to medical advice, and to the remission of withdrawal symptoms. Due to the potential risk of anticholinergic complications, it should be used with caution in patients predisposed to angle-closure glaucoma, in patients subject to intestinal or urinary tract obstructions and in those prone to tachyarrhythmia with autonomic central nervous system disorders, tachyarrhythmias, arterial hypertension, congestive heart failure and hyperthyroidism. All antimuscarinics reduce the volume of bronchial secretions; therefore they must be used with caution in subjects with chronic obstructive inflammatory diseases of the respiratory system. During treatment with paracetamol, before taking any other drug, check that it does not contain the same active ingredient, since if paracetamol is taken in high doses, serious adverse reactions may occur, see section 4.2. Invite the patient to contact the doctor before combining any other drug. See also paragraph 4.5. Buscopan Compositum 10 mg + 500 mg tablets contains 4.32 mg sodium per tablet, i.e. less than 1 mmol (23 mg) sodium, therefore it is essentially “sodium-free”.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with extreme caution and under strict control during chronic treatment with drugs that can cause the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example, rifampicin, cimetidine, hypnotics and antiepileptics such as glutetimide, phenobarbital, carbamazepine, phenytoin). The same situation occurs with potentially hepatotoxic substances and alcohol abuse. Concomitant administration of chloramphenicol may induce a prolongation of the half-life of chloramphenicol, with the risk of increasing its toxicity. Paracetamol may increase the risk of bleeding in patients taking warfarin and other vitamin K antagonists. Patients taking acetaminophen and vitamin K antagonists should be monitored for appropriate clotting and bleeding. Co-administration of flucloxacillin with paracetamol may lead to metabolic acidosis in patients with risk factors for glutathione depletion. Concomitant use of paracetamol and zidovudine (AZT or retrovir) increases the tendency to reduce leukocytes (neutropenia). Therefore Buscopan Compositum should be taken together with zidovudine only under medical supervision. Taking probenecid inhibits the binding of paracetamol to glucuronic acid, thereby reducing the clearance of paracetamol by approximately a factor of 2. The dose of paracetamol should therefore be reduced during concomitant administration with probenecid. Cholestyramine reduces the absorption of paracetamol. The anticholinergic effect of medicines such as tri- and tetracyclic antidepressants, antihistamines, antipsychotics, quinidine, amantadine, disopyramide and other anticholinergics (e.g. tiotropium, ipratropium, atropine-like substances) can be potentiated by Buscopan Compositum. Concomitant treatment with dopamine antagonists, such as metoclopramide, may result in a reduction in the effect of both drugs on the gastrointestinal tract. Tachycardia induced by β-adrenergic drugs can be potentiated by Buscopan Compositum. The tachycardic effects of beta-adrenergic agents may be intensified by Buscopan Compositum. \u003ci\u003eInterference with laboratory tests\u003c\/i\u003e The intake of paracetamol can influence the determination of uric acid by the phosphotungstic acid method and blood sugar by the glucose oxidase-peroxidase method. \u003ci\u003eAdditionally for oral use\u003c\/i\u003e: Drugs that slow gastric emptying (e.g. propantheline) can reduce the speed of absorption of paracetamol, delaying its therapeutic effect; on the contrary, drugs that increase the speed of gastric emptying (e.g. metoclopramide or domperidone) lead to an increase in the speed of absorption of paracetamol.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdverse reactions are listed below by system organ class and frequency, according to the following categories: Very common: ≥ 1\/10 Common: ≥ 1\/100, \u003c 1\/10 Uncommon: ≥ 1\/1,000, \u003c 1\/100 Rare: ≥ 1\/10,000, \u003c 1\/1,000 Very rare: \u003c 1\/10,000 Not note: frequency cannot be estimated from available data. \u003cu\u003ePathologies of the blood and lymphatic system\u003c\/u\u003e Not known: pancytopenia, agranulocytosis, thrombocytopenia, neutropenia, leukopenia, haemolytic anemia. \u003cu\u003eImmune system disorders, skin and subcutaneous tissue diseases\u003c\/u\u003e Uncommon: skin reactions, abnormal sweating, itching, nausea. Rare: erythema, decrease in blood pressure including shock. Very rare: urticaria, rash, exanthema, severe skin reactions (such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and generalized exanthematous pustulosis (AGEP)). Not known: anaphylactic shock, anaphylactic reactions, cutaneous drug reaction, dyspnoea, hypersensitivity, angioedema, fixed drug eruption. \u003cu\u003eCardiac diseases\u003c\/u\u003e. Rare: tachycardia. \u003cu\u003eRespiratory, thoracic and mediastinal disorders\u003c\/u\u003e. Not known: bronchial muscle spasms (especially in patients with a history of bronchial asthma or allergy). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e. Uncommon: dry mouth. \u003cu\u003eHepatobiliary disorders\u003c\/u\u003e. Not known: increased transaminases, cytolytic hepatitis which may lead to acute liver failure. \u003cu\u003eRenal and urinary disorders\u003c\/u\u003e. Not known: urinary retention. Cases of erythema multiforme have been reported with the use of paracetamol. Hypersensitivity reactions such as angioedema, laryngeal edema have been reported. Furthermore, the following side effects have been reported: anemia, alterations in liver function and hepatitis, alterations affecting the kidney (acute renal failure, interstitial nephritis, hematuria, anuria), gastrointestinal reactions and dizziness. Drowsiness, mydriasis, accommodation disorders, increased ocular tone, constipation and difficulty urinating have also been reported. \u003cu\u003eAdditional adverse reactions for suppositories only\u003c\/u\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e. Not known: anorectal discomfort. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDue to overdose of paracetamol, elderly people, young children, patients with liver disorders, chronic alcohol consumption or chronic malnutrition, as well as patients treated with enzyme-inducing medicines are subjected to an increased risk of intoxication, even with fatal outcome. \u003cb\u003e \u003ci\u003eSymptoms\u003c\/i\u003e \u003c\/b\u003e \u003ci\u003e \u003cu\u003eHyoscine N-butylbromide\u003c\/u\u003e \u003c\/i\u003e In case of overdose, anticholinergic effects have been observed. \u003ci\u003e \u003cu\u003eParacetamol\u003c\/u\u003e \u003c\/i\u003e In cases of chronic intoxication, hemolytic anemia, cyanosis, weakness, dizziness, paresthesia, tremors, insomnia, headache, memory loss, irritative phenomena of the central nervous system, delirium and convulsions may occur. Symptoms usually appear during the first 24 hours and include paleness, nausea, vomiting, anorexia and abdominal pain. Patients may then experience temporary subjective improvement but mild abdominal pain perhaps indicative of liver damage may persist; there may be a considerable increase in transaminases, jaundice, coagulation disorders, hypoglycemia and transition to hepatic coma. A single dose of paracetamol of approximately 6 g or more in adults or 140 mg\/kg in children can cause hepatocellular necrosis. This may induce complete irreversible necrosis and subsequently hepatocellular failure, gastrointestinal bleeding, metabolic acidosis, encephalopathy and disseminated intravascular coagulation which may in turn progress to coma and death. Concurrent increases in hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin with reduction in prothrombin levels and an increase in prothrombin time have been observed, occurring 12 - 48 hours after ingestion. Clinical symptoms of liver injury are normally evident after 2 days and reach a maximum after 4 - 6 days. Acute renal failure with acute tubular necrosis can develop even in the absence of severe liver damage. Other non-hepatic symptoms such as myocardial abnormalities, pancytopenia, and pancreatitis have also been reported to occur after overdose with acetaminophen. \u003cb\u003e \u003ci\u003eTherapy\u003c\/i\u003e \u003c\/b\u003e \u003ci\u003e \u003cu\u003eHyoscine N-butylbromide\u003c\/u\u003e \u003c\/i\u003e If required, parasympathomimetic medicinal products should be administered. In cases of glaucoma, an ophthalmological examination must be carried out urgently. Cardiovascular complications must be treated according to usual therapeutic principles. In case of respiratory paralysis, intubation and artificial respiration should be considered. Catheterization may be necessary for urinary retention. In addition, appropriate supportive measures should be used as needed. \u003ci\u003e \u003cu\u003eParacetamol\u003c\/u\u003e \u003c\/i\u003e Where paracetamol intoxication is suspected, intravenous administration of SH group donors such as N-acetylcysteine within the first 10 hours of ingestion is indicated. Although N-acetylcysteine ​​is most effective when administered within this period, it may still offer some degrees of protection when administered 48 hours after ingestion; in this case, it should be taken for longer. The plasma concentration of paracetamol can be lowered by dialysis. Quantitative analyzes of plasma paracetamol concentration are recommended. Further measures will depend on the severity, nature and course of the clinical symptoms of paracetamol intoxication and should follow standard intensive care protocols.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate data on the use of Buscopan Compositum during pregnancy. The long experience with the two substances in monotherapy has indicated insufficient evidence of adverse effects during pregnancy in women. After the use of hyoscine N-butylbromide, pre-clinical studies in rats and rabbits showed neither embryotoxic nor teratogenic effects. During pregnancy, potential data on paracetamol overdose have not shown an increased risk of malformations. Reproduction studies to investigate oral use have shown no signs suggesting malformations of foetotoxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically necessary, under normal conditions of use, paracetamol can be taken during pregnancy after a careful examination of the risk-benefit ratio. During pregnancy, paracetamol should not be taken for prolonged periods, at high doses, or in combination with other medicines as safety has not been confirmed in such cases. Therefore, Buscopan Compositum is not recommended during pregnancy. \u003cu\u003eBreastfeeding \u003c\/u\u003e The safety of hyoscine N-butylbromide during breastfeeding has not yet been established. Paracetamol is excreted in breast milk. However, it is foreseeable that at therapeutic doses it does not cause side effects in the newborn. The decision to continue or discontinue breastfeeding or to continue or discontinue therapy with Buscopan Compositum must be made considering the benefits of breastfeeding for the child and the benefits of therapy with Buscopan Compositum for the mother. \u003cu\u003eFertility\u003c\/u\u003e No studies on the effects on fertility in humans have been conducted (see section 5.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed. However, anticholinergics can induce visual accommodation disorders and drowsiness, which should be taken into account by those who drive vehicles or machinery or carry out jobs which require a high degree of vigilance.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131311784263,"sku":"029454042","price":13.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-buscopan-compositum-10mg-500mg-20-compresse-rivestite-farmacia-dottor-tili-1213792120.jpg?v=1767135406"},{"product_id":"magnesia-s-pellegrino-45-polvere-effervescente-gusto-limone-100g","title":"Magnesia S.Pellegrino 45% effervescent powder lemon flavour 100g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation. Antacid.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of powder contains: Magnesia S. Pellegrino 90% powder for oral suspension Active ingredient: magnesium hydroxide 90 g Excipient with known effects: sucrose. Magnesia S. Pellegrino 45% effervescent powder Active ingredient: magnesium hydroxide 45 g Excipient with known effects: sucrose and sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia S. Pellegrino 90% powder for oral suspension: without flavouring: sucrose. lemon flavour: sucrose, natural lemon flavour. Magnesia S. Pellegrino 45% effervescent powder: without flavouring: sodium bicarbonate, tartaric acid, sucrose. anise flavour: sodium bicarbonate, tartaric acid, sucrose, anethole. fruit flavour: sodium bicarbonate, tartaric acid, sucrose, natural fruit flavour. lemon flavour: sodium bicarbonate, tartaric acid, sucrose, natural lemon flavour. mandarin flavour: sodium bicarbonate, tartaric acid, sucrose, natural mandarin flavour.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients, listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Children under 6 years of age. Severe renal insufficiency (creatinine clearance less than 30 mL\/min)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eDosage\u003c\/u\u003e \u003c\/b\u003e \u003cu\u003eAdults\u003c\/u\u003e: as an antacid 1 teaspoon; as a laxative 1 teaspoon; as a purgative 1 tbsp. \u003cu\u003eChildren\u003c\/u\u003e: between 6 and 12 years: half the doses. Magnesia S. Pellegrino is contraindicated in children under 6 years of age (see section 4.3). Dilute the powder in half a glass of water and ingest. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMagnesia S. Pellegrino 90% powder for oral suspension\u003c\/i\u003e:without aroma: Store below 25°C. lemon flavour: This medicine does not require any special storage conditions. \u003ci\u003eMagnesia S. Pellegrino 45% effervescent powder\u003c\/i\u003e:\u003c\/p\u003e\n\u003cp\u003eunflavored: This medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003eanise flavour: This medicine does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003efruit flavour: This medicine does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003elemon flavour: Store below 25°C.\u003c\/p\u003e\n\u003cp\u003emandarin flavour: Store below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWarnings The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact ones (stimulant laxatives), can cause dependence (need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). The treatment of chronic or recurrent constipation always requires the formulation of a diagnosis, the prescription of drugs and monitoring during the course of therapy. When the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects, a clinical reassessment is necessary. \u003cu\u003eAdminister with caution in the elderly and in subjects with impaired renal function\u003c\/u\u003e. In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration. \u003cb\u003eMagnesia S. Pellegrino contains sucrose\u003c\/b\u003e Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase isomaltase insufficiency should not take this medicine. \u003cb\u003eMagnesia S. Pellegrino 45% effervescent powder contains sodium salts\u003c\/b\u003e. This medicine contains: • approximately 386 mg of sodium per 1 teaspoon (approximately 7 g of product) equivalent to 19.3% of the maximum daily intake recommended by WHO which corresponds to 2 g of sodium for an adult. • approximately 552 mg of sodium per 1 teaspoon (approximately 10 g of product) of substance taken equivalent to 27.6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • approximately 1.1 g of sodium per 1 tablespoon (approximately 20 g of product) equivalent to 55% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. To be taken into consideration in people with reduced renal function or who follow a low-sodium diet (low sodium diet).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid taking laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Magnesium hydroxide, like all antacids, should not be taken at the same time as antibiotics of the tetracycline class as it reduces their absorption. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed. Association to avoid: - tetracyclines: formation of insoluble complexes with reduction in the absorption and activity of these antibiotics. Association not recommended: - quinidine: increase in quinidine plasma levels and risk of overdose due to decreased excretion. Associations requiring precautions for use: - indomethacin, phosphorus, dexamethasone, digitalis, iron salts, nitrofurantoin, lincomycin: decreased absorption in the digestive system.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects are reported below with the following frequencies: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10), uncommon (≥ 1\/1,000, \u003c 1\/100), rare (≥ 1\/10,000, \u003c 1\/1,000), very rare (\u003c 1\/10,000), not known (the frequency cannot be estimated from the available data). \u003cb\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eNot known\u003c\/i\u003e: Abdominal pain, diarrhea, isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. \u003cb\u003e \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eVery rare\u003c\/i\u003e: Hypermagnesemia. Observed after prolonged administration of magnesium hydroxide to patients with renal impairment. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ewww.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Treatment of magnesium overdose: rehydration, forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePregnancy Magnesia S. Pellegrino must be used only if necessary after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. Breastfeeding Magnesium is considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia S. Pellegrino does not alter the ability to drive and use machinery.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51131313881415,"sku":"006570257","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-magnesia-s-pellegrino-45-polvere-effervescente-gusto-limone-100g-farmacia-dottor-tili-1213792126.jpg?v=1767135827"},{"product_id":"dulcosoft-soluzione-orale-250ml","title":"Dulcosoft oral solution 250ml","description":"\u003cp\u003eThe \u003cstrong\u003eDulcosoft oral solution 250ml\u003c\/strong\u003e is a medical device designed to offer gentle, natural relief from occasional constipation. Thanks to its main component, the \u003cstrong\u003emacrogol 4,000\u003c\/strong\u003e, an osmotic laxative, Dulcosoft works by retaining water in the intestine, softening the stool and increasing its volume. This process facilitates intestinal transit, making evacuation easier and more comfortable.\u003c\/p\u003e\n\n\u003cp\u003eThe Dulcosoft formula is free of flavourings, sugar, \u003cstrong\u003elactose\u003c\/strong\u003e e \u003cstrong\u003egluten\u003c\/strong\u003e, making it also suitable for those who follow particular diets or have food intolerances. It is ideal for adults and children, offering a safe and versatile option for the whole family. Its delicate action is particularly suitable for those looking for a treatment that is not absorbed by the body, since macrogol 4,000 is excreted unchanged.\u003c\/p\u003e\n\n\u003cp\u003eProduced by \u003cstrong\u003eOpella Healthcare Italy\u003c\/strong\u003e, Dulcosoft is available in a practical 250 ml format, perfect for prolonged use. Its effectiveness generally manifests itself within 24-72 hours of intake, guaranteeing rapid and long-lasting relief. Thanks to its composition, Dulcosoft is a precious ally for those who want to maintain regular intestinal transit without sacrificing safety and quality.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Dulcosoft oral solution 250ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eOral solution based on macrogol 4,000, medical device indicated for the relief of occasional constipation; works by retaining water in the intestine to soften stool and facilitate evacuation, suitable for adults and children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Dulcosoft oral solution 250ml contain?\u003c\/h3\u003e\u003cp\u003eMacrogol 4000, potassium sorbate (preservative), citric acid, purified water.\u003c\/p\u003e\u003cp\u003eWithout flavoring, sugar, \u003cstrong\u003elactose\u003c\/strong\u003e e \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Dulcosoft oral solution 250ml?\u003c\/h3\u003e\u003cp\u003eDilute with a drink to taste (about 150 ml).\u003cbr\u003eAdults and children over 8 years of age: 20-40 ml of solution per day, (equal to 10-20 g of macrogol 4,000) to be taken preferably in a single administration in the morning.\u003cbr\u003eChildren between 4-7 years: 16-32 ml of solution per day (equal to 8-16 g of macrogol 4,000), preferably taken in a single administration in the morning.\u003cbr\u003eChildren between 2-3 years: 8-16 ml of solution per day (equal to 4-8 g of macrogol 4,000), preferably taken in a single administration in the morning.\u003cbr\u003eChildren between 6 months and 1 year: 8 ml of solution per day (equal to 4 g of macrogol 4,000), preferably taken in a single administration in the morning.\u003cbr\u003eUse in children under 12 years of age should preferably take place under medical supervision.\u003cbr\u003eMeasure the dose using the measuring cup included in the package. The dose can be adapted to individual needs, without exceeding the maximum recommended dose: it can vary from one intake per day to one intake every two days.\u003cbr\u003eThe appropriate dose is the minimum sufficient to produce the regular evacuation of soft stools. The recommended daily dose should preferably be taken in a single administration in the morning.\u003cbr\u003eThe effectiveness of the product manifests itself between 24 and 72 hours after intake.\u003cbr\u003eDo not take for more than 7 days.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Dulcosoft oral solution 250ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not take in case of:\u003cbr\u003e- hypersensitivity to macrogol 4,000 or to any of the other components;\u003cbr\u003e- severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon;\u003cbr\u003e- gastrointestinal perforation or risk of gastrointestinal perforation;\u003cbr\u003e- paralytic ileus or suspicion of intestinal obstruction or symptomatic stricture;\u003cbr\u003e- painful abdominal syndromes for which the cause has not been established.\u003cbr\u003eIf you have any concerns, consult your doctor or pharmacist before taking DulcoSoft.\u003cbr\u003eDulcoSoft should not be taken daily for extended periods of time without investigating the cause of constipation.\u003cbr\u003eIn case of diarrhoea, caution should be used in patients subject to fluid or electrolyte imbalance (e.g. elderly, patients with impaired hepatic or renal function or patients receiving diuretics) and electrolyte monitoring should be considered.\u003cbr\u003eIf you are pregnant or breastfeeding, consult your doctor first.\u003cbr\u003eDo not use on children under 6 months of age.\u003cbr\u003eMacrogol 4,000 increases the osmotic pressure in the intestine and can therefore modify the intestinal absorption of other products taken at the same time. Inform your doctor or pharmacist if you are taking any other products.\u003cbr\u003eExcessive doses of DulcoFosft may cause diarrhoea, abdominal pain, abdominal distension and vomiting, which resolves when treatment is stopped or the dose is reduced.\u003cbr\u003eKeep out of the sight and reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Dulcosoft oral solution 250ml not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not take in case of: hypersensitivity to macrogol 4.000 or to any of the other components; severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon; gastrointestinal perforation or risk of gastrointestinal perforation; paralytic ileus or suspected intestinal obstruction or symptomatic stricture; painful abdominal syndromes for which the cause has not been established. If you have any concerns, consult your doctor or pharmacist before taking DulcoSoft. DulcoSoft should not be taken daily for extended periods of time without investigating the cause of constipation.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Dulcosoft oral solution 250ml stored?\u003c\/h3\u003e\u003cp\u003eStore at temperatures not exceeding 25°C. Do not store in the refrigerator.\u003cbr\u003eDo not use after the expiry date.\u003cbr\u003eThe expiry date refers to the last day of that month.\u003cbr\u003eValidity after first opening: 6 weeks.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Dulcosoft oral solution 250ml?\u003c\/h3\u003e\u003cp\u003e250 ml bottle.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131318042951,"sku":"971635925","price":14.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-dulcosoft-soluzione-orale-250ml-farmacia-dottor-tili-1213792107.jpg?v=1767136168"},{"product_id":"montefarmaco-paraffina-liquida-afom-fu-200ml","title":"Montefarmaco Liquid Paraffin AFOM FU 200ml","description":"\u003cp\u003e\u003cstrong\u003eMontefarmaco Liquid Paraffin AFOM FU\u003c\/strong\u003e it's a \u003cstrong\u003eemollient laxative\u003c\/strong\u003e used for the treatment of \u003cstrong\u003eoccasional constipation\u003c\/strong\u003e.\nIt works by softening the stool and facilitating intestinal transit, without being absorbed by the body.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use Montefarmaco Liquid Paraffin AFOM FU 200ml? What is it for?\u003c\/h3\u003e\u003cp\u003eMontefarmaco Liquid Paraffin is useful for:\u003c\/p\u003e\u003cp\u003eTreat occasional constipation. Promote effortless evacuation. Situations in which it is necessary to avoid straining during defecation (post-surgery, hemorrhoids, etc.).\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Montefarmaco Liquid Paraffin AFOM FU 200ml?\u003c\/h3\u003e\u003cp\u003eAdults: \u003cstrong\u003e1-3 tablespoons per day\u003c\/strong\u003e, preferably in the evening. Children over 6 years: \u003cstrong\u003e1-2 teaspoons per day\u003c\/strong\u003e, according to medical indication. Take on an empty stomach, accompanied by a large glass of water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Montefarmaco Liquid Paraffin AFOM FU 200ml?\u003c\/h3\u003e\u003cp\u003eAdults: \u003cstrong\u003e1-3 tablespoons per day\u003c\/strong\u003e, preferably in the evening.\nChildren over 6 years: \u003cstrong\u003e1-2 teaspoons per day\u003c\/strong\u003e, according to medical indication.\nTake on an empty stomach, accompanied by a large glass of water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Montefarmaco Paraffina Liquida AFOM FU 200ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eKeep out of the reach and sight of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Montefarmaco Paraffina Liquida AFOM FU 200ml not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use in case of:\u003c\/p\u003e\u003cp\u003eIntestinal obstruction or abdominal pain of unknown origin. Pregnancy and breastfeeding without medical consultation. Prolonged use without medical supervision.\u003c\/p\u003e\u003cp\u003ePossible side effects include:\u003c\/p\u003e\u003cp\u003eDiarrhea or abdominal cramps in case of overdose. Reduced absorption of fat-soluble vitamins (A, D, E, K) in case of prolonged use. Risk of pulmonary aspiration if ingested in a lying position.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Montefarmaco Liquid Paraffin AFOM FU 200ml stored?\u003c\/h3\u003e\u003cp\u003eThe expiry date indicated refers to the product in intact packaging and correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Montefarmaco Paraffina Liquida AFOM FU 200ml?\u003c\/h3\u003e\u003cp\u003e200ml.\u003c\/p\u003e","brand":"Montefarmaco","offers":[{"title":"Default Title","offer_id":51131327283527,"sku":"988671754","price":4.84,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/montefarmaco-montefarmaco-paraffina-liquida-afom-fu-200ml-farmacia-dottor-tili-1254211201.jpg?v=1786730619"},{"product_id":"melilax-adulti-6-microclismi","title":"Melilax Adults 6 micro enemas","description":"\u003cp\u003eThe \u003cstrong\u003eMelilax Adults 6 microenemas\u003c\/strong\u003e is a class IIb medical device, designed to offer an effective solution to constipation, combining an evacuating action with a protective and soothing action on the rectal mucosa. This microenema is formulated based on honey, taking advantage of the active complex \u003cstrong\u003ePROMELAXIN\u003c\/strong\u003e, which includes nectar and honeydew honeys selected for their content of monosaccharides, polysaccharides and melanoidins, enriched with polysaccharides from \u003cstrong\u003eAloe and Mallow\u003c\/strong\u003e. \u003c\/p\u003e\n\n\u003cp\u003eThanks to its composition, Melilax Adulti guarantees a non-irritating evacuating action, stimulating a physiological and balanced activation of defecation. Its mucous-like properties and viscosity protect the rectal mucosa during the passage of feces, mimicking the lubricating action of physiological mucus. Furthermore, the antioxidant action of the product helps to protect and soothe the mucosa, offering an indirect anti-inflammatory action. \u003c\/p\u003e\n\n\u003cp\u003eIndicated for the treatment of constipation, the \u003cstrong\u003eMelilax Adults\u003c\/strong\u003e it is particularly useful in the presence of visceral hypersensitivity, as in the case of irritable bowel syndrome, fissures and hemorrhoids. It is also suitable for use during pregnancy and breastfeeding, making it a versatile choice for adults and children aged 12 and over. Furthermore, the product is \u003cstrong\u003egluten free\u003c\/strong\u003e, guaranteeing safety even for those with food intolerances. \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Melilax Adults 6 microenemas used? What is it for?\u003c\/h3\u003e\u003cp\u003eMicroenema medical device based on honey (PROMELAXIN complex) with aloe and mallow, indicated for the treatment of constipation; promotes a non-irritating evacuating action and protects and soothes the rectal mucosa during the passage of feces.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Melilax Adults 6 microenemas contain?\u003c\/h3\u003e\u003cp\u003ePromelaxin complex of honey and polysaccharides from aloe and mallow\u003cbr\u003eTitle in: monosaccharides ≥ 50%, polysaccharides (Molecular Weight \u003e 20,000 Daltons) ≥ 0.3%.\u003cbr\u003eIt also contains: hydroglycerine mixture; Lemon juice; Lavender essential oil.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e1 10 g microenema as needed.\u003cbr\u003eIn case of stubborn constipation, apply 2 doses consecutively.\u003c\/p\u003e\u003cp\u003eOpen the microenema by removing the safety cannula cover:\u003cbr\u003e- grasp the white round ring located above the bellows;\u003cbr\u003e- with the other hand bend the cannula cover until it breaks and completely detaches from the ring nut;\u003cbr\u003e- remove the cannula cover.\u003cbr\u003eApply a few drops of product to the perianal area and gently introduce the cannula into the rectum. Press the microenema thoroughly and at the end of the application keep it pressed until the cannula is completely extracted, to prevent the product from being re-aspirated.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eIn case of persistent constipation it is important to consult your doctor to rule out other pathologies.\u003cbr\u003eThe microenema is disposable, therefore it must not be reused if half a dose is administered, as in the case of infants.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Melilax Adults 6 microenemas not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Melilax Adults 6 microenemas stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, away from heat sources and protected from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product. Do not use after the indicated expiry date.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e6 disposable microenemas with cannula cover for adults and children, 10 g each.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51131344847175,"sku":"932501392","price":11.31,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-melilax-adulti-6-microclismi-farmacia-dottor-tili-1213791970.jpg?v=1767149430"},{"product_id":"magnesia-bisurata-aromatic-40-pastiglie","title":"Magnesia Bisurata Aromatic 40 tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of upper digestive tract pathologies characterized by hyperacidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: Active ingredients: Magnesium Carbonate 71.0 mg, Sodium bicarbonate 64.2 mg, Calcium carbonate 525.0 mg. \u003cu\u003eExcipients with known effects\u003c\/u\u003e: sucrose, sodium saccharin. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium saccharin, sucrose, corn starch, calcium stearate, mint essential oil.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients, listed in paragraph 6.1. Renal failure. Do not administer simultaneously with tetracyclines (see section 4.5). Do not administer other drugs within 1 or 2 hours of using the product (see section 4.5). Administration of the medicine in pediatric age is not recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne tablet to dissolve slowly in the mouth after meals and whenever you feel pain. If necessary, repeat after a quarter of an hour. DO NOT EXCEED THE RECOMMENDED DOSES Use only for short treatment periods. \u003cb\u003ePatients with renal insufficiency: \u003c\/b\u003ethe reduced ability to eliminate the exogenous salt supplement provided by antacids with urine can lead to potentially severe electrolyte imbalances. Treatment with magnesium and calcium salts requires periodic checks of magnesium and calcium levels.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients with severe renal insufficiency, plasma magnesium levels tend to increase. In these patients, long exposures to high doses of magnesium can lead to encephalopathy or worsening of dialysis-induced osteomalacia. Generally, caution should be exercised in patients with impaired renal function. In these patients, plasma calcium and magnesium levels should be monitored regularly. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e \u003cb\u003eMagnesia Bisurata Aromatic contains sucrose\u003c\/b\u003e. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. \u003cb\u003eMagnesia Bisurata Aromatic contains less than 1 mmol (23 mg) sodium per tablet\u003c\/b\u003e, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt should be kept in mind that antacids can, through different mechanisms, interfere with the oral administration of other drugs. In particular, the simultaneous administration of tetracyclines can give rise to insoluble complexes, with a reduction in the absorption of these antibiotics. However, it is advisable not to administer other drugs within 1 or 2 hours of using the product. \u003ci\u003eAssociations to avoid:\u003c\/i\u003e tetracyclines: formation of insoluble complexes with reduction in the absorption and activity of these antibiotics. \u003ci\u003eAssociation not recommended:\u003c\/i\u003e quinidine: increased plasma levels of quinidine and risk of overdose due to decreased excretion. \u003ci\u003eAssociations that require precautions for use:\u003c\/i\u003e indomethacin, phosphorus, dexamethasone, digitalis, iron salts, nitrofurantoin, lincomycin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on the available bibliographic data, there are no known side effects related to the specialty. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. As in all cases of overdose, treatment should be symptomatic, adopting general supportive measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAlthough no adverse reactions are known, the product must be used under direct medical supervision in pregnant and breastfeeding women.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia Bisurata Aromatic does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131349926215,"sku":"005781036","price":11.69,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-magnesia-bisurata-aromatic-40-pastiglie-farmacia-dottor-tili-1213791959.jpg?v=1767149829"},{"product_id":"guttalax-7-5mg-ml-gocce-orali-15ml","title":"Guttalax 7.5mg\/ml oral drops 15ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 ml (15 drops) of solution contains: Active ingredient: sodium picosulphate 7.5 mg. Excipient with known effects: Sorbitol (E420) 450 mg (see section 4.4). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium benzoate, liquid sorbitol (E420), sodium citrate, citric acid monohydrate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGuttalax is contraindicated in patients with: • Hypersensitivity to the active substance and to any excipients, listed in paragraph 6.1; • Paralytic ileus or intestinal or biliary tract obstruction or stenosis; • Acute severe painful and\/or febrile abdominal conditions (such as appendicitis) associated with nausea and vomiting; • Severe state of dehydration; • Rare hereditary conditions of incompatibility with one of the excipients (see section 4.4). • Nausea or vomiting; • Acute inflammation of the gastrointestinal tract; • Rectal bleeding of unknown origin; • Gallstones; • Liver failure; • Pregnancy and breastfeeding (see section 4.6). Do not administer to children under 3 years of age (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following dosages are recommended: \u003cu\u003eAdults\u003c\/u\u003e In adults it is recommended to start with 7-8 drops in water per day and to decrease if the effect is excessive or to increase if the laxative effect is not achieved. In cases of stubborn constipation, up to 15-20 drops in water can be used. \u003cu\u003ePediatric population\u003c\/u\u003e In children (over 3 years): 2-3 drops in water per day. Do not exceed the recommended doses. It is advisable to initially use the minimum doses provided. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Guttalax should preferably be taken in the evening to induce evacuation the following morning. Swallow together with an adequate amount of water. A diet rich in liquids favors the effect of the medicine. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep the bottle in the outer carton in order to protect the medicine from light. Validity after first opening: 12 months.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Guttalax should not be taken continuously every day or for long periods of time without investigating the cause of constipation. Prolonged and excessive use can lead to diarrhea, electrolyte imbalance and hypokalemia. Cases of dizziness and\/or syncope have been reported in patients taking Guttalax. The data available on these cases suggest that the events could be related to syncope from defecation (or syncope attributable to the effort of evacuation), or to a vasovagal response to abdominal pain related to constipation, and not necessarily to the intake of sodium picosulfate itself. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 3 and 12 years the medicine can only be used after consulting the doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. This medicinal product contains 450 mg of sorbitol in 1 ml (15 drops), equivalent to 600 mg of sorbitol in the maximum recommended daily dose of 1.33 ml (20 drops) in the treatment of an adult patient. Sorbitol is a source of fructose. Patients with hereditary fructose intolerance (HFI), a rare genetic disease, should not be given this medicine. This medicinal product contains less than 1 mmol sodium (23 mg) in 20 drops, the maximum recommended daily dose for an adult, i.e. it is essentially “sodium-free”.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Continued use of Guttalax may increase patients' response to oral anticoagulants and change glucose tolerance. The concomitant use of diuretics or adrenocorticosteroids and excessive doses of Guttalax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Concomitant administration of antibiotics may reduce the laxative effect of Guttalax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLike all medicines, Guttalax can cause side effects, although not everybody gets them. Adverse reactions are listed below by system organ class and frequency, according to the following categories: Very common ≥ 1\/10 Common ≥ 1\/100, \u003c 1\/10 Uncommon ≥ 1\/1,000, \u003c 1\/100 Rare ≥ 1\/10,000, \u003c 1\/1,000 Very rare \u003c 1\/10,000 Not known frequency cannot be defined on the basis of available data. \u003cu\u003eImmune system disorders\u003c\/u\u003e. Not known*: hypersensitivity. \u003cu\u003eNervous system disorders\u003c\/u\u003e. Uncommon: dizziness; Not known*: syncope. The phenomena of dizziness and syncope that occur after taking sodium picosulphate appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e. Very common: diarrhea; Common: abdominal cramps, abdominal pain and abdominal discomfort; Uncommon: vomiting, nausea. Occasionally: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e. Not known*: skin reactions such as angioedema, rash on taking the medicine, rash, itching. \u003ci\u003e*These adverse reactions were observed in post-marketing experience. At 95% probability, the frequency category is not greater than uncommon, but could be lower. A precise estimate of the frequency is not possible since these adverse reactions did not occur in 1020 patients in clinical trials\u003c\/i\u003e. \u003cu\u003eReporting of side effects\u003c\/u\u003e If you get any side effects, including any not listed in this leaflet, contact your doctor or pharmacist. Undesirable effects can also be reported directly via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse. Reporting side effects helps provide more information on the safety of this medicine\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSigns and symptoms\u003c\/u\u003e Following the intake of high doses of the drug, the following may occur: watery stools (diarrhoea), abdominal cramps and a significant loss of fluids, potassium and other electrolytes. Cases of colonic mucosal ischemia have been reported with doses of Guttalax considerably higher than the recommended dosage for the treatment of occasional constipation. Guttalax, like other laxatives, in case of overdose causes chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. In association with chronic laxative abuse, renal tubular injury, metabolic alkalosis and muscle weakness secondary to hypokalemia have also been described. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting Guttalax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in the elderly and young people. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to evaluate the effects on human fertility. Non-clinical studies have revealed no effects on fertility (see section 5.3). \u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Long experience has shown no evidence of unwanted or harmful effects during pregnancy. Although toxic effects have never been reported during pregnancy, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active fraction of sodium picosulphate, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor the conjugated form (its glucuronic derivatives), are excreted in measurable quantities in breast milk. However, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince no specific studies have been carried out, there are no known inhibitory effects of Guttalax that would compromise the ability to drive and use machinery. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131350286663,"sku":"020949020","price":10.36,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-guttalax-7-5mg-ml-gocce-orali-15ml-farmacia-dottor-tili-1213791960.jpg?v=1767149908"},{"product_id":"alaxa-5mg-20-compresse-gastroresistenti","title":"Alaxa 5mg 20 gastro-resistant tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach gastro-resistant tablet contains: Active ingredient: bisacodyl 5 mg; Excipients with known effects: lactose monohydrate, sucrose, carboxymethylcellulose \u003cb\u003esodium\u003c\/b\u003e. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eTablet core\u003c\/i\u003e: \u003cb\u003elactose monohydrate\u003c\/b\u003e, corn starch, magnesium stearate, gelatin. \u003ci\u003eGastro-resistant film-coating\u003c\/i\u003e: diethyl phthalate, cellulose acetophthalate, talc. \u003ci\u003eSugary coating\u003c\/i\u003e: acacia, \u003cb\u003esucrose\u003c\/b\u003e, carboxymethylcellulose\u003cb\u003e sodium\u003c\/b\u003e, macrogol 6000, titanium dioxide, calcium carbonate, talc.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to other chemically related substances or to any of the excipients listed in paragraph 6.1. - Children under 3 years of age. - Generally contraindicated during pregnancy and breastfeeding (see section 4.6). - Subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration, acute surgical abdomen, appendicitis, gastroenteritis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e: 2 tablets per day; in particularly stubborn cases, 3 tablets. \u003ci\u003ePediatric population\u003c\/i\u003e. \u003cu\u003eChildren aged between 3 and 12 years\u003c\/u\u003e: 1-2 tablets per day (0.3 mg\/kg) under direct medical supervision. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. \u003cu\u003eMethod of administration\u003c\/u\u003e: The tablets should be swallowed whole, without chewing, together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. The tablets should preferably be administered after the evening meal, so that the effect of the laxative, which occurs after 10-12 hours, does not disturb sleep. If taken on an empty stomach, the laxative effect occurs within approximately 5 hours. Take ALAXA at ​​least 1 hour after taking milk or antacids and at least two hours after taking other medicines orally.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine does not require any particular storage temperature. Store in the original packaging, to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAbuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Furthermore, the abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and therefore the possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Frequent or prolonged use of the medicine must be avoided as it can cause addiction and atonic colitis. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Caution is recommended if the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks; when rectal bleeding is present; when the use of the laxative fails to produce effects or when the patient suffers from diabetes mellitus, hypertension or heart disease. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003ci\u003ePediatric population\u003c\/i\u003e: In children under 12 years of age the medicine can only be used after consulting a doctor. \u003cu\u003eImportant information about some excipients:\u003c\/u\u003e ALAXA contains: - lactose monohydrate: patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine; - sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. - sodium: This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMilk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of diuretics, cardiac glycosides or adrenocorticosteroids may promote electrolyte imbalance. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOccasionally: isolated cramping pain or abdominal colic. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Muscle weakness and weight loss may occur. In case of accidental overdose, gastric lavage is indicated. See also what is reported in paragraph 4.4 regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no limitations. However, those carrying out an activity that requires vigilance should use caution.\u003c\/p\u003e","brand":"Angelini Acraf","offers":[{"title":"Default Title","offer_id":51131368341831,"sku":"009262015","price":7.51,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-a-c-r-a-f-spa-alaxa-5mg-20-compresse-gastroresistenti-farmacia-dottor-tili-1213791893.jpg?v=1767150208"},{"product_id":"tamarine-8-0-39-marmellata-vasetto-260g","title":"Tamarine 8% + 0.39% jam jar 260g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of product contains: \u003cb\u003eActive ingredients:\u003c\/b\u003e Cassia Angustifolia 8 g - Cassia fistula 0.39 g. \u003cu\u003eExcipients with known effects\u003c\/u\u003e: sucrose, sodium methyl parahydroxybenzoate, sodium hydroxide For the complete list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTamarindus indica soft extract, coriandrum sativum powder, glycyrrhiza glabra dry extract, sodium methyl parahydroxybenzoate, mirabella essence, sodium hydroxide (for pH adjustment), citric acid (for flavor adjustment), jam (sucrose, fruit, tartaric acid, potassium sorbate, water).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes. Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Children under 10 years old. Pregnancy and breastfeeding (see p. 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to use the minimum doses initially. When necessary, the dose can then be increased, but without ever exceeding the indicated one. Take preferably in the evening. \u003cb\u003eAdults: \u003c\/b\u003e1 teaspoon. \u003cb\u003eChildren over 10 years old\u003c\/b\u003e: ¼ teaspoon. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C. Keep container tightly closed. For storage conditions after first opening, see paragraph 6.3.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eWarnings\u003c\/u\u003e \u003c\/b\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cb\u003e \u003cu\u003ePrecautions for use \u003c\/u\u003e \u003c\/b\u003e The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003cb\u003eTamarine contains sucrose.\u003c\/b\u003e Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine \u003cb\u003eTamarine contains sodium methyl parahydroxybenzoate.\u003c\/b\u003e May cause allergic reactions (even delayed). \u003cb\u003eTamarine contains less than 1 mmol (23 mg) sodium per serving (1 teaspoon)\u003c\/b\u003e, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other drugs that induce hypokalemia (e.g. diuretics, adrenocorticosteroids and licorice) may increase electrolyte imbalance. Hypokalemia (resulting from abuse of laxatives taken for a long time) enhances the action of cardiac glycosides and interferes with antiarrhythmic drugs, with other drugs that induce the return to sinus rhythm (quinidine) and with drugs that induce prolongation of the Q-T interval.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine may occasionally cause: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. With the use of this medicine, the urine sometimes turns slightly yellow-brown or red. This coloring is simply due to the presence of senna components in the urine and is not clinically significant. Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10); uncommon (≥ 1\/1,000, \u003c 1\/100); rare (≥ 1\/10,000; \u003c 1\/1,000); very rare (\u003c 1\/10,000), or not known (frequency cannot be estimated from the available data). \u003cb\u003eTable 4-1 Undesirable effects in the post-marketing experience\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eImmune system disorders (not known) - Adverse event: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders (not known) - Adverse event: Hyperaldosteronism, Hypocalcemia, Hypomagnesemia, Dehydration, Hypokalemia, Hyponatremia, Decreased blood electrolytes.\u003c\/p\u003e\n\u003cp\u003eVascular disorders (not known) - Adverse event: Hypotension.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders (not known) - Adverse event: Megacolon, Diarrhea, Nausea, Abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal system and connective tissue disorders (not known) - Adverse event: Myopathy.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders (not known) - Adverse event: Kidney problems, Chromaturia.\u003c\/p\u003e\n\u003cp\u003eSystemic disorders and conditions relating to the site of administration (not known) - Adverse event: Fatigue, Tolerance to the drug (see Warnings and Precautions for use).\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced with fluid intake. Treatment: discontinuation of the drug. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, since anthraquinone laxatives may be excreted in breast milk, breastfeeding mothers should avoid taking Tamarine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known effects on the ability to drive and use machines.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131368407367,"sku":"021528157","price":18.76,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-tamarine-8-0-39-marmellata-vasetto-260g-farmacia-dottor-tili-1213791898.jpg?v=1767150189"},{"product_id":"guna-nux-vomica-50-tavolette","title":"Guna Nux Vomica 50 Tablets","description":"\u003cp\u003e\u003cstrong\u003eGuna Nux Vomica\u003c\/strong\u003e it is a homeopathic remedy useful for \u003cstrong\u003edigestive well-being\u003c\/strong\u003e and to counteract disorders such as gastric acidity, reflux and digestive difficulties.\nThanks to its natural formulation, it helps to rebalance the digestive system and promotes better food tolerance.\u003c\/p\u003e\n\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Guna Nux Vomica 50 Tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eGuna Nux Vomica is indicated for:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003ePromote digestion and reduce the feeling of heaviness.\u003c\/li\u003e\n\u003cli\u003eCounteract acidity and gastric reflux.\u003c\/li\u003e\n\u003cli\u003eHelp in disorders caused by overeating or consumption of irritating foods.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Guna Nux Vomica 50 Tablets?\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eIt is recommended to hire \u003cstrong\u003e1-2 tablets\u003c\/strong\u003e up to 3 times a day.\u003c\/li\u003e\n\u003cli\u003eThe tablets should be dissolved slowly in the mouth or swallowed with a little water.\u003c\/li\u003e\n\u003cli\u003eTake preferably between meals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Guna Nux Vomica 50 Tablets?\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eIt is recommended to hire \u003cstrong\u003e1-2 tablets\u003c\/strong\u003e up to 3 times a day.\u003c\/li\u003e\n\u003cli\u003eThe tablets should be dissolved slowly in the mouth or swallowed with a little water.\u003c\/li\u003e\n\u003cli\u003eTake preferably between meals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Guna Nux Vomica 50 Tablets not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not take in case of:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eHypersensitivity to the components.\u003c\/li\u003e\n\u003cli\u003ePregnancy and breastfeeding without medical consultation.\u003c\/li\u003e\n\u003cli\u003eSerious gastrointestinal disorders.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eGenerally well tolerated. In rare cases the following may occur:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eMild allergic reactions.\u003c\/li\u003e\n\u003cli\u003eMild alteration of intestinal motility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Guna Nux Vomica 50 Tablets?\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eDo not exceed the recommended dose.\u003c\/li\u003e\n\u003cli\u003eKeep out of reach of children.\u003c\/li\u003e\n\u003cli\u003eIf symptoms persist, consult a doctor.\u003c\/li\u003e\n\u003cli\u003eStore in a cool, dry place.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Guna Nux Vomica 50 Tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature. The expiry date is indicated on the packaging.\u003c\/p\u003e\n\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Guna Nux Vomica 50 Tablets?\u003c\/h3\u003e\u003cp\u003eBottle of \u003cstrong\u003e50 tablets\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2\u003eDRUG LEGAL TEXT\u003c\/h2\u003e\n\u003cp\u003eContent responsibility\u003c\/p\u003e\u003cp\u003eThis sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.\u003c\/p\u003e\u003cp\u003ePlease note\u003c\/p\u003e\u003cp\u003eThe product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.\u003c\/p\u003e\u003cp\u003eData source: Farmadati Italia\u003c\/p\u003e\u003cp\u003eWebsite: www.farmadati.it\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO\/IEC 27001:2017 for information security management systems.\u003c\/p\u003e","brand":"Guna","offers":[{"title":"Default Title","offer_id":51131374567751,"sku":"909467728","price":11.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/guna-spa-guna-nux-vomica-50-tavolette-farmacia-dottor-tili-1213791867.jpg?v=1767137746"},{"product_id":"regolint-9-7-g-20-bustine-polvere-per-soluzione-orale","title":"Regolint 9.7 g 20 sachets powder for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eOne sachet contains\u003c\/u\u003e: \u003cu\u003eActive ingredient\u003c\/u\u003e: macrogol 4000 g 9,736. For the complete list of excipients see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAcesulfame potassium, banana flavour.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to macrogol (polyethylene glycol) or to any of the excipients; severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon, associated with symptomatic stricture; perforation or risk of perforation of the digestive tract; ileus or suspected intestinal obstruction; acute abdominal pain or pain of unknown origin; nausea or vomiting, marked accentuation or reduction of peristalsis, rectal bleeding; severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults and children over 8 years of age and weighing over 20 kg\u003c\/i\u003e The daily dose must be adapted based on the clinical effect obtained and can vary from one sachet every other day (especially in children) up to 2 sachets per day. Do not exceed the maximum daily dosage of 20 g of macrogol. The indicated dose should be adjusted based on individual response. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. The daily dose can be taken in one or two fractions, between meals. If you need to take a sachet, it must be taken in the morning. If you need to take multiple sachets, you will need to divide the doses between morning and evening. The effect of REGOLINT manifests itself in the 24-48 hours following its administration. Sometimes it can take two days (or more) before you get the desired effect. In this case, continue the treatment keeping in mind, however, that laxatives must be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. In children, in the absence of clinical data on administration periods exceeding three months, treatment should not exceed three months. Dissolve the contents of one sachet in at least 125 ml (equal to a glass) of water. Do not add other ingredients. It is preferable to drink the entire quantity quite quickly (within a few minutes) avoiding sipping it for a long time. A diet rich in liquids favors the effect of the medicine. The regularization of intestinal motility induced by the treatment must be maintained with a healthy lifestyle and correct nutrition.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original package to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eWarnings\u003c\/i\u003e \u003c\/b\u003e Efficacy data in children under 2 years of age are limited. The treatment of constipation with any medicine is only an adjunct to a healthy lifestyle and correct nutrition, for example: increased intake of liquids and vegetable fibres, appropriate physical activity and restoration of intestinal motility. Before starting treatment, organic diseases must be excluded. Laxatives should not be used by subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, marked accentuation or reduction of peristalsis, rectal bleeding. The presence of one or more of these symptoms or signs requires an adequate diagnostic investigation by the doctor in order to exclude one of the pathological conditions that contraindicate the use of laxatives (for example: obstruction or suspected intestinal obstruction, intestinal stenosis or perforation, paralytic ileus, serious inflammatory diseases of the intestine). After a 3-month course of treatment, full clinical supervision of constipation should be performed. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Caution should be exercised in the elderly, in patients with hepatic insufficiency, renal insufficiency, heart failure. In these cases it is advisable to periodically check serum electrolyte levels. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). REGOLINT, not containing any sugar or polyol, can be taken by diabetic patients or those undergoing a galactose-free regime. \u003cb\u003e \u003ci\u003ePrecautions for use\u003c\/i\u003e \u003c\/b\u003e In children the medicine can only be used after consulting a doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative arises from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Very rare cases of hypersensitivity reactions (rash, urticaria, edema) have been reported with some macrogol-containing medicinal products, including exceptional cases of anaphylactic shock. In these cases, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine and therefore the absorption of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Caution should be used when Regolint is used with drugs with a narrow therapeutic index (e.g. antiepileptics and immunosuppressive agents). The use of licorice increases the risk of hypokalemia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdverse drug reactions are listed by frequency using the following frequency classes: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10), uncommon (≥1\/1,000, \u003c1\/100), rare (≥1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000) and not known (frequency cannot be estimated). based on available data). \u003cu\u003eAdults\u003c\/u\u003e: The side effects listed in the following table were reported during clinical trials involving 600 adult patients and from post-marketing data. The reported adverse reactions are usually mild in intensity and transient, and mainly affect the gastrointestinal system. In case of hypersensitivity reactions, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal distension.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Nausea.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Vomiting.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Urgent evacuation.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Faecal incontinence.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Rectal irritation.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Electrolyte imbalance (hyponatremia, hypokalemia).\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Dehydration (particularly in the elderly).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Hypersensitivity reactions (pruritus, rash, urticaria, edema, face edema, angioedema, dyspnoea, anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The side effects listed in the table below were reported during clinical trials involving 147 children aged 6 months to 15 years, and from post-marketing data. As in the case of adults, the reported adverse reactions are usually mild in intensity and transient, and mainly affect the gastrointestinal system. In case of hypersensitivity reactions, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Diarrhoea*.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Vomiting.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Abdominal distension.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Nausea.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Rectal irritation.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Hypersensitivity\u003c\/p\u003e\n\u003cp\u003e* Diarrhea can cause perianal pain \u003ci\u003eReporting of suspected adverse reactions\u003c\/i\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOverdose causes diarrhea which disappears with temporary interruption of treatment or reduction of the dose. Excessive fluid loss caused by diarrhea or vomiting may require correction of the electrolyte imbalance. Excessive doses can cause abdominal pain. Cases of aspiration have been reported during administration of large volumes of polyethylene glycol and electrolytes with a nasogastric tube. Children with neurological impairment who suffer from oromotor dysfunction are particularly at risk for aspiration. Also see what is reported in the paragraph \"Special warnings and precautions for use\" regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed.\u003c\/p\u003e","brand":"Baldacci","offers":[{"title":"Default Title","offer_id":51730202788167,"sku":"038204020","price":14.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/baldacci-regolint-9-7-g-20-bustine-polvere-per-soluzione-orale-farmacia-dottor-tili-1258975917.jpg?v=1789560579"},{"product_id":"simecrin-120-mg-24-compresse-masticabili","title":"Simecrin 120 mg 24 chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of gastrointestinal meteorism and aerophagia in adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eSimecrin 40 mg chewable tablets\u003c\/i\u003e One tablet contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: simethicone mg 40 Excipient with known effects: 158.8 mg of lactose. \u003ci\u003eSimecrin 80 mg chewable tablets\u003c\/i\u003e One tablet contains \u003cu\u003eActive ingredient\u003c\/u\u003e: simethicone mg 80 Excipient with known effects: 317.6 mg of lactose. \u003ci\u003eSimecrin 120 mg chewable tablets\u003c\/i\u003e One tablet contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: simethicone 120 mg Excipient with known effects: 476.4 mg of lactose. \u003ci\u003eSimecrin 80 mg\/ml oral emulsion\u003c\/i\u003e 1 ml of emulsion contains: Active ingredient: simethicone 80 mg Excipients with known effect: methyl parahydroxy benzoate 0.9 mg, propyl parahydroxy benzoate 0.1 mg and sodium 2.71 mg. For the complete list of excipients see paragraph 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eChewable tablets\u003c\/i\u003e Mannitol (E421), hydrated colloidal silica, pregelatinized starch, lactose monohydrate, polyvinylpyrrolidone K30, crospovidone, talc, magnesium stearate, mint flavour. \u003ci\u003eOral emulsion:\u003c\/i\u003e Citric acid monohydrate, Sodium citrate, Carbomers, Sodium saccharin, Hypromellose, Methyl parahydroxybenzoate, Propyl parahydroxybenzoate, Tuttifrutti flavour, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Generally contraindicated during pregnancy (see section 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eAdults\u003c\/u\u003e: \u003ci\u003eSimecrin 40 mg Chewable Tablets:\u003c\/i\u003e 4 tablets per day (two at the end of each main meal). \u003ci\u003eSimecrin 80 mg Chewable Tablets:\u003c\/i\u003e 2 tablets per day (one at the end of each main meal). \u003ci\u003eSimecrin 120 mg Chewable Tablets:\u003c\/i\u003e 2 tablets per day (one at the end of each main meal). The tablets must be chewed. \u003ci\u003eSimecrin 80 mg\/ml oral emulsion:\u003c\/i\u003e 1-1.5 ml (at the end of each main meal). The prescribed quantity of oral emulsion should be taken with the measuring syringe and dispersed in a glass of water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eChewable tablets: store the medicine in the original packaging to protect the product from light and humidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not exceed the recommended doses. After a short period of treatment without appreciable results, consult your doctor. Important information about some excipients The chewable tablets contain lactose: patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine. The oral emulsion contains para-hydroxybenzoates which may cause allergic reactions (even delayed). The oral emulsion contains less than 1 mmol (23 mg) sodium per ml, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known, nor have been reported, interactions with other drugs.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo side effects due to Simecrin have been highlighted. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo overdose phenomena have been reported with the use of Simecrin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate data on the use of Simecrin in pregnant women, therefore it should not be used during pregnancy unless there is a real need and after a risk\/benefit assessment by the doctor. \u003cu\u003eBreastfeeding\u003c\/u\u003e It is not known whether simethicone is excreted in breast milk. The excretion of simethicone in breast milk has not been studied in animals. The decision whether to continue\/discontinue breastfeeding or to continue\/discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the infant and of simethicone therapy for the woman.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo effects on the ability to drive or use machines are reported.\u003c\/p\u003e","brand":"Eg","offers":[{"title":"Default Title","offer_id":51730202886471,"sku":"034842031","price":14.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/eg-simecrin-120-mg-24-compresse-masticabili-farmacia-dottor-tili-1254211101.jpg?v=1786730199"},{"product_id":"casenlax-10-g-20-bustine-polvere-per-soluzione-orale","title":"Casenlax 10 g 20 sachets powder for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of constipation in adults and children aged 8 years and older. An organic disorder must be excluded before starting treatment. Casenlax must remain a temporary treatment adjuvant to an appropriate lifestyle and diet for constipation, with a maximum treatment cycle of 3 months in children. If symptoms persist despite associated dietary measures, a different underlying cause should be suspected and treated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains 10 g of macrogol 4000. Excipients with known effects: 0.0000018 mg sulfur dioxide (E220) per sachet and less than 1 mmol (23 mg) sodium per sachet. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium saccharin (E954), apple flavour* *Composition of apple flavour: Natural flavour, maltodextrin, gum arabic E414, sulfur dioxide E220, alpha tocopherol E307.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. - Severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon, associated with symptomatic stricture. - Perforation of the digestive system or risk of perforation of the digestive system. - Paralytic ileus or suspected intestinal obstruction. - Painful abdominal syndromes of an undetermined nature.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral use \u003cu\u003eDosage\u003c\/u\u003e 1 to 2 sachets per day, preferably taken as a single dose in the morning. It is recommended to drink 125 ml of fluid (e.g. water) after each dose. The effect of Casenlax occurs within 24-48 hours after administration. The daily dose must be adapted according to the clinical effects and can vary from one sachet every other day (especially in children) up to 2 sachets per day. Treatment should be stopped gradually and restarted if constipation recurs. \u003ci\u003ePediatric population\u003c\/i\u003e 1 to 2 sachets per day, preferably taken as a single dose in the morning. It is recommended to drink 125 ml of fluid (e.g. water) after each dose. In children, treatment should not exceed 3 months due to the lack of clinical data in treatments lasting longer than 3 months. The regularization of intestinal motility induced by the treatment will be maintained by lifestyle and dietary measures. \u003cu\u003eMethod of administration\u003c\/u\u003e Each sachet should be dissolved in a glass of water (approximately 125 ml) just before use. The resulting solution will be clear and transparent like water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe treatment of constipation with any medicine is only an adjunct to a healthy lifestyle and diet, for example: - Increased intake of liquids and dietary fibre, - Adequate physical activity and re-education of intestinal motility. Due to the presence of sulfur dioxide Casenlax can rarely cause severe hypersensitivity reactions and bronchospasm. In case of diarrhoea, caution should be used in patients predisposed to water and\/or electrolyte balance disorders (e.g. elderly, patients with hepatic or renal impairment or patients being treated with diuretics) and electrolyte control should be considered. Hypersensitivity reactions (rash, urticaria and edema) have been reported with drugs containing macrogol (polyethylene glycol). Exceptional cases of anaphylactic shock have been reported. Casenlax contains a non-significant amount of sugars or polyols and can be prescribed to diabetic patients or patients following a galactose-free diet. This medicinal product contains less than 1 mmol (23 mg) sodium per sachet, i.e. essentially 'sodium-free'. Based on the mechanism of action of macrogol, fluid intake is recommended during treatment with this medicinal product (see section 5.1). The absorption of other medicinal products may be temporarily reduced due to the macrogol-induced increase in gastrointestinal transit rate (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere is a possibility that the absorption of other medicines may be temporarily reduced while using Casenlax. The therapeutic effect of medicinal products with a narrow therapeutic index (e.g. antiepileptics, digoxin and immunosuppressive agents) may be particularly affected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects are listed by frequency using the following categories: Very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003cb\u003e \u003cu\u003eAdult population\u003c\/u\u003e:\u003c\/b\u003e The side effects listed in the following table were reported during clinical trials including 600 adult patients and in post-marketing experience. In general, adverse reactions were mild and transient and mainly affected the gastrointestinal system:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Very rare - Adverse reactions: Hypersensitivity reactions (pruritus, rash, facial edema, Quincke's edema, urticaria, anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003eSystem organs: Not known - Adverse reactions: Erythema.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eSystem Organs: Not known - Adverse reactions: Electrolyte disturbances (hyponatremia, hypokalemia) and\/or dehydration, especially in elderly patients.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Common - Adverse reactions: Abdominal pain and\/or distension, Diarrhoea, Nausea.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Uncommon - Adverse reactions: Vomiting, Defecation urgency, Fecal incontinence.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003ePediatric population:\u003c\/u\u003e \u003c\/b\u003e The side effects listed in the following table were reported during clinical trials involving 147 children aged between 6 months and 15 years and in post-marketing use. As in the adult population, adverse reactions were generally mild and transient and mainly concerned the gastrointestinal system:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Not known - Adverse reactions: Hypersensitivity reactions (anaphylactic shock, angioedema, urticaria, rash, pruritus).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Common - Adverse reactions: Abdominal pain, Diarrhoea*.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Uncommon - Adverse reactions: Vomiting, Bloating, Nausea.\u003c\/p\u003e\n\u003cp\u003e* Diarrhea can cause perianal pain \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOverdose can lead to diarrhea, abdominal pain and vomiting which disappear when treatment is stopped temporarily or the dosage is reduced. Excessive fluid loss due to diarrhea or vomiting may require correction of electrolyte imbalances. Cases of aspiration have been reported when large volumes of macrogol (polyethylene glycol) and electrolytes were administered via nasogastric tube. Neurologically compromised children who suffer from oromotor dysfunction are particularly at risk for aspiration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Animal studies do not indicate direct or indirect harmful effects of reproductive toxicity (see section 5.3). Data relating to the use of Casenlax in pregnant women are limited (less than 300 pregnancy outcomes). Casenlax is not expected to cause any effects during pregnancy, since systemic exposure to Casenlax is negligible. Casenlax can be used during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e There are no data on the excretion of Casenlax in breast milk. Macrogol 4000 is not expected to cause any effects on newborns\/infants, as systemic exposure to macrogol 4000 of breastfeeding women is negligible. Casenlax can be used during breastfeeding. \u003cu\u003eFertility\u003c\/u\u003e No fertility studies have been conducted with Casenlax; however, since macrogol 4000 is not significantly absorbed, no effects are expected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCasenlax does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51730205573447,"sku":"042583029","price":14.92,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-casenlax-10-g-20-bustine-polvere-per-soluzione-orale-farmacia-dottor-tili-1254215771.jpg?v=1786736397"},{"product_id":"antispasmina-colica-forte-50-mg-10-mg-30-compresse-rivestite","title":"Antispasmin colic forte 50 mg + 10 mg 30 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment in spastic-painful manifestations of the gastrointestinal system.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntispasmin Colic Each coated tablet contains 10 mg of papaverine hydrochloride (equal to 9.016 mg of papaverine) and 10 mg of belladonna extract 1% hyoscyamine Excipients with known effects: Each tablet contains 75 mg of lactose and 42.8 mg of sucrose and 0.2 mg of castor oil Antispasmin Colic Forte Each coated tablet contains 50 mg of papaverine hydrochloride (equal to 45.08 mg of papaverine) and 10 mg of belladonna extract 1% hyoscyamine Excipients with known effects: Each tablet contains 49 mg of lactose and 67.8 mg of sucrose and 0.3 mg of castor oil. For the complete list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eAntispasmin Colic\u003c\/b\u003e Lactose, corn starch, povidone, magnesium stearate, precipitated silica, shellac, castor oil, cellulose acetophthalate, diethyl phthalate, magnesium carbonate, talc, charcoal, gum arabic, sucrose. \u003cb\u003e \u003ci\u003eAntispasmin ColicaForte\u003c\/i\u003e \u003c\/b\u003eLactose, corn starch, povidone, magnesium stearate, precipitated silica, shellac, castor oil, cellulose acetophthalate, diethyl phthalate, magnesium carbonate, talc, charcoal, gum arabic, sucrose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIpersensibilità ai principi attivi, a uno qualsiasi degli eccipienti elencati al paragrafo 6.1. or to other substances closely related from a chemical point of view; in particular towards atropine, methyl homatropine, scopolamine, drotaverine, moxaverine. Children under 12 years old. Pregnancy and breastfeeding. Glaucoma, pyloric stenosis, prostatic hypertrophy and other stenosing diseases of the urinary system; paralytic ileus and obstructive diseases of the gastrointestinal system; intestinal atony in the elderly and debilitated subjects; colite ulcerosa, megacolon tossico, miastenia grave. In patients with disorders of the autonomic nervous system, in carriers of hepato-renal diseases, hyperthyroidism, coronary artery disease, in cardiac tachyarrhythmias, in arterial hypertension and in congestive heart failure, simultaneous intake of sulphonamides and beta blockers (see section 4.5), intake of medicines belonging to different therapeutic groups but with anticholinergic action such as antihistamines, butyrophenones, phenothiazines, antidepressants tricyclics and amantadine (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntispasmin Colic: 2 to 6 tablets per day Antispasmin Colic Forte: 1 to 3 tablets per day Do not exceed the recommended doses. The tablets should be swallowed before meals or when needed and should be swallowed whole because they must reach the intestine intact, where they carry out their action at the level of spasm. In case of diarrhea or hypermotility of the intestine, the tablets may, exceptionally, be expelled whole; in this case it is advisable, at least for a few days, to ingest the tablets after having fragmented them. Antispasmin Colica is contraindicated in children (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter a short period of treatment without appreciable results, consult your doctor. Preparations containing anticholinergics must be used only in case of real need and under the direct supervision of a doctor in the elderly. The effects of these compounds are accentuated by the simultaneous administration of substances belonging to different therapeutic groups but with anticholinergic action such as antihistamines, butyrophenones, phenothiazines, tricyclic antidepressants, amantadine, which therefore should not be taken at the same time. Likewise, sulphonamides and beta blockers should not be taken at the same time; the appearance of secondary manifestations requires suspension of therapy. The medicine contains sucrose and lactose, this should be taken into account in case of diabetes or low-calorie diets. Antispasmin Colica contains sucrose therefore patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine; furthermore, the medicine contains lactose so patients suffering from rare hereditary problems of galactose intolerance or lactase deficiency should not take it.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not administer simultaneously with sulphonamides and beta blockers. The effects of preparations containing anticholinergics are accentuated by the simultaneous administration of substances belonging to different therapeutic groups but with anticholinergic action such as antihistamines, butyrophenones, phenothiazines, tricyclic antidepressants and amantadine, which therefore should not be taken at the same time.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFollowing treatment with Antispasmina Colica the following side effects have been reported:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Side Effects (Preferred Terms): Allergic reactions.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Undesirable effects (Preferred Terms): Drowsiness.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Undesirable effects (Preferred Terms): Dizziness.\u003c\/p\u003e\n\u003cp\u003eEye disorders - Undesirable effects (Preferred Terms): Conjunctival irritation.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Undesirable effects (Preferred Terms): Tachycardia.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Undesirable effects (Preferred Terms): Dry mouth.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Undesirable effects (Preferred Terms): Nausea.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Undesirable effects (Preferred Terms): Vomiting.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Undesirable effects (Preferred Terms): Gastroesophageal reflux.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Undesirable effects (Preferred Terms): Constipation.\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders - Undesirable effects (Preferred Terms): Jaundice.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Undesirable effects (Preferred Terms): Urticaria.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Undesirable effects (Preferred Terms): Skin reactions.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Undesirable effects (Preferred Terms): Difficulty in urination.\u003c\/p\u003e\n\u003cp\u003eSystemic disorders and conditions relating to the administration site - Undesirable effects (Preferred Terms): Retrosternal pain.\u003c\/p\u003e\n\u003cp\u003eInvestigations - Undesirable Effects (Preferred Terms): Increased intraocular pressure.\u003c\/p\u003e\n\u003cp\u003eInvestigations - Undesirable Effects (Preferred Terms): Alteration of liver function tests.\u003c\/p\u003e\n\u003cp\u003eAt high doses, anticholinergics can cause urinary retention, cardiac arrhythmias, breathing difficulties, agitation and mental confusion. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ewww.agenziafarmaco.gov.it\/it\/responsabili\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, consult your doctor immediately. At high doses, anticholinergics can cause urinary retention, cardiac arrhythmias, respiratory difficulty, agitation and mental confusion. As in all cases of overdose, treatment should be symptomatic, adopting general supportive measures. There is no known specific antidote.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntispasmin Colica is contraindicated during pregnancy and breastfeeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntispasmin Colica impairs the ability to drive or use machinery. Since the product may induce drowsiness, those who may drive motor vehicles or carry out operations that require a high degree of vigilance should be warned of this.\u003c\/p\u003e","brand":"Recordati","offers":[{"title":"Default Title","offer_id":51730207932743,"sku":"002918050","price":9.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/recordati-spa-antispasmina-colica-forte-50-mg-10-mg-30-compresse-rivestite-farmacia-dottor-tili-1213791084.jpg?v=1767140567"},{"product_id":"agiolax-granulato-400-g-confezione-con-cucchiaio-dosatore","title":"Agiolax granules 400 g pack with measuring spoon","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and adolescents over 12 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of granules contain \u003ci\u003eActive ingredients:\u003c\/i\u003e - Ispagula seed 52 g - Ispagula cuticle 2.2 g - Senna fruit 6.74 - 13.15 g equivalent to 300 mg of hydroxyanthracene derivatives calculated as sennoside B Excipients with known effects: sucrose For the complete list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTalc, gum arabic, cumin essence, sage essence, mint essence, liquid paraffin, solid paraffin, E 172, sucrose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active substances or to any of the excipients listed in section 6.1 • sudden irregularity of intestinal functions that persists for more than 2 weeks • acute abdominal pain or of unknown origin • nausea or vomiting • intestinal obstruction • esophageal or gastrointestinal stricture • rectal bleeding of unknown origin • failure to defecate following the use of laxatives • severe state of dehydration • dysphagia, hiatal hernia or conditions which pose a risk of regurgitation • atony of the colon • megacolon • faecal impaction • children under 12 years of age • pregnancy and breast-feeding (see section 4.6) • Crohn's disease, ulcerative colitis and appendicitis\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage The correct dose is the minimum sufficient to produce an easy evacuation of soft stools. It is recommended to initially use the minimum doses envisaged. When necessary, the dose can be increased. Do not exceed the maximum recommended daily dose. \u003cstrong\u003eAdults and adolescents over 12 years:\u003c\/strong\u003e The recommended dose is 5 g or 10 g of granules (corresponding to 1 - 2 measuring spoons) once a day. 1-2 sachets of 5 g once a day. Do not exceed the maximum recommended daily dose. \u003cb\u003eChildren \u003c\/b\u003e Agiolax is contraindicated in children under 12 years of age (see section 4.3). A unit dose of 5 g of granules contains: 2.6 g of Ispagula seed 0.11 g of Ispagula cuticle 0.34 - 0.66 g of Senna fruit \u003cu\u003eMethod of administration\u003c\/u\u003e For oral use. The granules should not be chewed or dissolved, but must be placed on the tongue and swallowed, standing upright, drinking a large glass of water. Agiolax should always be taken with liquids. Without sufficient fluids, the product may swell and obstruct the pharynx or esophagus, creating a risk of suffocation (see section 4.4). It can be taken regardless of meals. Take preferably in the evening, one hour before bedtime. Use the graduated measuring spoon supplied with the package. \u003cu\u003eDuration of treatment\u003c\/u\u003e Laxatives should be used as infrequently as possible and should not be used for more than 7 days. If after 3 days no improvements are observed or abdominal pain or bowel irregularities arise, re-evaluate the clinical picture. Prolonged use should be established after adequate clinical evaluation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g, 250 g, 400 g container: Store below 25°C Sachets: Store below 30°C. Keep in the original packaging in order to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings\u003c\/b\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction especially in case of simultaneous treatment with some medicinal products (see section 4.5). The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). During treatment with Agiolax it is necessary to ingest a large quantity of water (6-8 glasses per day) to prevent the onset of intestinal obstruction. Agiolax should be used only if a therapeutic effect cannot be achieved by changing the diet or administering bulking laxatives. The use of laxatives concomitantly with thyroid hormones may make it necessary to adjust the dose of thyroid hormones. Given the risk of gastrointestinal obstruction, Agiolax should not be used together with medicinal products known to inhibit peristaltic movement (see section 4.5). After oral intake or skin contact Agiolax may cause hypersensitivity reactions (see section 4.8). Abdominal pain, spasms and diarrhea may occur, especially in the case of pre-existing irritable bowel syndrome (see section 4.8). These symptoms can also arise following overdose; in this circumstance it is necessary to reduce the dose (see section 4.9). Important information about some excipients Agiolax contains sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypokalaemia (resulting from long-term abuse of laxatives) potentiates the effects of cardiac glycosides and interacts with antiarrhythmic medicinal products, medicinal products that induce sinus rhythm reversal (e.g. quinidine) and medicinal products that induce QT prolongation. Concomitant use of diuretics, corticosteroids and licorice root may increase electrolyte imbalance. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally (e.g. vitamin B12, coumarin derivatives, lithium and carbamazepine). Concomitant administration of antidiabetics may increase the risk of hypoglycemia. Avoid ingesting laxatives and other medicines at the same time: leave an interval of at least 2 hours before or after taking the laxative and another medicine. Agiolax may potentiate the risk of occlusion from opioid-induced reduced peristalsis (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSide effects are reported according to system organ class according to MedDRA. Undesirable effects are listed using the MedDRA frequency convention: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥ 1\/1000, \u003c 1\/100); rare ≥ 1\/10,000, \u003c 1\/1000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). Undesirable effects are presented in order of decreasing severity.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Rare (≥ 1\/10,000, ≤ 1\/1,000): Abdominal colic*, Flatulence, Abdominal distension, Gastrointestinal obstruction, Faecal impaction. Very rare (≤1\/10,000): Obstruction of the esophagus. Not known: Nausea, Vomiting, Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Rare (≥ 1\/10,000, ≤ 1\/1,000): Chromaturia***. Not known: Albuminuria**, Haematuria**.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Not known: Hypersensitivity reactions, Anaphylactic reactions, Rash, Pruritus.\u003c\/p\u003e\n\u003cp\u003e*more frequently in case of severe constipation or irritable bowel syndrome; ** from prolonged use; *** this coloring is due to the presence of senna components in the urine and is not clinically significant. Furthermore, melanosis of the colon which recedes after discontinuation of the medicinal product has been reported. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal spasms, abdominal pain, flatulence, intestinal obstruction and severe diarrhoea, in which case treatment should be suspended and the resulting losses of fluids and electrolytes must be replenished. Prolonged use of high doses of medicines containing anthraquinones may cause toxic hepatitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Use during pregnancy is contraindicated due to the known genotoxicity of anthraquinones contained in senna (see section 4.3). \u003cu\u003eBreastfeeding\u003c\/u\u003e Small quantities of active anthraquinone metabolites, such as rhein, are excreted in breast milk, therefore the use of Agiolax during breast-feeding is contraindicated (see section 4.3). \u003cu\u003eFertility\u003c\/u\u003e No fertility studies have been conducted.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAgiolax does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Viatris Healthcare","offers":[{"title":"Default Title","offer_id":51730208358727,"sku":"023714037","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/viatris-healthcare-limited-agiolax-granulato-400-g-confezione-con-cucchiaio-dosatore-farmacia-dottor-tili-1213791076.jpg?v=1767154367"},{"product_id":"mylicon-bambini-66-6-mg-30-ml-gocce-orali","title":"Mylicon children 66.6 mg 30 ml oral drops","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of gastrointestinal meteorism and aerophagia in infants and children.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 ml of solution contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: simethicone (activated dimethylpolysiloxane) 66.6 mg. \u003ci\u003eExcipient with known effects\u003c\/i\u003e: sodium, sodium benzoate, ethanol, propylene glycol. For the full list of excipients, see 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCitric acid monohydrate; sodium citrate; methylhydroxypropylcellulose; carboxypolymethylene; saccharin; sodium benzoate; sorbic acid; sodium bicarbonate; raspberry essence; concentrated vanilla essence; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the components listed in paragraph 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003cu\u003eInfants and children\u003c\/u\u003e: 20 drops (= 0.6 ml), 2-4 times a day preferably after meals or otherwise according to medical prescription. \u003cb\u003eDo not exceed the recommended doses.\u003c\/b\u003e After a short period of treatment (7 days) without appreciable results, consult your doctor. \u003cu\u003eMethod of administration\u003c\/u\u003e Shake well before use. The drops should be dispersed in a little water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not exceed the recommended doses. After a short period of treatment (7 days) without appreciable results, consult your doctor. In case of persistence, worsening of symptoms, or if new symptoms appear or in case of prolonged constipation, treatment should be discontinued and the patient should consult his doctor. Do not use in case of suspected intestinal perforation or ileus. \u003ci\u003eImportant information about some excipients:\u003c\/i\u003e MYLICON contains: • less than 1mmol of \u003cb\u003e \u003ci\u003esodium\u003c\/i\u003e \u003c\/b\u003e (23 mg) per dose (20 drops). It can therefore be considered essentially sodium-free; • 0.6 mg of \u003cb\u003e \u003ci\u003esodium benzoate\u003c\/i\u003e \u003c\/b\u003e per dose (20 drops) equivalent to 0.17 mg\/kg for a 3.5 kg newborn and 0.03 mg\/kg for a 20 kg child. The increase in bilirubin levels following its detachment from albumin can increase neonatal jaundice which can evolve into kernicterus (deposits of unconjugated bilirubin in the brain tissue); • 0.7025 mg of \u003cb\u003e \u003ci\u003epropylene glycol\u003c\/i\u003e \u003c\/b\u003e for each dose (20 drops), equivalent to 1.17 mg\/ml. Coadministration with any alcohol dehydrogenase substrate such as ethanol may induce serious adverse effects in neonates. • 0.174 mg of \u003cb\u003e \u003ci\u003eethanol\u003c\/i\u003e \u003c\/b\u003e in each single dose (20 drops) which is equivalent to 0.290 mg\/ml. The amount of this medicine is equivalent to less than 0.00435 ml of beer or 0.00174 of wine. This medicine contains a quantity of ethanol that does not produce significant effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking SIMETICONE and mineral oil (paraffin) laxatives at the same time is not recommended, as the combination of these two products reduces their effectiveness.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSide effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥ 1\/10 Common ≥ 1\/100 and \u003c 1\/10; Uncommon ≥ 1\/1,000 and \u003c 1\/100; Rare ≥ 1\/10,000 and \u003c 1\/1,000; Very rare \u003c 1\/10,000\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Vomiting, diarrhoea, abdominal pain, ileus, nausea.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eVery rare: Angioedema Rash.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003erare: hypersensitivity reactions.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e Simethicone is a chemically inert substance, pharmacologically inactive and not absorbed from the gastrointestinal tract. Simethicone is also eliminated unchanged in the faeces. Accidental exposure to the product by children revealed no symptoms in most cases. The reported symptoms were mild to moderate in nature and can be explained by the pre-existing condition.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003ePregnancy\u003c\/u\u003e.\u003c\/i\u003e There are no adequate data on the use of Mylicon in pregnant women, therefore it should not be used during pregnancy unless clearly necessary and after a risk\/benefit assessment by the doctor. \u003ci\u003e \u003cu\u003eBreastfeeding\u003c\/u\u003e.\u003c\/i\u003e It is not known whether simethicone is excreted in breast milk. The excretion of simethicone in breast milk has not been studied in animals. The decision whether to continue\/discontinue breastfeeding or to continue\/discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the infant and of simethicone therapy for the woman. Consult a doctor before taking Mylicon during pregnancy or breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo effects on the ability to drive or use machines are reported.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51730208424263,"sku":"020708069","price":19.03,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-mylicon-bambini-66-6-mg-30-ml-gocce-orali-farmacia-dottor-tili-1213791074.jpg?v=1767154329"},{"product_id":"clisma-lax-133-ml-4-flaconi-soluzione-rettale","title":"Lax enema 133 ml 4 bottles rectal solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml contain 13.91 g of anhydrous monobasic sodium phosphate (NaH\u003csub\u003e2\u003c\/sub\u003ePO\u003csub\u003e4\u003c\/sub\u003e); 3.18 g of dibasic sodium phosphate (Na\u003csub\u003e2\u003c\/sub\u003eHPO\u003csub\u003e4\u003c\/sub\u003e). Excipients with known effects: sodium benzoate (100mg per 100ml) and methylparahydroxybenzoate (50mg per 100ml). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium hydroxide, sodium benzoate, methyl parahydroxybenzoate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e-Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - acute abdominal pain or of unknown origin - nausea or vomiting - intestinal obstruction or stenosis or anorectal stenosis - intestinal sub-occlusion - mechanical ileus - paralytic ileus - inflammatory intestinal disorders and other conditions that can increase the absorption of the medicine - anal perforation - congenital or acquired megacolon - Hirschsprung's disease - rectal bleeding of unknown origin - acute haemorrhoidal crisis with pain and bleeding - severe state of dehydration - children under the age of twelve. Phosphates are contraindicated in patients with cardiac disorders, severe renal insufficiency or in the presence of hyperphosphatemia. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and adolescents (12-18 years): the entire dose of the bottle. \u003cu\u003eMethod of administration\u003c\/u\u003e Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Take preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The 133 ml bottle should not be used in children under 12 years of age. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Patients should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration, or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans), or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Clisma lax contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels, and consequently hypernatraemia, hyperphosphataemia, hypocalcaemia and hypokalaemia, which may occur with clinical signs such as tetany and renal failure. Abuse of laxatives can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Repeated use of laxatives can give rise to addiction or various types of damage. Prolonged use of a laxative to treat constipation is not recommended. The pharmacological treatment of constipation must be considered an adjuvant to the hygienic-dietary treatment (e.g. increase in vegetable fibers and liquids in the diet, physical activity and re-education of intestinal motility). The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. A careful evaluation by the doctor is essential when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. Elderly people or those in poor health and patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures) should consult their doctor before using the medicine. Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe systemic absorption of sodium phosphate rectal solution is limited, however in some conditions it may be increased and predispose to possible interactions with other drugs. The simultaneous intake of drugs that can have effects on electrolyte balance (such as diuretics, cortisone, calcium channel blockers, lithium) can facilitate the onset of hyperphosphatemia, hypercalcemia and hypernatremia. Patients taking drugs that can prolong the QT interval may be at greater risk of developing this adverse reaction if treated concomitantly with sodium phosphate. Since hypernatremia is associated with low lithium levels, the concomitant use of Enema lax and lithium may cause a reduction in serum lithium levels, with a decrease in efficacy. Concomitant use of calcium supplements or calcium-containing antacids may increase the risk of ectopic calcification. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of sodium phosphate organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e Hypersensitivity reactions (e.g. urticaria) \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Blisters, itching, burning \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation. Nausea, vomiting. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e Hyperphosphatemia, hypokalemia, hypernatremia, hypocalcemia, and tissue calcification may rarely occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe effect most frequently observed following ingestion or rectal administration is gastrointestinal irritation (abdominal pain, nausea, vomiting, diarrhoea). Persistent diarrhea results in loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Fluid and electrolyte losses must be replaced. Generally, conservative measures are sufficient; plenty of liquids must be given, especially fruit juices. See also what is reported in paragraph 4.4 regarding the abuse of laxatives. If a significant amount of phosphate is absorbed, hyperphosphatemia, hypocalcemia, and hypomagnesemia may occur. Alterations in fluid and electrolyte balance have been observed following oral, rectal and intravenous exposure. Severe hyperphosphatemia and hypocalcemia may cause tetany, convulsions, bradycardia, QT interval prolongation, arrhythmia, coma and cardiac arrest. Severe dehydration, hypernatremia, hypotension, metabolic acidosis, and tachycardia may also occur. The elderly, children and patients with renal insufficiency are at increased risk of toxic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730212061511,"sku":"024995045","price":17.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-clisma-lax-133-ml-4-flaconi-soluzione-rettale-farmacia-dottor-tili-1213791008.jpg?v=1767155829"},{"product_id":"verolax-3-g-6-monodose-soluzione-rettale","title":"Verolax 3 g 6 single-dose rectal solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConstipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eVerolax “6.75 g Adults Rectal Solution” 6 Single-dose Containers 9 G\u003c\/i\u003e: Each 9G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 6.75 g \u003ci\u003eVerolax “2.25 g Children Rectal Solution” 6 Single-dose Containers 3 G\u003c\/i\u003e: Each 3G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “2.25 g Adult Suppositories” 18 Suppositories\u003c\/i\u003e:Each adult suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “1,375 g Children Suppositories” 18 Suppositories\u003c\/i\u003e: Each children's suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 1.375 g \u003ci\u003eVerolax “0.675 g Infant Suppositories” 12 Suppositories\u003c\/i\u003e: Each infant suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 0.675 g\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution for adults and children:\u003c\/i\u003e Mallow fluid extract; Chamomile fluid extract; Wheat starch; Purified water. \u003ci\u003eSuppositories Adults, Children, Infants:\u003c\/i\u003e Sodium stearate, Sodium carbonate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndividual hypersensitivity confirmed towards the product. Anorectal diseases, hemorrhagic rectocolitis and inflammation of hemorrhoids. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution:\u003c\/i\u003e 1 or 2 single-dose containers in 24 hours. In case of stubborn constipation, no more than 2 doses can be introduced into the rectum at the same time. \u003ci\u003eSuppositories:\u003c\/i\u003e 1 suppository as needed. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe continuous use of laxatives can cause addiction or damage of various types. Do not use laxatives if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interactions with other drugs have been found. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe only effects that may be encountered are irritative, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking the drug does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Angelini Acraf","offers":[{"title":"Default Title","offer_id":51730213273927,"sku":"026525042","price":5.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-a-c-r-a-f-spa-verolax-3-g-6-monodose-soluzione-rettale-farmacia-dottor-tili-1213791002.jpg?v=1767155951"},{"product_id":"aloe-vera-succo-premium-1000-ml-intestino-e-digestione","title":"Aloe Vera Premium Juice 1000 ml for Intestine and Digestion","description":"\u003cp\u003e\n\u003cstrong\u003eAloe Vera juice Premium 1000 ml intestine and digestion\u003c\/strong\u003e is a food supplement based on \u003cstrong\u003epure Aloe Vera juice\u003c\/strong\u003e (Aloe barbadensis Mill.), obtained exclusively from \u003cstrong\u003e100% pure leaf gel\u003c\/strong\u003e without adding water. This product is formulated to offer a \u003cstrong\u003ecomplete support for digestive well-being\u003c\/strong\u003e, thanks to yours \u003cstrong\u003eemollient and soothing action\u003c\/strong\u003e throughout the digestive system, from the stomach to the intestinal tract. Aloe Vera is known for its properties \u003cstrong\u003epurifying, draining and antioxidant\u003c\/strong\u003e, ideal for those who want \u003cstrong\u003epurify the body\u003c\/strong\u003e and favor the \u003cstrong\u003edrainage of body fluids\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe presence of \u003cstrong\u003epolysaccharides titrated at 10%\u003c\/strong\u003e guarantees high effectiveness, helping to protect and soothe the mucous membranes of the digestive system and to support the \u003cstrong\u003epurifying function of the organism\u003c\/strong\u003e. Premium Aloe Vera juice is also \u003cstrong\u003egluten-free and lactose-free\u003c\/strong\u003e, also suitable for those who follow specific diets. It can be taken for prolonged periods, also being useful for \u003cstrong\u003ethroat wellbeing\u003c\/strong\u003e and for the \u003cstrong\u003esupport of the immune system\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe packaging from \u003cstrong\u003e1000ml\u003c\/strong\u003e ensures a practical oral solution, ideal for those looking for a \u003cstrong\u003enatural supplement\u003c\/strong\u003e for the \u003cstrong\u003edigestion\u003c\/strong\u003e and the \u003cstrong\u003eintestinal well-being\u003c\/strong\u003e. Thanks to its concentrated formula, Aloe Vera Premium juice represents an excellent choice for those who want to take care of their body in a natural way, promoting the \u003cstrong\u003ewell-being of the digestive system\u003c\/strong\u003e and the \u003cstrong\u003edaily purification\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Aloe Vera juice Premium 1000 ml intestine and digestion? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on 100% pure Aloe Vera juice (Aloe barbadensis Mill.), titrated to 10% polysaccharides, formulated to promote digestive well-being thanks to its emollient and soothing action on the mucous membranes of the digestive system, and to support the body's purifying and draining functions.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Aloe Vera juice Premium 1000 ml intestine and digestion contain?\u003c\/h3\u003e\u003cp\u003eAloe vera (Aloe barbadensis Mill.) juice from the leaf gel (100% pure gelum sine cute), titrated at 10% in polyxacharides; acidifier: citric acid; preservatives: sodium benzoate, potassium sorbate.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e and without \u003cstrong\u003elactose.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Aloe Vera juice Premium 1000 ml intestine and digestion contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage contents for 50 ml and 100 ml\u003c\/strong\u003e\u003cbr\u003eAloe vera: 49.8 g per 50 ml; 99.6g per 100ml\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Aloe Vera juice Premium 1000 ml intestine and digestion?\u003c\/h3\u003e\u003cp\u003eIt is recommended to take 50 ml, 1 or 2 times a day, in the morning before breakfast or in the evening, as such or diluted in water or other drink.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Aloe Vera juice Premium 1000 ml intestine and digestion?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Aloe Vera juice Premium 1000 ml preserved for intestine and digestion?\u003c\/h3\u003e\u003cp\u003eValidity with intact packaging: 18 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Aloe Vera juice Premium 1000 ml intestine and digestion?\u003c\/h3\u003e\u003cp\u003eOral solution.\u003cbr\u003eNet weight: 1,000 ml.\u003c\/p\u003e","brand":"Erba Vita","offers":[{"title":"Default Title","offer_id":51749039079751,"sku":"985773252","price":22.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/erba-vita-group-spa-aloe-vera-succo-premium-1000-ml-intestino-e-digestione-farmacia-dottor-tili-1213791329.jpg?v=1767156610"},{"product_id":"carbone-vegetale-120-compresse-digestione","title":"Vegetable charcoal 120 tablets digestion","description":"\u003cp\u003e\u003cstrong\u003eVegetable charcoal 120 digestion tablets\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e formulated to favor the \u003cstrong\u003edigestive well-being\u003c\/strong\u003e and counteract the hassles related to \u003cstrong\u003eabdominal swelling\u003c\/strong\u003e, \u003cstrong\u003eintestinal gas\u003c\/strong\u003e, \u003cstrong\u003emeteorism\u003c\/strong\u003e, \u003cstrong\u003eflatulence\u003c\/strong\u003e e \u003cstrong\u003eaerophagia\u003c\/strong\u003e. Its composition is based on \u003cstrong\u003ehigh quality vegetable charcoal\u003c\/strong\u003e, obtained from beech and birch wood, known for its properties \u003cstrong\u003enatural absorbent\u003c\/strong\u003e capable of binding and retaining the gases present in the digestive system, thus helping to reduce the sensation of air in the stomach and intestines.\u003c\/p\u003e\n\n\u003cp\u003eLe \u003cstrong\u003echarcoal tablets\u003c\/strong\u003e they are particularly suitable in case of \u003cstrong\u003eslow digestion\u003c\/strong\u003e or large meals, helping to \u003cstrong\u003erelieve swelling\u003c\/strong\u003e and to promote a feeling of lightness. The formula is enriched with stabilizers and anti-caking agents of plant origin, guaranteeing a product \u003cstrong\u003enatural\u003c\/strong\u003e and well tolerated. The format from \u003cstrong\u003e120 tablets\u003c\/strong\u003e ensures prolonged and practical use, ideal for those who want daily support for digestion and the reduction of intestinal discomfort.\u003c\/p\u003e\n\n\u003cp\u003eThanks to its targeted action, \u003cstrong\u003eVegetable charcoal 120 digestion tablets\u003c\/strong\u003e represents an effective solution for those looking for a natural remedy against digestive disorders, improving the quality of life and comfort after meals. Choosing this supplement means relying on a safe, practical and suitable product for the whole family \u003cstrong\u003ewell-being of the digestive system\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eVegetable charcoal 120 digestion tablets is a food supplement based on vegetal charcoal, obtained from beech and birch wood.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Vegetable Charcoal 120 digestion tablets? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on activated vegetal charcoal (from beech and birch wood), formulated to promote digestive well-being; thanks to its absorbent action it helps to reduce abdominal swelling, intestinal gas, meteorism and flatulence.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Vegetable Charcoal 120 Digestion Tablets contain?\u003c\/h3\u003e\u003cp\u003eVegetable charcoal powder, stabilizers: gum arabic, polyvinylpyrrolidone, cross-linked sodium carboxymethylcellulose, sodium carboxymethylcellulose; Maltodextrins from corn, sugar, anti-caking agent: Vegetable magnesium stearate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Vegetable Charcoal 120 Digestion Tablets?\u003c\/h3\u003e\u003cp\u003eTake 1-2 tablets after meals, swallowing them with a liquid.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Vegetable Charcoal 120 digestion tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Vegetable Charcoal 120 digestion tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at temperatures below 30°C; avoid exposure to localized heat sources, sunlight and keep away from humidity. The expiry date refers to the product correctly stored, in intact packaging. Any slight variation in the color of the capsules can be attributed to the ingredients of natural origin contained in them and does not indicate an alteration in the quality of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Vegetable Charcoal 120 digestion tablets?\u003c\/h3\u003e\u003cp\u003eBottle of 40 or 120 tablets\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51749046911303,"sku":"909273043","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-carbone-vegetale-120-compresse-digestione-farmacia-dottor-tili-1213791253.jpg?v=1767157486"},{"product_id":"elgasin-30-compresse-gonfiore-e-ristagno","title":"Elgasin 30 tablets swelling and stagnation","description":"\u003cp\u003e\u003cstrong\u003eElgasin 30 tablets\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e formulated to favor the \u003cstrong\u003eintestinal well-being\u003c\/strong\u003e and counter effectively \u003cstrong\u003eabdominal swelling\u003c\/strong\u003e, \u003cstrong\u003eintestinal gas\u003c\/strong\u003e e \u003cstrong\u003eflatulence\u003c\/strong\u003e. Thanks to the presence of \u003cstrong\u003edigestive enzymes\u003c\/strong\u003e how \u003cstrong\u003ebeta-galactosidase\u003c\/strong\u003e e \u003cstrong\u003ealpha-galactosidase\u003c\/strong\u003e, Elgasin supports the \u003cstrong\u003edifficult digestion\u003c\/strong\u003e and helps prevent the formation of \u003cstrong\u003emeteorism\u003c\/strong\u003e e \u003cstrong\u003eabdominal tension\u003c\/strong\u003e. The \u003cstrong\u003ecaraway\u003c\/strong\u003e, known for its carminative properties, helps to regulate the \u003cstrong\u003eintestinal motility\u003c\/strong\u003e and favors the\u003cstrong\u003eelimination of gases\u003c\/strong\u003e, offering rapid relief from discomfort related to air stagnation in the intestine.\u003c\/p\u003e\n\n\u003cp\u003eElgasin is particularly suitable for those suffering from \u003cstrong\u003elactose intolerance\u003c\/strong\u003e, since the \u003cstrong\u003ebeta-galactosidase\u003c\/strong\u003e improves the digestion of lactose in subjects who poorly digest it. Its formula is \u003cstrong\u003egluten free\u003c\/strong\u003e e \u003cstrong\u003elactose free\u003c\/strong\u003e, making it also suitable for those who follow specific diets. Each tablet contains a balanced mix of active ingredients that act in synergy to offer a \u003cstrong\u003eeffective remedy against swelling\u003c\/strong\u003e and the \u003cstrong\u003eprevention of intestinal gas\u003c\/strong\u003e. Elgasin 30 tablets is the ideal solution for those who want to find comfort and lightness after meals, improving the quality of daily life.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Elgasin 30 tablets used for swelling and stagnation? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on digestive enzymes (beta-galactosidase and alpha-galactosidase) and caraway, formulated to aid digestion and combat abdominal swelling, intestinal gas and flatulence; beta-galactosidase is useful for those who have difficulty digesting lactose.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Elgasin 30 swelling and stagnation tablets contain?\u003c\/h3\u003e\u003cp\u003eSweetener: sorbitol; beta-galactosidase from Aspergillus oryzae; anti-caking agents: vegetable magnesium sterate and silicon dioxide; stabilizer: sodium carboxymethyl cellulose; alpha-galactosidase from Aspergillus niger, caraway (Carum Carvi L., fruit) dry extract; stabilizer: polyvinylpyrrolidone; flavourings; sweetener: acesulfame K.\u003cbr\u003eWith sweetener.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e and without \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Elgasin 30 tablets contain swelling and stagnation?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per daily dose and 1 tablet\u003c\/strong\u003e\u003cbr\u003eBeta-galactosidase: 180 mg per daily dose; 45 mg per 1 tablet\u003cbr\u003eequal to: 18,000 CFU per daily dose; 4,500 Ufcc for 1 tablet\u003cbr\u003eAlpha-galactosidase: 40 mg per daily dose; 10 mg per 1 tablet\u003cbr\u003eequal to: 1,200 Gal U per daily dose; 300 GalU per 1 tablet\u003cbr\u003eE.s. of caraway fruits: 40 mg per daily dose; 10 mg per 1 tablet\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Elgasin 30 tablets for swelling and stagnation?\u003c\/h3\u003e\u003cp\u003e1-2 tablets at the beginning of main meals (4 tablets in total) as needed. The tablet can be taken with water or can be chewed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Elgasin 30 tablets swelling and stagnation?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eExcessive consumption can have laxative effects. For optimal reduction of the disorder, take the product before consuming foods containing lactose. Lactose tolerance is variable and it is advisable to ask your doctor for advice on the role of this substance in your diet.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Elgasin 30 tablets stored for swelling and stagnation?\u003c\/h3\u003e\u003cp\u003eThe product must be stored at a temperature between 10°C and 25°C, in a dry place away from light and localized heat sources.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Elgasin 30 tablets swelling and stagnation?\u003c\/h3\u003e\u003cp\u003eBox of 30 tablets.\u003c\/p\u003e","brand":"Sanitas","offers":[{"title":"Default Title","offer_id":51749050876231,"sku":"933013397","price":16.06,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sanitas-lab-chimico-farm-srl-elgasin-30-compresse-gonfiore-e-ristagno-farmacia-dottor-tili-1213791260.jpg?v=1767158089"},{"product_id":"laevolac-stick-10-bustine-lassativo","title":"Laevolac stick 10 laxative sachets","description":"\u003cp\u003e\u003cstrong\u003eLaevolac stick 10 laxative sachets\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e formulated to favor the \u003cstrong\u003eslow intestinal transit\u003c\/strong\u003e and counteract the \u003cstrong\u003econstipation\u003c\/strong\u003e, even the occasional one. Thanks to the presence of \u003cstrong\u003elactulose\u003c\/strong\u003e, a \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e of proven effectiveness, Laevolac stick works by attracting water into the intestine, softening the stool and stimulating the \u003cstrong\u003eintestinal peristalsis\u003c\/strong\u003e. This natural mechanism helps \u003cstrong\u003eregularize the intestine\u003c\/strong\u003e and to facilitate evacuation, improving the general well-being of the organism.\u003c\/p\u003e\n\n\u003cp\u003eLaevolac stick is particularly suitable for those suffering from \u003cstrong\u003eslowed intestinal transit\u003c\/strong\u003e due to stress, disordered eating or a sedentary lifestyle. Le \u003cstrong\u003esingle-dose sachets\u003c\/strong\u003e they are practical to use and guarantee a precise dosage of \u003cstrong\u003e10 g of lactulose\u003c\/strong\u003e per sachet, ideal for a targeted and delicate action. The product is \u003cstrong\u003egluten free\u003c\/strong\u003e and can also be used by children and elderly people, offering a safe and well-tolerated solution for the whole family.\u003c\/p\u003e\n\n\u003cp\u003eLaevolac stick 10 laxative sachets is the ideal choice for those who want a \u003cstrong\u003eeffective laxative\u003c\/strong\u003e that acts naturally, helping to \u003cstrong\u003esoften the stool\u003c\/strong\u003e and to restore intestinal regularity without irritating the intestine. Thanks to its formulation, it helps reduce the feeling of bloating, heaviness and irritability often associated with constipation, promoting daily well-being.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Laevolac stick 10 laxative sachets? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on lactulose (10 g per sachet), indicated to promote regular intestinal transit in case of constipation, even occasional, by recalling water into the intestine and softening the stool.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Laevolac stick 10 laxative sachets contain?\u003c\/h3\u003e\u003cp\u003eLiquid lactulose EP 667 g\/L.\u003cbr\u003eMay contain other sugars including \u003cstrong\u003elactose\u003c\/strong\u003e, epilactose, galactose, tagatose and fructose. May contain sulphites.\u003cbr\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Laevolac stick 10 laxative sachets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values for 1 envelope\u003c\/strong\u003e\u003cbr\u003eLactulose: 10 g\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Laevolac stick 10 laxative sachets?\u003c\/h3\u003e\u003cp\u003eTo promote intestinal transit: 1 sachet per day (equivalent to 10 g of lactulose) preferably in the morning or in the evening before going to bed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Laevolac stick 10 laxative sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Laevolac stick 10 laxative sachets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place at a temperature between 2°C and 25°C.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Laevolac stick 10 laxative sachets?\u003c\/h3\u003e\u003cp\u003e10 single-dose sachets of 15 ml each containing 10 g of lactulose.\u003c\/p\u003e","brand":"Chiesi","offers":[{"title":"Default Title","offer_id":51749056938311,"sku":"978269532","price":9.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/chiesi-italia-spa-laevolac-stick-10-bustine-lassativo-farmacia-dottor-tili-1213791198.jpg?v=1767150707"},{"product_id":"peyrocur-forte-14-bustine-digestione-gonfiore","title":"Peyrocur Forte 14 sachets digestion + bloating","description":"\u003cp\u003e\n\u003cstrong\u003ePeyrocur Forte 14 sachets\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e formulated to promote \u003cstrong\u003edigestion\u003c\/strong\u003e and counteract the \u003cstrong\u003eabdominal swelling\u003c\/strong\u003e, the \u003cstrong\u003emeteorism\u003c\/strong\u003e and related disorders such as \u003cstrong\u003estomach acidity\u003c\/strong\u003e, \u003cstrong\u003eabdominal pain\u003c\/strong\u003e, \u003cstrong\u003eirritable bowel\u003c\/strong\u003e, \u003cstrong\u003enausea\u003c\/strong\u003e e \u003cstrong\u003econstipation\u003c\/strong\u003e. Its advanced composition combines \u003cstrong\u003ecoenzyme Q10\u003c\/strong\u003e, \u003cstrong\u003eastaxanthin\u003c\/strong\u003e, \u003cstrong\u003eL-arginine\u003c\/strong\u003e, \u003cstrong\u003ePABA\u003c\/strong\u003e e \u003cstrong\u003ecarnitine\u003c\/strong\u003e with a mix of \u003cstrong\u003evitamins\u003c\/strong\u003e e \u003cstrong\u003eminerals\u003c\/strong\u003e essentials, including \u003cstrong\u003evitamin C\u003c\/strong\u003e, \u003cstrong\u003evitamin E\u003c\/strong\u003e, \u003cstrong\u003ezinc\u003c\/strong\u003e, \u003cstrong\u003efolic acid\u003c\/strong\u003e e \u003cstrong\u003eselenium\u003c\/strong\u003e. These ingredients contribute to \u003cstrong\u003eprotection of cells from oxidative stress\u003c\/strong\u003e and the maintenance of \u003cstrong\u003etissue functionality\u003c\/strong\u003e, supporting the \u003cstrong\u003egeneral well-being\u003c\/strong\u003e of the organism.\n\u003c\/p\u003e\n\u003cp\u003e\nThe extract of \u003cstrong\u003eChinese sage root\u003c\/strong\u003e adds powerful action \u003cstrong\u003eantioxidant\u003c\/strong\u003e, while the presence of L-carnitine and L-arginine promotes energy metabolism and vitality. Peyrocur Forte is \u003cstrong\u003egluten free\u003c\/strong\u003e and comes in practical sachets to dissolve in water, ideal for quick and easy intake. Thanks to its complete formula, Peyrocur Forte is the ideal choice for those who want effective support against digestive discomfort and bloating, improving the quality of daily life and the health of the digestive system.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Peyrocur Forte 14 sachets used for digestion + swelling? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on coenzyme Q10, astaxanthin, L-arginine, carnitine, vitamins and minerals, indicated to aid digestion and combat abdominal swelling and flatulence; its components also contribute to the protection of cells from oxidative stress.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Peyrocur Forte 14 sachets for digestion + swelling contain?\u003c\/h3\u003e\u003cp\u003eSweetener: isomalt; maltodextrin, L-carnitine (L-carntine-L-tartrate), vitamin C (L-ascorbic acid), Chinese sage (Salvia miltiorrhiza Bunge, extract from the root, D\/E ratio 4:1), L-arginine, coenzyme Q10, vitamin E (DL-alpha-tocopheryl acetate), zinc (zinc gluconate), Paba, astaxanthin (from Haematococcus pluvialis Flotow dry extract of the thallus, titrated at 10% in astaxanthin); acidity regulator: citric acid; aroma; anti-caking agent: silicon dioxide; thickener: xanthan gum; sweetener: sucralose; folic acid, selenium (sodium selenite).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAverage values for 1 sachet\u003c\/strong\u003e\u003cbr\u003eL-carnitine: 500 mg\u003cbr\u003eVitamin C: 500 mg (625% VNR*)\u003cbr\u003eChinese sage dry extract: 300 mg\u003cbr\u003eL-arginine: 200 mg\u003cbr\u003eCoenzyme Q10: 160 mg\u003cbr\u003eVitamin E: 60 mg (500% VNR*)\u003cbr\u003eZinc: 15 mg (150% NRV*)\u003cbr\u003ePaba: 100 mg\u003cbr\u003eHaematococcus pluvialis dry extract: 80 mg\u003cbr\u003eastaxanthin: 8 mg\u003cbr\u003eFolic acid: 400 mcg (200% NRV*)\u003cbr\u003eSelenium: 100 mcg (182% VNR*)\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values.\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Peyrocur Forte 14 sachets digestion + swelling contain?\u003c\/h3\u003e\u003cp\u003eL-carnitine: 500 mg per sachet\u003cbr\u003eVitamin C: 500 mg per sachet (625% VNR)\u003cbr\u003eChinese sage dry extract: 300 mg per sachet\u003cbr\u003eL-arginine: 200 mg per sachet\u003cbr\u003eCoenzyme Q10: 160 mg per sachet\u003cbr\u003eVitamin E: 60 mg per sachet (500% VNR)\u003cbr\u003eZinc: 15 mg per sachet (150% VNR)\u003cbr\u003ePABA: 100 mg per sachet\u003cbr\u003eHaematococcus pluvialis dry extract: 80 mg per sachet\u003cbr\u003eAstaxanthin: 8 mg per sachet\u003cbr\u003eFolic acid: 400 mcg per sachet (200% VNR)\u003cbr\u003eSelenium: 100 mcg per sachet (182% VNR)\u003cbr\u003e*VNR: Nutrient Reference Values\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Peyrocur Forte 14 sachets for digestion + swelling?\u003c\/h3\u003e\u003cp\u003eWe recommend taking 1 sachet per day.\u003cbr\u003eDissolve the contents of the sachet in 200 ml (one glass) of water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Peyrocur Forte 14 sachets digestion + swelling?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFor the daily intake of zinc, the product is intended for adults.\u003cbr\u003eExcessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Peyrocur Forte 14 sachets for digestion + swelling stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from light and heat sources.\u003cbr\u003eThe expiry date indicated refers to the product in intact packaging, correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Peyrocur Forte 14 sachets digestion + swelling?\u003c\/h3\u003e\u003cp\u003e14 sachets of 4 g.\u003cbr\u003eTotal net quantity: 56 g.\u003c\/p\u003e","brand":"Leonardo Medica","offers":[{"title":"Default Title","offer_id":51749063917895,"sku":"984099630","price":31.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/leonardo-medica-srl-peyrocur-forte-14-bustine-digestione-gonfiore-farmacia-dottor-tili-1213791125.jpg?v=1767161371"},{"product_id":"tamacid-pro-digestivo-20-stick-solubili-15-g","title":"Tamacid Pro digestive 20 soluble sticks 15 g","description":"\u003cp\u003e\u003cstrong\u003eTamacid Pro digestive 20 soluble sticks 15 g\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e innovative, formulated to promote \u003cstrong\u003edigestive function\u003c\/strong\u003e and the well-being of the gastrointestinal system. Thanks to the presence of \u003cstrong\u003esodium alginate\u003c\/strong\u003e, \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e, \u003cstrong\u003etamarind juice\u003c\/strong\u003e and exclusive \u003cstrong\u003eplant extracts\u003c\/strong\u003e, Tamacid Pro helps regulate the \u003cstrong\u003egastrointestinal motility\u003c\/strong\u003e and to facilitate the\u003cstrong\u003eelimination of gases\u003c\/strong\u003e, contributing to \u003cstrong\u003econtrol of gastric acidity\u003c\/strong\u003e and offering an emollient and soothing action on the entire digestive system.\u003c\/p\u003e\n\n\u003cp\u003eThe advanced formula with \u003cstrong\u003eGingigel PRO\u003c\/strong\u003e and natural ingredients such as ginger, emblica officinale and astragalus, is designed to offer complete support also for \u003cstrong\u003eoropharyngeal mucosa\u003c\/strong\u003e et al \u003cstrong\u003etone of voice\u003c\/strong\u003e. Each 15 g soluble stick is practical to take and ideal after main meals, for quick and targeted relief. Tamacid Pro is the ideal choice for those looking for a \u003cstrong\u003edigestive\u003c\/strong\u003e effective, natural and easy to use, in a format of \u003cstrong\u003e20 sticks\u003c\/strong\u003e perfect for everyday use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Tamacid Pro digestive 20 soluble sticks 15 g? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on sodium alginate, hyaluronic acid, tamarind juice and plant extracts, formulated to promote digestive function and the well-being of the gastrointestinal system, with an emollient and soothing action. Ginger, emblica officinale and astragalus extracts also offer support to the oropharyngeal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Tamacid Pro digestive 20 soluble sticks 15 g contain?\u003c\/h3\u003e\u003cp\u003eGingigel Pro [water, ginger glyceric extract (Zingiber officinalis Rosc., rhizome), naringin, sodium citrate, potassium citrate; thickener: xanthan gum), fructose, glycerol, sodium alginate, flavouring; preservatives: sodium lactate, lactic acid, potassium sorbate; hyaluronic acid, tamarind juice, e.s. of emblica (Emblica officinalis, fructus), d.e. of astragalus (Astragalus Verus Olivier, gummi).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Tamacid Pro digestive 20 soluble sticks 15 g contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values for maximum daily dose of 2 sticks (equal to 30 g)\u003c\/strong\u003e\u003cbr\u003eGingigel Pro: 6 ml\u003cbr\u003eof which ginger e.g.: 1,660 mg\u003cbr\u003eof which sodium citrate: 1,000 mg\u003cbr\u003eof which potassium citrate: 300 mg\u003cbr\u003eof which naringin: 50 mg\u003cbr\u003eSodium alginate: 840 mg\u003cbr\u003eHyaluronic acid: 80 mg\u003cbr\u003eTamarind juice: 30 mg\u003cbr\u003eAstragalus: 30 mg\u003cbr\u003eEmblica officinale: 30 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003eThe recommended dosage is 1 stick pack (equal to 15 g of product) for a maximum of 2 times a day, preferably after the main meals. Take the contents of the stick directly without water. Avoid drinking water for 30 minutes after taking it.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFood supplement for adults.\u003cbr\u003eDo not take in case of hypersensitivity to one of the components.\u003cbr\u003eDo not consume after the shelf life has expired. The end of validity date refers to the product correctly stored in intact packaging.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Tamacid Pro digestive 20 soluble sticks 15 g stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources, at a controlled temperature not exceeding 25°C.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003ePack of 20 stick packs.\u003cbr\u003eNet weight: 300g.\u003c\/p\u003e","brand":"Levante","offers":[{"title":"Default Title","offer_id":51749071618375,"sku":"985661356","price":20.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/levante-srl-tamacid-pro-digestivo-20-stick-solubili-15-g-farmacia-dottor-tili-1213790710.jpg?v=1767162586"},{"product_id":"mannite-cubo-25g","title":"Mannitol cube 25g","description":"\u003cp\u003e\u003cstrong\u003eMaco Screws Mannite Cube\u003c\/strong\u003e it's a \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e based on \u003cstrong\u003emannitol\u003c\/strong\u003e, a polyol of natural origin, commonly extracted from fruit and widely used in the medical field for its osmotic properties. The product comes in size \u003cstrong\u003e25 g cube\u003c\/strong\u003e, to be dissolved in water, and is indicated for the treatment of \u003cstrong\u003eoccasional constipation\u003c\/strong\u003e, in adults and children over 3 years.\u003c\/p\u003e\n\u003cp\u003eMannite works by retaining water in the intestinal lumen, thus promoting the softening of the stool and stimulating the natural evacuation reflex, without causing cramps or irritation. It is not absorbed by the body, does not create addiction and can also be used by subjects with sensitive intestines, the elderly or people with chronic pathologies, on medical advice.\u003c\/p\u003e\n\u003cp\u003eProduced by Viti Farmaceutici, an Italian company with consolidated experience in the production of natural therapeutic solutions, cubic mannite represents a \u003cstrong\u003esimple, natural and well tolerated choice\u003c\/strong\u003e for the rebalancing of intestinal motility.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Mannite cube 25g used? What is it for?\u003c\/h3\u003e\u003cp\u003eThe product is indicated in case of:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eOccasional or chronic constipation\u003c\/strong\u003e, even in elderly subjects or with lazy intestines Intestinal preparation before diagnostic tests (subject to medical advice) Gentle treatment of constipation in \u003cstrong\u003echildren over 3 years old\u003c\/strong\u003e Constipation secondary to dietary changes or sedentary lifestyle\u003c\/p\u003e\u003cp\u003eIts action is mechanical and does not interfere with digestive or metabolic processes.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Mannite cube 25g?\u003c\/h3\u003e\u003cp\u003eHiring method:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAdults:\u003c\/strong\u003e dissolve 1 cube (25 g) in a glass of water (about 200 ml) and drink preferably in the morning on an empty stomach. \u003cstrong\u003eChildren over 3 years:\u003c\/strong\u003e half cube, always dissolved in water, unless otherwise indicated by the pediatrician.\u003c\/p\u003e\u003cp\u003eThe effect generally occurs within 6-12 hours. Do not take for more than 7 consecutive days without medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Mannite cube 25g?\u003c\/h3\u003e\u003cp\u003eHiring method:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAdults:\u003c\/strong\u003e dissolve 1 cube (25 g) in a glass of water (about 200 ml) and drink preferably in the morning on an empty stomach.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eChildren over 3 years:\u003c\/strong\u003e half cube, always dissolved in water, unless otherwise indicated by the pediatrician.\u003c\/p\u003e\u003cp\u003eThe effect generally occurs within 6-12 hours. Do not take for more than 7 consecutive days without medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Mannite cube 25g?\u003c\/h3\u003e\u003cp\u003eDo not use for prolonged periods without medical advice Keep out of reach of children Do not use in children under 3 years May cause a slight diuretic effect In case of chronic pathologies or concomitant use of other drugs, consult your doctor\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Mannite cube 25g not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use in case of:\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKnown allergy to mannitol\u003c\/strong\u003e or to any of the excipients \u003cstrong\u003eIntestinal obstruction or subocclusion\u003c\/strong\u003e \u003cstrong\u003eGlucose-galactose malabsorption syndromes\u003c\/strong\u003e Severe uncorrected electrolyte or water disorders\u003c\/p\u003e\u003cp\u003eIn case of high doses they may occur \u003cstrong\u003ebloating, flatulence, abdominal cramps or diarrhoea\u003c\/strong\u003e Rare allergic reactions (skin rash, itching)\u003c\/p\u003e\u003cp\u003eIn case of persistent effects, discontinue use and consult your doctor or pharmacist.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Mannite cube 25g stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources and direct light. Do not use after the expiry date shown on the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the size of Mannite cube 25g?\u003c\/h3\u003e\u003cp\u003ePackage containing \u003cstrong\u003e1 cube of 25 g\u003c\/strong\u003e of pure mannite. Single dose. Oral use.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51821904560455,"sku":"900166531","price":3.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-mannite-cubo-25g-farmacia-dottor-tili-1213790934.jpg?v=1767167530"},{"product_id":"clin-4000-macrogol-senza-elettroliti-lassativo-osmotico-30-bustine-monouso-da-10-g","title":"Clin 4000 Macrogol Without Electrolytes Osmotic Laxative 30 Disposable Sachets of 10 g","description":"\u003cp\u003e\u003cstrong\u003eClin 4000 Macrogol Without Electrolytes Osmotic Laxative 30 Disposable Sachets of 10 g\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e ad \u003cstrong\u003elaxative action\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e: each contains \u003cstrong\u003e10 g\u003c\/strong\u003e of \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e and nothing else, because the formula does not have \u003cstrong\u003eexcipients\u003c\/strong\u003e, has no aromas and no sugars. It is used in \u003cstrong\u003echronic constipation\u003c\/strong\u003e and in cases of \u003cstrong\u003eoccasionally irregular bowel\u003c\/strong\u003e, and it is a macrogol \u003cstrong\u003ewithout electrolytes\u003c\/strong\u003e, which distinguishes it from most products of the same family.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e it is the only substance present, and it is worth knowing what that number means, because almost everyone reads it as a dosage and it is not. \u003cstrong\u003eMacrogol\u003c\/strong\u003e is the name that the \u003cstrong\u003eEuropean Pharmacopoeia\u003c\/strong\u003e gives to \u003cstrong\u003epolyethylene glycol\u003c\/strong\u003e, a polymer made of repeating units; the following number indicates the \u003cstrong\u003eaverage molecular weight\u003c\/strong\u003e of the espresso chain in \u003cstrong\u003edalton\u003c\/strong\u003e. Macrogol 4000 therefore means chains on average 4,000 daltons long: a large molecule, and the size is precisely the reason why it works the way it does. I \u003cstrong\u003e10 g\u003c\/strong\u003e of the sachet they are instead the quantity of substance, and they are the whole sachet.\u003c\/p\u003e\n\u003cp\u003eThe way he acts is \u003cstrong\u003ephysical\u003c\/strong\u003e, non-pharmacological, and you can feel the difference. Water molecules bind to the polymer to \u003cstrong\u003ehydrogen bond\u003c\/strong\u003e even before it reaches the intestine, and they remain attached: in the intestinal lumen the retained water increases the volume of the stool and softens its consistency. A \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e as this does not affect the nerve plexuses of the wall or the muscles, which is what laxatives do instead \u003cstrong\u003estimulants\u003c\/strong\u003e or contact. The chain is too large to cross the mucosa, therefore \u003cstrong\u003eit is not absorbed\u003c\/strong\u003e, and is not a substrate for colon bacteria, therefore \u003cstrong\u003eit doesn't ferment\u003c\/strong\u003e: it is the reason why it does not produce the gas that accompanies sugar osmotics such as \u003cstrong\u003elactulose\u003c\/strong\u003e. \u003cstrong\u003eMacrogol 4000 is useful in cases of chronic constipation and occasionally irregular bowel movements.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe word \u003cstrong\u003ewithout electrolytes\u003c\/strong\u003e deserves its own line, because two different things with the same name coexist in the department. Different macrogols are formulated together with \u003cstrong\u003ego up\u003c\/strong\u003e (sodium, potassium, bicarbonate, chloride) which serve to maintain the balance of electrolytes when drinking a lot of liquid in one go: these are preparations designed for large volumes. \u003cstrong\u003eClin 4000\u003c\/strong\u003e it doesn't contain them: it just carries the polymer, and for this reason the powder doesn't have the salty taste that macrogols with electrolytes carry with them. It is also \u003cstrong\u003ewithout aroma\u003c\/strong\u003e, and this is not a shortcoming but the reason why it can be combined with any drink, from tea to broth to fruit juice, without changing its taste.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eClin 4000\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e, for \u003cstrong\u003e300 g\u003c\/strong\u003e total of macrogol 4000: the single-dose sachet avoids having to weigh the powder and the single wrapper remains closed until needed. The formula is \u003cstrong\u003esugar free\u003c\/strong\u003e, which matters to those keeping carbs under control, and it has no added excipients. In the same line there is the \u003cstrong\u003e200 g bottle\u003c\/strong\u003e with measuring spoon, the format that allows divided doses and is the one aimed at younger children: the MINSAN it looks a lot like the one in the sachets, so it's worth looking carefully at which one you're taking. Those looking for a pure macrogol, without salts and without flavourings, will find it in \u003cstrong\u003eClin 4000\u003c\/strong\u003e the most essential form.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should you use Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g? What is it for?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eClin 4000\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e ad \u003cstrong\u003elaxative action\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e, each with \u003cstrong\u003e10 g\u003c\/strong\u003e of \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is used in \u003cstrong\u003echronic constipation\u003c\/strong\u003e and in cases of \u003cstrong\u003eoccasionally irregular bowel\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e it's a \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e: retains water in the intestinal lumen and makes stool softer.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g contain?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMacrogol 4000.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains \u003cstrong\u003e10 g of macrogol 4000\u003c\/strong\u003e. It contains no excipients or flavourings. Without sugar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003eDissolve the powder by mixing in any drink. The contents of one sachet (10 g) must be dissolved in at least \u003cstrong\u003e125ml\u003c\/strong\u003e (increase to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal teas, milk, broth or fruit juice. The product does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take between meals.\u003c\/p\u003e\n\u003cp\u003eDue to its safety features, it allows for wide dosing flexibility.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdults and children weighing more than 20 kg:\u003c\/strong\u003e 10 g (1 sachet), 1-3 times a day, according to individual response. To obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (1 sachet) 1-2 times a day, even every other day, preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eChildren up to 20 kg:\u003c\/strong\u003e the dosage should be commensurate with body weight. We therefore recommend using the 200 g bottle of powder with measuring spoon, which allows you to customize the dose according to the child's real needs until soft stools are obtained. Do not exceed the maximum daily dosage of 30 g.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003eDo not take in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction.\u003c\/p\u003e\n\u003cp\u003eDuring pregnancy and breastfeeding the product must be used upon medical prescription.\u003c\/p\u003e\n\u003cp\u003eThere are no known interactions with drugs, but it is advisable to take the product at least 2 hours apart from that of oral drugs.\u003c\/p\u003e\n\u003cp\u003eOccasionally abdominal distension and\/or nausea may be noted, which resolve with continued use. Rare cases of allergic reactions (rash, urticaria): in this case, suspend use of the product and inform your doctor or pharmacist.\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, diarrhea may occur, which resolves spontaneously upon discontinuation of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g stored?\u003c\/h3\u003e\n\u003cp\u003eStore in the original packaging \u003cstrong\u003ecool and dry place\u003c\/strong\u003e. The expiry date indicated refers to the product in intact packaging and correctly stored.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer also declares, in the European registration of the device, to maintain the product \u003cstrong\u003ebelow 25 °C\u003c\/strong\u003e, in a dry place and away from direct sources of heat or light.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e30 sachets of 10 g.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Shedir Pharma","offers":[{"title":"Default Title","offer_id":54137682493767,"sku":"931774119","price":21.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/shedir-pharma-srl-unipersonale-clin-4000-30bust-farmacia-dottor-tili-1244017616.jpg?v=1781241477"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/collections\/Frame_53_36.svg?v=1784273869","url":"https:\/\/www.dottortili.com\/en-eu\/collections\/drugs-for-constipation-swelling-and-difficult-digestion.oembed?page=4","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}